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Abstract 
The differentiation of pluripotent stem cells (PSCs) to progenitors of the three germ layers mimics one of 
the earliest events in mammalian development and is regulated by an intricate network of transcription 
factors, RNA binding proteins (RBPs) and chromatin-remodeling complexes. Moreover, a handful of long 
non-coding RNAs (lncRNAs) were implicated in this process, however the vast majority of lncRNAs have 
not been analyzed, yet. Here, I demonstrated that nuclear lncRNAs, including NEAT1, which scaffolds 
membraneless condensates named paraspeckles, generally exhibited dynamic regulation during multi-
lineage differentiation of human PSCs. By analyzing paraspeckle formation in 24 human cell types, I 
revealed general traits such as nucleus size and differentiation characteristics that can explain the 
variability in paraspeckle numbers between cells within and across different cell populations. On a 
molecular level, paraspeckle formation is regulated by the RBP TDP-43 via post-transcriptional processing 
of NEAT1.  Furthermore, by treatment with DNA-binding chemotherapeutic reagents, which I showed for 
the first time to dissolve chromatin-bound lncRNA condensates, I determined that assembly of 
paraspeckles across the germ layers relies on DNA accessibility.   
 To interrogate the connection of paraspeckles and human embryonic development, I generated 
genetically-modified PSCs that exhibited altered expression of either one or both NEAT1 isoforms. The 
differentiation of these lines revealed that NEAT1_2, but not NEAT1_1, is fine-tuning the early 
differentiation process by maintaining the expression of pluripotency and differentiation genes, amongst 
others of the transcription factors NANOG and PAX6, which respectively sustain pluripotency or drive 
neural differentiation.  
 Finally, I dissected the function of paraspeckle core proteins SFPQ, NONO and PSPC1 in human 
PSCs. Whereas the knock-out of NONO and PSPC1 induced stem cell differentiation, the depletion of SFPQ 
is lethal for PSCs. Transcriptome analysis revealed that NONO regulates the expression of cholesterol-
producing enzymes, whereas PSPC1 is mainly involved in adipogenesis. Moreover, I identified SFPQ as 
part of the polyadenylation complex that regulates the expression of genes involved in cell cycle and 
homeostasis.  
Collectively, this study provides a comprehensive analysis of paraspeckle components during 
mammalian stem cell differentiation. Paraspeckles are paradigmatic for phase-separated, chromatin-
embedded condensates and principles of their formation, dynamics and perturbations by small molecules, 
which have been demonstrated here, might be exploited in medicine as many diseases are accompanied by 
accumulation of lncRNA condensates whose functions have not been overtly addressed, yet. 
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Zusammenfassung 
Die Differenzierung von pluripotenten Stammzellen (PSCs) zu Vorläufern der drei Keimblätter bildet eines 
der frühesten Ereignisse in der Säugetierentwicklung nach und wird durch ein kompliziertes Netzwerk an 
Transkriptionsfaktoren, RNA Bindeproteinen (RBPs) und Chromatinkomplexen reguliert. Außerdem 
wurden wenige lange, nicht-kodierende RNAs (lncRNAs) gefunden, welche diesen Prozess beeinflussen, 
allerdings sind die meisten lncRNAs noch nicht diesbezüglich analysiert worden. Ich demonstrierte hier, 
dass lncRNAs aus dem Zellkern, einschließlich NEAT1, welches das Gerüst für membranlose Kondensate 
namens Paraspeckles ist, dynamisch während der Zelldifferenzierung von humanen PSCs reguliert ist. 
Durch die Analyse von Paraspeckles in 24 humanen Zellarten habe ich allgemeine Merkmale wie 
Kerngröße und Differenzierungstatus entdeckt, welche die Variabilität bei der Anzahl der Paraspeckles 
zwischen verschiedenen Zelltypen erklären können. Auf molekularer Ebene werden Paraspeckles durch 
das RBP TDP-43 via post-transkriptioneller Prozessierung von NEAT1 reguliert. Desweiteren habe ich zum 
ersten Mal gezeigt, dass DNA-bindende Moleküle, welche zur Chemotherapie eingesetzt werden, 
Chromatin-gebundene lncRNA Kondensate auslösen können, woraus ich schloss, dass der Aufbau von 
Paraspeckles von der DNA Zugänglichkeit abhängt. 
 Um die Beteiligung von Paraspeckles an der humanen embryonalen Entwicklung herauszufinden, 
habe ich genetisch-modifizierte PSCs hergestellt, welche veränderte Expression von einer, oder beiden 
NEAT1 Isoformen aufweisen. Die Differenzierung dieser Zelllinien zeigte, dass NEAT1_2, aber nicht 
NEAT1_1, den frühen Differenzierungsprozess feintunen, in dem es die Expression von Pluripotenz- und 
Differenzierungsgenen aufrechterhält darunter die der Transkriptionsfaktoren NANOG und PAX6, welche 
entweder die Pluripotenz erhalten oder neurale Differenzierung vorantreiben.  
 Abschließend habe ich noch die Funktion der Paraspecklekernproteine SFPQ, NONO und PSPC1 
in humanen PSCs untersucht. Während der Knockout von NONO und PSPC1 die Differenzierung von 
Stammzellen induziert, ist die Ausschaltung von SFPQ tödlich für PSCs. Die Transkriptomanalyse zeigte, 
dass NONO die Expression von Cholesterin-produzierenden Enzymen reguliert, während PSPC1 
hauptsächlich die Adipogenese beeinflusst. Zusätzlich identifizierte ich SFPQ als Teil des 
Polyadenylierungskomplexes, welcher die Expression von Zellzyklus- und Homöostasegenen reguliert. 
 Zusammengefasst stellt diese Studie eine vollständige Analyse von Paraspecklekomponenten 
während der Differenzierung von Säugetierstammzellen dar. Paraspeckles stehen paradigmatisch für 
Phasen-getrennte, Chromatin-gebundene Kondensate und die hier demonstrierten Prinzipien ihrer 
Bildung, Dynamik und Veränderungen durch kleine Moleküle könnten für medizinische Zwecke genutzt 
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werden, da viele Krankheiten die Akkumulation von lncRNA Kondensaten aufweisen, deren Funktionen 
bis jetzt noch nicht genau adressiert wurden. 
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1. Introduction 
1.1 Exordium 
The central question of developmental biology is as follows: how can a multicellular organism with trillions 
of highly specialized cells arise from a single cell that is created after the fusion of male and female gametes? 
The importance of addressing this question is highlighted  by the fact that 6% of infants born worldwide 
exhibit serious birth defects caused by genetic or environmental abnormalities during gestation [1]. The 
desire to control and correct potential threats for the embryo even beyond ethical boundaries was recently 
demonstrated by genetic germline manipulation using the CRISPR/Cas9 system to mutate HIV-targeted 
receptors in the human embryo [2]. Moreover, many parents need to turn to assisted reproductive 
technology, such as in vitro fertilization (IVF), to conceive a child. Even though seminal progress was made 
during the past decades, the success rate of IVF is still relatively low and a better understanding of human 
embryonic development is required to increase chances of a successful pregnancy [3]. 
Developmental studies in humans have been historically difficult due to limited access to material, 
however, a milestone was reached with the successful isolation and cultivation of human embryonic stem 
cells (hESCs) [4] that recapitulate the early pluripotent state during development when the cells are still 
capable to differentiate to all cell types of the human embryo. In the following sections, I will introduce 
principles of human development with focus on pluripotent stem cells (PSCs) that are widely used, also in 
this study, as paradigm for human early embryogenesis.  
 
1.2 The early stages of human embryonic development 
Embryonic development begins with the fusion of sperm cell and oocyte, followed by reprogramming of 
both gametes into the totipotent zygote that can give rise to all embryonic cell types and extraembryonic 
tissue. While the transcriptional program controlling this process relies initially only on maternally 
provided mRNAs, this changes during maternal-to-zygotic transition, a process that is conserved in all 
animal clades, during which the zygotic genome is activated [5]. After a series of cellular divisions, the 
blastocyst is formed 5 days post fertilization (Fig. 1), a process with a success rate of only 50% [6]. The 
blastocyst contains two types of cells, one surrounding cell layer, the trophectoderm, which will form the 
placenta, and the inner cell mass (ICM) that contains the founder cells for the embryo, namely pluripotent 
stem cells.   
The next milestone during embryonic development is the implantation of the blastocyst into the 
uterine wall, which is an intricate process that relies on successful execution of the following steps: a) 
hormone-controlled formation of a receptive uterus, b) escape of the blastocyst from their outer shell (zona 
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pellucida), c) apposition and adhesion of the blastocyst to the uterine wall and finally, d) the invasion of 
fetal trophoblast cells with the reconstruction of maternal spiral arteries to ensure blood flow between 
mother and fetus [7]. The timing of implantation is not conserved and occurs in H.Sapiens 6 to 12 days after 
fertilization [8].  
After implantation, gastrulation, the process of germ layer development, is initiated by formation 
of the primitive streak, which arises from a two-dimensional layer of ICM-originating cells, the epiblast 
cells, that undergo epithelial-to-mesenchymal transition (EMT) to form the mesoderm and endoderm [9]. 
Conversely, neural cells arise from the ectodermal cell layer that is positioned directly above the notochord, 
a cylindrical accumulation of mesoderm cells that extends from the posterior to the anterior axis [10]. These 
processes lay the groundwork for subsequent patterning and development of functional organs, which 
begins between gestational weeks 3 and 8 and lasts until and beyond birth [11]. 
 
Figure 1: Scheme of the first stages of embryonic development. Features that are concomitant with 
blastocyst formation. Adapted from [12]. 
 
1.3 Modeling embryonic development with pluripotent stem cells 
The study of human embryonic development is hindered by ethical concerns regarding the usage of human 
embryos as a research object [13], however, these concerns were to some extent circumvented by the 
successful isolation and cultivation of human embryonic stem cells from the ICM of IVF embryos that 
would have been discarded otherwise [4]. With hESCs, it is now possible to mimic germ layer formation in 
vitro, which has fueled a plethora of studies to understand the molecular mechanisms of human pre- and 
post-implantation development. Most notably, studies have identified the core transcriptional network 
underpinning pluripotency maintenance, which is composed of the genes OCT4 (POU5F1), SOX2 and 
NANOG. All three factors co-localize at the chromatin to collectively stabilize the pluripotent state [14]. 
Both SOX2 and OCT4 protein production is tightly regulated and expression changes of either one induces 
stem cell differentiation in mouse ESCs (mESCs) [15], [16]. The pluripotency factors work not in isolation 
but are associated with many other factors, including ESRRB, REX1 and SALL4 that have been identified 
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and extensively characterized by proteomic pull-down and chromatin immunoprecipitation studies [17]. 
Collectively, the OCT4/SOX2/NANOG complex binds to roughly 600 genes that are part of the extended 
network of pluripotency [18]. The acquired knowledge of the core transcriptional program in ESCs was 
exploited in a seminal study by Yamanaka and colleagues, who overexpressed Oct4, Sox2, Klf4 and Myc 
(now known as Yamanaka factors) to reprogram somatic mouse fibroblasts to induced pluripotent stem 
cells (iPSCs) [19]. This was recapitulated shortly after in human cells by replacing KLF4 and MYC with 
NANOG and the RNA binding protein LIN28A [20]. Nowadays, iPSCs are widely used as a research 
paradigm to model embryonic development and as a therapeutic tool to understand, recapitulate and 
correct genetic diseases [21].  
 
1.3.1 Extrinsic factors regulating PSC maintenance 
OCT4, SOX2 and NANOG expression relies on an intricate network of signaling pathways fueled by 
extrinsic factors that are added to the culture medium. Here, profound differences in the maintenance of 
human and mouse ESCs are observed. Activation of the JAK/STAT signaling pathway by the addition of 
leukemia inhibitory factor (Lif) is instrumental to propagate mouse ESCs. Furthermore, two inhibitors of 
the mitogen-activated protein kinase (MAPK) and the glycogen synthase kinase 3β (GSK3β) are required 
to keep mESCs in a stable pluripotent state [22].  
In contrast, the ligands ACTIVIN and NODAL were shown to maintain pluripotency 
characteristics of human ESCs by activation of the transcription factors SMAD2/3 that bind to promoters of 
the master pluripotency genes OCT4 and NANOG [23]. Moreover, the use of FGF2 is crucial for the 
maintenance of hESCs by activating the RAS-MAPK, PI3K-AKT, PLCγ and STAT intracellular signaling 
pathways [24]. The differences in stem cell maintenance have fueled the discussion whether mouse and 
human ESCs are molecularly related, or in fact represent two different stages of development [25]. 
 
1.3.2 Naïve and primed ESCs 
Although ESCs of human or mouse origin were both isolated from the ICM of a developing blastocyst, they 
depict clear molecular differences. Studies have shown that mESCs are in a “ground”, or naïve state of 
pluripotency, which is defined by various naïve marker genes, and most importantly the state prior to X-
chromosome inactivation (XCI) that takes place after blastocyst implantation. Contrarily, hESCs are 
considered to be in a primed state of pluripotency, analogous to mouse epiblast stem cells that can be 
induced from mESCs by removal of LIF and addition of ACTIVIN and FGF [26]. Besides culture 
requirements, hESCs differ from mESCs in their morphology (flat vs. dome-shaped), transcriptional profile 
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(similar to mouse epiblast stem cells) and X-chromosome activation status (X-chromosome is already 
silenced). Furthermore, naïve cells primarily employ mitochondrial respiration for energy generation, 
whereas primed cells rely on glycolysis [27], [28]. During the last 5 years, numerous studies were published 
that reported the conversion of human primed to naïve ESCs by using a cocktail of small molecules. All 
protocols are derived from the 2i/Lif culture condition for mESCs, however mostly with the supplement of 
additional inhibitors or growth factors such as, but not limited to, BMP4 and JNK inhibitors in combination 
with FGF2 or ACTIVIN [29]. Nevertheless, all studies report somewhat different gene expression profiles 
and morphology of naïve hESCs, hence the molecular profile of naïve hESCs is still controversial, as well 
as to what extent they are similar to mESCs [30]. 
 
1.3.3 Germ layer differentiation of pluripotent stem cells 
The power of PSCs is undoubtedly their ability to differentiate into virtually any cell type, which opens the 
door for potential therapeutic applications. A myriad of studies has been published in the last 3 decades 
that describe differentiation protocols for the generation of various cell types from PSCs. Generally, three 
main signaling pathways are targeted to induce germ layer differentiation. Endoderm differentiation relies 
on hyperactivation of the ACTIVIN/NODAL signaling pathway [31], whereas mesoderm commitment can 
be achieved by activation of the WNT pathway through inhibition of GSK3β which, as consequence, 
increases the concentration of free β-CATENIN, the signal transducer of the WNT pathway [32]. In contrast, 
neuroectoderm development is commonly induced by inhibition of the TGFβ pathway including besides 
the ACTIVIN clade, the BMP4 signaling cascade [33]. Combinatorial treatment with distinct cytokines, 
often for many months, leads to differentiation of more sophisticated cell types, such as motor neurons 
[34], astrocytes [35], nephrons [36], hepatocytes [37] and others, which were also generated for this study.  
 
1.4 RNA binding proteins regulate pluripotency-differentiation transition 
Transcriptional and epigenetic mechanisms that govern stem cell maintenance and differentiation have 
been extensively researched, however, more recently, many RNA binding proteins (RBPs) were identified 
to be instrumental for pluripotency maintenance, mainly by regulating co- or post-transcriptional processes 
(Fig. 2). The fate of an mRNA molecule is tightly controlled by various means, including transcription 
initiation, capping, polyadenylation, splicing, export, translation and degradation [38], all processes that 
are regulated by RBPs. Transcriptome comparison across 31 different tissues showed that 6% of RBPs 
exhibit tissue specificity [39], and thus are able to regulate cell type-specific post-transcriptional events, 
which makes RBPs a versatile tool for the control of cell fate decisions.  
1. Introduction 
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1.4.1 Alternative splicing is crucial for pluripotency maintenance 
Historically, alternative splicing has been linked first to the maintenance of ESCs and many pluripotency 
factors, including OCT4, SALL4, TCF3, NANOG and DNMT3B contain various splice isoforms that exhibit 
differences in their ability to maintain pluripotency [40]. This was further demonstrated by the 
identification of an ESC-specific isoform of the transcription factor FOXP1, which is regulated by alternative 
splicing of exon 18b, that confers changes in DNA binding capability of FOXP1 between pluripotent and 
differentiated cells [41]. Recently, a handful of RBPs were found to regulate alternative splicing in ESCs, 
thereby functioning either as positive or negative regulators of pluripotency. Genome-wide RNAi screens 
for pluripotency factors resulted in the identification of the spliceosome-associated RBP SON, which 
regulates splicing of pluripotency genes in hESCs [42]. Conversely, MBNL1 represses the pluripotency state 
in ESCs, mainly by inhibiting inclusion of exon 18b of FOXP1, thus changing its transcriptional circuit 
towards a differentiation program [43].  
 
1.4.2 The alternative polyadenylation profile changes during stem cell differentiation 
Besides alternative splicing, changes in the mRNA sequence can be mediated by alternative 
polyadenylation (APA), a process which amongst others, leads to changes in the length of the 
3`untranslated region (UTR) [44]. Technologies for mapping and identification of APA sites significantly 
improved over the last years and demonstrated that approximately 70% of all transcripts undergo APA 
[45]. Differentiation of PSCs and conversely, the reprogramming of fibroblasts, is accompanied by 
respective lengthening or shortening of 3`UTRs, providing an intriguing connection between APA and the 
pluripotency-differentiation transition. A mechanistic link between APA and stem cell differentiation has 
been lacking, until Lackford and colleagues showed that FIP1, a subunit of the canonical cleavage and 
polyadenylation specificity factor (CPSF), is important for self-renewal of mESCs. The authors 
demonstrated that Fip1 is developmentally regulated and changes the polyadenylation pattern of several 
hundred genes, many of which are important for embryonic development [46]. Along these lines, we have 
recently identified TDP-43 as an important regulator of stem cell differentiation and somatic 
reprogramming. TDP-43 is a multifunctional RBP that is highly expressed in ESCs but down-regulated 
upon differentiation. We showed that many pluripotency factors change their polyadenylation profile 
upon TDP-43 depletion, in a manner that is similar to the changes that occur during differentiation. This 
was confirmed by the identification of TDP-43 binding sites at UG-repeats surrounding the 
polyadenylation site of deregulated transcripts, which include amongst others the mRNA of the master 
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pluripotency factor SOX2. Together, we found that TDP-43 is important for pluripotency-differentiation 
transition in m/hESCs by regulating APA of many pluripotency-associated transcripts [47]. 
To summarize, a growing body of literature underscores the importance of RBP-mediated post-
transcriptional gene regulation for stem cell maintenance and differentiation (Fig. 2). 
 
Figure 2: RNA binding proteins mediate the pluripotency-differentiation transition. Adapted from [48]. 
 
1.5 Long non-coding RNAs are new players in embryonic development 
Long non-coding (lnc) RNAs represent a class of non-coding RNAs that have a profound impact on cell 
fate decisions [49]. More than 50000 lncRNAs have been detected in H.Sapiens, defined by having a  length 
of >200 nucleotides, however only ~1000 exhibit a moderate-to-high expression level, out of which, 300 are 
conserved across mammals and other vertebrate species [50]. LncRNAs are typically shorter, have fewer 
exons and are one order of magnitude lower expressed than mRNAs. Moreover, they tend to be more 
temporarily and spatially regulated and evolve much faster compared to mRNAs, which is manifested by 
the lack of homologs for many lncRNAs [51]. LncRNAs can adapt a complex secondary or higher-ordered 
structure to orchestrate binding of RBPs [49]. There are nuclear lncRNAs that have been implicated in 
guiding chromatin modifiers to mediate transcription and cytoplasmic lncRNAs that control stabilization 
and mRNA translation [49]. 
Nuclear lncRNAs can be broadly distinguished in cis- and trans-acting lncRNAs depending on 
their mode of action which is either confined to the lncRNA gene locus (cis) or to a distal gene locus (trans) 
[52] (Fig. 3). Examples of cis-acting lncRNAs include Xist and Kcnq1ot1, which have been implicated 
respectively in X-chromosome inactivation and genomic imprinting. Xist is transcribed from the X-
chromosome to which it binds to initiate the formation of transcriptionally inactive heterochromatin [53]. 
Interestingly, Xist itself is regulated by lncRNAs such as its antisense non-coding transcript Tsix, which 
represses Xist expression by inducing epigenetic modifications at its promoter, and Jpx, which acts as an 
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activator of Xist by sequestration of the transcriptional repressor CTCF [54]. A similar mechanism was 
shown for Kcnq1ot1, which is required for genomic imprinting, the gene silencing mechanism of only one 
parental chromosome during gametogenesis [55].  
Moreover, lncRNAs are involved in the regulation of HOX genes, which are instrumental for 
spatiotemporal control of body axis formation [56]. A lncRNA that regulates HOX gene expression in cis is 
HOTTIP, which recruits the histone complex MLL1 and activates distal HOX gene promoters [57]. HOX 
genes are also regulated in trans by the lncRNA HOTAIR, which interacts with repressive histone-
modifying complexes and recruits them to specific target genes [58].  
Furthermore, many lncRNAs have been implicated in organogenesis, including braveheart and 
Fendrr, which are required for coordinated heart development [59], [60], H19, which sequesters miRNA let-
7 to regulate muscle differentiation [61] and TINCR, which is required for keratinocyte differentiation, 
likely by binding to STAU1 and stabilizing differentiation-associated transcripts [62]. Similarly, brain 
development is affected by lncRNAs such as Malat1, a conserved, abundant lncRNA that regulates synapse 
formation in cultured mouse hippocampal neurons [63] and Dlx6os1, which mediates expression of 
neighboring Dlx genes that are important for forebrain development [64].  
Lastly, genome-wide mapping of chromatin marks of actively transcribed genes outside of known 
protein-coding genes revealed that PSCs express thousands of lncRNAs [65]. A comprehensive loss-of-
function screen of 147 lncRNAs by Guttman and colleagues showed that many of them affect the 
pluripotency characteristics of mESCs [66], however, lacking mechanistic insights and how this relates to 
human differentiation. Some of these lncRNAs are controlled by OCT4 or NANOG, for instance MIAT and 
AK141205, which in turn regulate pluripotency maintenance [67]. Moreover, lncRNA TUNA maintains 
mESCs by interaction with RBPs that bind to the promoters of the pluripotency factors Nanog, Sox2 and 
Fgf4 [68]. In hESCs, the lncRNA lncPRESS1 was shown to interact with the histone H3 deacetylase SIRT6 
to prevent its access to chromatin, thus maintaining histone acetylation at promoters of pluripotency genes 
[69]. Moreover, the lncRNAs lncRNA-ES1 and lncRNA-ES2 are abundantly expressed in hESCs, where they 
interact with the repressive Polycomb protein SUZ12 and the pluripotency factor SOX2 to block neural 
differentiation [70]. Another example includes linc-RoR which is enriched in iPSCs and sequesters miRNA-
145 to impair differentiation [71]. There are also developmentally regulated lncRNAs such as DIGIT and 
TERRA that are respectively up-regulated during endoderm differentiation [72] or down-regulated upon 
exit from pluripotency [73], however it is not clear whether they have a function during this process.  
1. Introduction 
17 
 
To summarize, there are several lncRNAs that regulate gene expression during mammalian development, 
nevertheless, the function of many lncRNAs remains uncharacterized, especially in human cell types, 
which is one objective of this thesis.  
 
Figure 3: The mode-of-action of nuclear lncRNAs. Nuclear lncRNAs are classified into cis- (A) and trans-
acting (B), depending on whether they mediate gene expression of neighboring or distal genes, 
respectively. Modified from [49]. 
 
1.6 Membraneless organelles are phase-separated entities 
Many RBPs and lncRNAs exhibit spatial organization by aggregation into higher-ordered, macromolecular 
structures, often referred to as granules, membraneless organelles or condensates, which are prevalent in 
the nucleus (for example: nucleoli, Cajal bodies, gems, speckles, paraspeckles, histone-locus bodies, 
promyelocytic leukemia (PML) bodies) and the cytoplasm (for example: P-bodies, stress granules, germ 
granules, RNA transport particle) [74]. Due to the lack of a confining membrane, these granules are highly 
dynamic and able to react rapidly to environmental changes in order to spatiotemporally control 
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biochemical reactions. In contrast to membrane-surrounded organelles, it is still unsettled how formation 
and maintenance of membraneless organelles is achieved [75]. Hyman and colleagues demonstrated in a 
seminal publication that P-bodies in C.elegans have fluid-like properties, as they are spherical, can be 
deformed under stress and recover quickly after laser-induced photobleaching of a fluorescently-labeled 
P-body protein [76]. By now, many other membraneless organelles were identified to behave like “liquid 
droplets”, amongst others nucleoli [77], stress granules [78] and the centrosome [79]. The liquid-like 
property was postulated for other granules as well, however, a rigorous experimental assessment is yet 
awaiting.  
Based on their properties, it was proposed that membraneless aggregates form by liquid-liquid 
phase separation, a process which is analogous to an oil-water vinaigrette, where after vigorous mixing, oil 
and water remain separated in two phases. Whereas entropy would favor a mixing of the two substances, 
homophobic interactions between the molecules lead to a system with  lower free energy, thereby inhibiting 
the mixing process [75]. A similar process was proposed for the aggregation of RBPs, which often possess 
intrinsically-disordered domains that mediate intermolecular interactions [74]. Recent developments 
indicate that also the formation of heterochromatin is driven by phase separation [80].  
To summarize, the process of phase separation is an emerging concept in cell biology by which the 
formation of membraneless granules is explained, which happens mainly through interactions of molecules 
with similar biophysical properties.  
 
1.7 Composition and function of paraspeckles 
One type of granule that is thought to assembly by liquid-liquid phase separation are nuclear paraspeckles 
[81]. In 2002, paraspeckles were identified by Archa Fox and colleagues who performed a proteomic screen 
for nucleoli proteins and found the RBPs SFPQ and PSPC1 that form distinct nuclear foci in close proximity 
to splicing speckles [82].  Almost a decade later, a comprehensive screen for paraspeckle components was 
performed, extending the repertoire of known paraspeckle proteins to 40 members [83] (Fig. 4A). 
Intriguingly, paraspeckles contain mainly RBPs with annotated function in mRNA processing, which 
makes them a potential hub for co- and post-transcriptional processes [84].  
Besides proteins, various types of RNAs are enriched in paraspeckles (summarized in Fig. 4B), 
most notably, the lncRNA NEAT1 [85]–[88]. The NEAT1 gene produces a short and a long isoform, from 
here on referred to as NEAT1_1 (3.7 kb) and NEAT1_2 (23 kb), previously known as MENε/β. Both are 
single exon RNAs, however with different modes of terminal end processing. While NEAT1_1 is 
polyadenylated, NEAT1_2 contains a triple helix t-RNA-like structure at its 3`end, a feature that is shared 
1. Introduction 
19 
 
with 129 other lncRNAs in vertebrates [89]. Electron microscopy and super-resolution studies have 
uncovered that NEAT1_1 and the 3`and 5` arms of NEAT1_2 are located at the outer shell of paraspeckles 
while the middle segment of NEAT1_2 is positioned in the paraspeckle center [90], [91] (Fig. 4C). 
Paraspeckle proteins exhibit a similar spatial relationship [91], which provides evidence that paraspeckles, 
similar to other phase-separated entities like germ granules [92], stress granules [93] and nucleoli [94] 
contain sub-compartments that might assume different functions within the granule. By differential over-
expression of short and long NEAT1 isoform, it was shown that only NEAT1_2 is crucial for paraspeckle 
formation [85], [86]. While NEAT1_2 is solely localized in paraspeckles, NEAT1_1 can also occupy space 
outside of paraspeckles, where it mostly exists as single molecules, however, it is unknown, whether 
NEAT1_1 has paraspeckle-independent functions [95].  
In mammalian cells, transcription of NEAT1_2 is regulated by an intricate network of RBPs that 
bind to the NEAT1 polyadenylation site. By mutating binding sites of the polyadenylation complex CFIm 
and the RBP hnRNPK, Naganuma and colleagues showed that the former is inducing polyadenylation, 
thereby producing NEAT1_1, while binding of the latter prevents polyadenylation by capturing and 
inactivating a subunit of the CFIm complex, consequently leading to transcription of NEAT1_2 [83]. 
Following those events, the essential paraspeckle proteins SFPQ and NONO bind to the nascent NEAT1_2 
transcript and stabilize it. More paraspeckle proteins are recruited that are likely responsible for 
compaction and keeping all proteins in place before transcription of NEAT1_2 is terminated and a mature 
paraspeckle diffuses away from the transcription start site [81]. 
 
Figure 4: A scheme of paraspeckle components. A) A summary of paraspeckle proteins as listed before 
[81] including AGO1 and CARM1 that have been identified, recently [91], [96]. Proteins in red are 
mentioned more in detail in this study. B) A summary of paraspeckle RNA components. Adapted from 
Fox et al. [81] and including lincRNA-p21 and mitochondrial mRNAs, which were recently found to be 
localized in paraspeckles [97], [98]. C) A schematic depiction of the paraspeckle substructure as shown 
before [91]. 
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1.7.1 Molecular mechanism of paraspeckles 
The last decade of research uncovered three main mechanisms of how paraspeckles exert their function, 
which is either by retention of RNA, sequestration of proteins or binding to chromatin, or likely a 
combination of all three mechanisms (Fig. 5).  
 
1.7.1.1 RNA retention 
RNA retention was shown first for the RNA CTN, which is the 3`UTR-extended isoform of the mouse 
cationic amino acid transporter 2 (mCat2) mRNA. While the long CTN-RNA is retained in the nucleus, it 
is endonucleolytically cleaved upon stimulation of interferon gamma or polysaccharide receptors, for 
instance during viral infection. This results in the production of the shorter mCat2 mRNA, which is 
exported to the nucleus and translated [99]. There is evidence that nuclear RNA retention is triggered by 
binding and sequestration of the core paraspeckle protein NONO to hyper-edited stretches within an RNA. 
RNA editing is defined as the change of the RNA sequence, for instance  by an adenosine-to-inosine switch 
that is mediated by the enzyme ADAR via adenosine deamination [100]. ADAR-mediated editing occurs 
primarily on double-stranded RNA sequences, likely as part of an immune response to target viral double-
stranded RNA for degradation [101]. Recent computational analysis showed that humans contain 333 
mRNAs with putative double-stranded regions, which are mostly originating from primate-specific short 
interspersed elements (SINEs), so-called Alu elements that comprise 11% of the human genome [102]. 
Inverted repeat Alu elements in an mRNA can base-pair and form double-stranded regions that are 
targeted by ADAR and then potentially bound by NONO and retained in paraspeckles. Evidence for this 
hypothesis was provided by Chen and colleagues who fused GFP reporter mRNAs with inverted Alu 
repeat elements and observed their translocation to paraspeckles [103]. 
Besides Alu-element containing mRNAs, pull-down studies of Neat1-associated RNAs revealed 
that paraspeckles in murine cells contain AG-rich, intronic RNA sequences [91]. A similar study in human 
U2OS and HEK293 cells uncovered that mRNAs encoding for mitochondrial genes were found in 
paraspeckles, which was shown to be the mechanism for cross-talk between paraspeckles and 
mitochondria [97]. Given the little overlap in the identified RNA species between those studies, it is likely 
that the RNA repertoire of paraspeckles is dynamic and dependent on the cellular context.  
 
1.7.1.2 Protein sequestration 
Paraspeckles, similar to many other membraneless organelles [104], can sequester proteins and by this alter 
or inactivate their function in the nucleus. A particularly well-studied example is the translocation of the 
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core paraspeckle protein SFPQ from the nucleoplasm to paraspeckles in HeLa cells that were transfected 
with poly I:C double-stranded RNA, which mimics viral infection and increased the formation of 
paraspeckles. ChIP-qPCR analysis indicated that SFPQ binds and represses IL-8, a major immunological 
response gene [105]. The authors propose a model where virally-induced paraspeckle formation triggers 
SFPQ relocation from chromatin to paraspeckles, which in turn leads to expression of IL-8 for appropriate 
viral response. A question that is rarely addressed is how much protein is sequestered to paraspeckles and 
whether this is meaningful, considering that SFPQ and other paraspeckle proteins are also found in the 
nucleoplasm. Hirose et al. estimated that inhibition of the proteasome activity, which induces NEAT1 
expression, resulted in relocation of 50% of nucleoplasmic SFPQ and NONO to paraspeckles. They showed 
that SFPQ is required for expression of RNA-specific adenosine deaminase B2 (ADARB2), which 
consequently, is down-regulated upon proteasome inhibition and SFPQ translocation [106]. Furthermore, 
it was shown that SFPQ and NONO bind to many primary miRNA transcripts in the nucleus, which 
enhanced their processing by the Drosha-DGCR8 microprocessor complex. The authors demonstrated that 
NEAT1_2 sequesters SFPQ, NONO and the microprocessor, which is required for effective pri-miRNA 
processing, thereby providing a mechanistic link for many previous studies that described aberrant miRNA 
expression upon NEAT1 misregulation in various cancer cells [107]. 
 
1.7.1.3 Chromatin binding 
Many lncRNAs exert their function by direct binding to DNA and attracting chromatin-remodeling 
complexes [108]. Using complementary capture oligonucleotides, West et al. identified binding sites of 
NEAT1 at hundreds of genomic loci, the majority of which are positive for H3K4me3, a marker of actively 
transcribed genes and interestingly also co-occupied by MALAT1, a lncRNA that is located next to NEAT1 
in the genome [109]. This indicates that NEAT1 acts as sponge for chromatin regulators and might even be 
involved in the spatial organization of the chromatin. Indeed, the catalytic subunit of the SWI/SNF complex 
BRG1 was found to be associated to paraspeckles [110] and it was shown that nuclear AGO1 is sequestered 
in paraspeckles where it is involved in maintaining chromatin organization [96]. Recently, it was reported 
that NEAT1 undergoes triple helix formation with the double-stranded DNA via Hoogsteen base-pairing, 
suggesting that the mode of binding is sequence-mediated [111].  
To summarize, paraspeckles have vast possibilities to alter gene expression and it remains to be 
analyzed for each cell type individually, whether regulation of RNA, protein or chromatin is the prevalent 
mode-of-action of paraspeckles. 
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Figure 5: A schematic overview of the molecular functions of paraspeckles. References are listed in the 
section above. 
 
1.7.2 Paraspeckles in development and disease 
Countless studies have demonstrated the up-regulation of paraspeckles in various disease models and in 
certain stages of development (Fig. 6), however, addressing mostly correlation and failing to establish 
causative relationships. The following sections outline the physiological functions of paraspeckles in 
mammals. 
 
1.7.2.1 Paraspeckles in development 
The first link of paraspeckles to developmental processes was established after demonstrating their up-
regulation during differentiation of myoblasts to myotubes, a study that identified NEAT1 as the core 
component of paraspeckle [87]. Following the generation of Neat1-/- mice, Nakagawa and colleagues 
observed that the number of parturitions from female Neat1-/- were reduced by 50%, concomitant with 
reduced litter size and serum progesterone levels [112].  The latter is a hormone that is produced in the 
ovarian corpus luteum, a tissue that contains many paraspeckles and which was disrupted in Neat1-/- mice. 
A thorough dissection of Neat1 dynamics in pre-blastocyst development revealed that in mice, paraspeckles 
are highly up-regulated during the 4-cell developmental stage before being down-regulated upon 
blastocyst formation [113]. The authors showed that paraspeckles contain the arginine methyltransferase 
CARM1, which is instrumental for the arginine methylation of histone H3, an activating mark for the 
development of embryonic rather than extra-embryonic tissue [114]. Over-expression or down-regulation 
of Carm1 inhibited aggregation of the core paraspeckle constituent NONO and conversely knock-down of 
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Neat1 reduced CARM1 speckles in the 4-cell embryo. Intriguingly, down-regulation of Neat1 or Nono 
resulted in a developmental arrest at the 16- or 32-cell stage, which the authors explained by up-regulation 
of Cdx2, a transcription factor that is crucial for the development of extra-embryonic tissue. While this study 
showed convincingly the contribution of Neat1 to pre-blastocyst development, the function and dynamics 
of paraspeckles in gastrulation remains enigmatic and is one objective of this study.  
 
1.7.2.2 Paraspeckles in disease 
1.7.2.2.1 Paraspeckles in cancer 
Whereas the developmental aspect of paraspeckles is understudied, many publications established a link 
between paraspeckle formation and disease progression (Fig. 6). Undeniably, the bulk body of literature 
focuses on paraspeckle contribution in cancer. Up to now, studies showed elevated NEAT1 expression in 
the following tumors: lung cancer, esophageal squamous cell carcinoma, laryngeal squamous cell 
carcinoma, oral squamous cell carcinoma, nasopharyngeal carcinoma, endometrial cancer, 
cholangiocarcinoma, colorectal cancer, hepatocellular cancer, breast cancer, ovarian cancer, prostate cancer, 
pancreatic cancer, thyroid carcinoma, osteosarcoma, renal cell carcinoma and glioma [115], [116]. These 
studies suggested that for many cancer types, NEAT1 could serve as a prognostic biomarker whose up-
regulation indicates poor patient outcome. The causes of NEAT1 up-regulation are diverse and range from 
an increase in copy numbers [115], mutations of the NEAT1 promoter [117] and transcription factors that 
target the NEAT1 locus such as hypoxia-inducible factor 2 (HIF-2) [118] and RUNX1 [119]. Moreover, it 
was shown that the EGFR signaling pathway with its downstream effectors STAT3 and NF-ƙB activates 
the NEAT1 promoter in glioblastoma [120]. Adriaens et al. recently demonstrated that the tumor suppressor 
gene p53 induces paraspeckle formation in skin fibroblasts and that silencing of NEAT1 impaired skin 
tumorigenesis [121]. Mechanistically, it was shown that NEAT1 sponges and inhibits many miRNAs, which 
leads to increased cell proliferation, migration, invasion, EMT and chemoresistance [115]. Moreover, 
NEAT1 binds EZH2, a subunit of the polycomb repressive complex and change expression of its 
downstream targets [122]. While these studies clearly emphasize the role of NEAT1 as oncogene, there is 
also evidence that NEAT1 acts as tumor suppressor in acute promyelocytic leukemia where NEAT1 is 
significantly down-regulated compared to healthy subjects. This discrepancy might be due to the different 
environment in solid tumors relative to cancer arising from the blood [116].  
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1.7.2.2.2 Paraspeckles during viral infection 
The infection with RNA viruses including Japanese encephalitis, HIV, rabies, influenza, Hantaan and 
herpes simplex virus (HSV) is concomitant with up-regulation of NEAT1 [123]. Hantaan virus induces 
NEAT1 by the RIG-I signaling pathway and establishes a feed-forward loop by sequestration of paraspeckle 
core protein SFPQ, which in turn cannot exert its inhibitory effect on RIG-I expression, thus leading to more 
paraspeckles [124]. A different mechanism was demonstrated for HIV-1 infection where NEAT1 retains 
HIV-1 mRNAs in the nucleus and a down-regulation of NEAT1 is accompanied by enhanced virus 
replication [125]. NEAT1 was also attributed with pro-viral activities as shown in HSV whose DNA is 
bound by the paraspeckle proteins PSPC1 and NONO to facilitate the interaction between STAT3 and viral 
gene promoters, which increased viral infection [126]. To summarize, it depends on downstream 
mechanisms whether NEAT1 is pro- or antiviral, which is reminiscent to the function of paraspeckles in 
cancer [123]. 
 
1.7.2.2.3 Paraspeckles in neurodegenerative diseases 
Finally, paraspeckle formation was linked to the onset or progression of diverse neurodegenerative 
diseases. Whereas healthy neurons are devoid of paraspeckles, Nishimoto and colleagues found 
paraspeckles in spinal motor neurons from patients with the sporadic form of amyotrophic lateral sclerosis 
(ALS) [127]. This was supported by similar findings in familial ALS caused by mutations in the C9ORF72 
and TARDBP genes. Likely, the increase in paraspeckles is due to nuclear depletion and inactivation of 
TDP-43, which we and others have shown to regulate NEAT1 expression [128] and which happens in 95% 
of all sporadic ALS patients. Of note is that 8 out of 25 proteins, genetically associated with ALS, are 
paraspeckle proteins. These proteins can be mutated and sequester other paraspeckle proteins, thereby 
disrupting proper paraspeckle-mediated signaling in ALS [129]. Furthermore, NEAT1 up-regulation was 
observed in Parkinson`s [130], Huntington`s [131] and Alzheimer`s disease [132], however the mechanistic 
impact of paraspeckles in these pathologies remains to be studied. 
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Figure 6: A summary of conditions and diseases that are concomitant with up-regulation of NEAT1. 
References are listed in the text above.  
 
1.8 DBHS proteins are involved in transcriptional and post-transcriptional gene regulation 
DBHS proteins were the first components identified in paraspeckles [133]. Humans express three members 
of the DBHS protein family, namely SFPQ (PSF), NONO (p54nrb) and PSPC1 (PSP1), which all contain 
conserved RNA recognition domains (RRMs), a NonA/paraspeckle domain (NOPS) and a C-terminal 
coiled-coil domain (Fig. 7) [134]. Importantly, DBHS proteins rarely act alone but are able to homo- and 
heterodimerize with each other via reciprocal interaction of RRM2, NOPS and coiled-coil domains of both 
proteins, thereby forming a globular structure with extended coiled-coil domains [135]. Recently, Lee et al. 
showed that the coiled-coil extension is used as oligomerization site of many DBHS protein dimers, which 
is crucial for paraspeckle formation [136]. On some occasions, the loss of one DBHS protein can be 
compensated, for instance by up-regulation of Pspc1 in Nono-/- mouse fibroblasts to form a functionally 
intact heterodimer with SFPQ [135]. On the other hand, cognitive disabilities in mice are a result of NONO 
depletion and cannot be compensated by SFPQ [138] and similarly, knock-down of PSPC1 in HeLa cells is 
not compensated by SFPQ and NONO and results in reduced cell proliferation and increased DNA damage 
[139].  It should be emphasized that many studies did not discuss the possibility of heterodimerization and 
focused only on the function of one DBHS protein. Nevertheless, important insights into molecular 
functions of DBHS proteins were generated in those studies, which are summarized in the next paragraphs. 
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Figure 7: Protein domains of DBHS family members SFPQ, NONO and PSPC1. Adapted from Knott et 
al. [135]. Low complexity domains are indicated in dashed boxes, as well as the uncharacterized DNA 
binding domain in SFPQ. Numbers indicate amino acid boundaries in H. sapiens. 
 
1.8.1 Molecular functions of DBHS proteins 
Members of the DBHS protein family bind to single- and double-stranded DNA and RNA and hence have 
multiple functions depending on the cellular context (Fig. 8) [135]. They have been described in all stages 
of the mRNA live cycle, starting with transcription that is mainly mediated by NONO, which binds to 
many gene promoters, as shown by chromatin immunoprecipitation and sequencing (ChIP-seq) 
experiments, including photoreceptor genes to regulate their expression in mouse retina cells [140]. 
Another study demonstrated that NONO acts as a bridge between RNA polymerase II (RNA-PolII) and a 
coactivator complex of the cAMP response pathway, thereby mediating the expression of cAMP-response 
genes [141]. In contrast to NONO, SFPQ acts mainly as transcription repressor, exemplified by studies that 
identified SFPQ binding to promoters of hormone receptors where it recruits the epigenetic silencer 
proteins HDAC or Sin3A [142], [143]. Moreover, SFPQ and NONO are required for transcription elongation 
by binding to RNA-PolII and mediating co-transcriptional processing and termination, the latter by 
recruiting the exonuclease XRN2 [142]. Furthermore, they are known to stabilize transcripts, most 
prominently the lncRNA NEAT1, but also histone-encoded mRNAs [145]. Splicing of pre-mRNAs was the 
first activity that was described for SFPQ [146]. Many studies have identified SFPQ and NONO as 
associated non-essential factors of the human spliceosome that regulate alternative splicing of the tyrosine 
phosphatase CD45 in T cells [145], the microtubule-binding protein Tau [148], neural-specific genes [149] 
and the spinal muscular atrophy genes SMN1/SMN2 [148]. DBHS proteins also mediate RNA export and 
transport, which was shown for U snRNAs whose export is facilitated by SFPQ and NONO [151]. 
Furthermore, neurons have a cytoplasmic pool of SFPQ and NONO, which are part of the RNA transport 
granule [152]. Recently, Cosker and colleagues demonstrated that SFPQ binds and localizes multiple, 
functionally related mRNAs essential for axon survival [153]. The molecular functions of DBHS proteins in 
human PSCs have not been analyzed, yet, and are one aim of this study.  
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1.8.2 Physiological roles of DBHS proteins 
DBHS proteins are best characterized by their function in a) circadian rhythm, b) DNA damage repair and 
c) paraspeckle assembly. The circadian rhythm is a mechanism where organisms adapt to a 24 hour, day-
and-night cycle [154]. In mammals, this is mainly controlled by the PER proteins (Period1 and Period2), 
which regulate the transcription of further components of the circadian rhythm in an oscillating manner 
[155]. Mass spectrometry analysis identified NONO as a PER protein interactor, which antagonizes its 
function and consequently, depletion of the Drosophila homolog NonA results in arrhythmic flies [156]. 
Moreover, it was shown that the SFPQ protein amount oscillates with the day-and-night cycle and that it 
recruits the HDAC-Sin3A histone deacetylation complex to repress the expression of Per genes [157]. DBHS 
proteins are also crucial for DNA double-strand repair by non-homologous end joining or homologous 
recombination. SFPQ and NONO bind directly to the DNA ends and interact with other proteins of the 
double-strand break pre-ligation complex [158], [159]. Furthermore, SFPQ is involved in homologous 
recombination by assisting in strand invasion, D-loop formation and topoisomerase activity [135].  
 
Figure 8: A scheme depicting the molecular functions of SFPQ and NONO. Adapted from Knott et al. 
[135]. 
 
1.8.3 DBHS proteins in disease  
Large-scale analysis of genetic variations in humans has shown that DBHS proteins belong to the class of 
genes with the lowest tolerance of missense and loss-of-function mutations [160], stressing their importance 
in disease and development.  
Similar to paraspeckles, DBHS proteins are deregulated in many cancer types, however often 
exhibiting trends that are not correlated with paraspeckles. NONO is up-regulated in malignant breast 
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cancer where it binds and stabilizes SREBP-1A, a master regulator of lipid biogenesis [161]. Both SFPQ and 
NONO are also up-regulated in colorectal cancers and a potential oncogenic function of both proteins is 
hypothesized [162], [163]. Another feature of DBHS proteins is their ability to modulate the immune 
response after viral infection, exemplified by SFPQ, which influences the transcription and processing of 
virus RNAs from hepatitis delta [164], influenza A [165] and HIV [166], the latter also being regulated by 
NONO [167]. Lastly, DBHS proteins affect neural development and mutations in NONO were connected 
to intellectual disability in mice and humans [138]. Moreover, all three DBHS proteins were shown to be 
important for neuronal development and axonal growth [135]. 
Taken together, DBHS proteins exert a multitude of cellular functions due to their ability to 
oligomerize, and to interact with DNA, RNA and a plethora of other proteins. DBHS proteins are 
sequestered to paraspeckles and are in fact important for their structural integrity, hence their function is 
linked with the appearance of paraspeckles, although many studies fail to analyze this connection.  
 
1.9 Aims and impact of this work 
LncRNAs can be important regulators of mammalian embryogenesis and disease, however, the function 
of many lncRNAs during human embryonic development remains enigmatic. Given that there is a plethora 
of lncRNAs that form condensates in the nucleus which likely have an impact on gene expression, I sought 
to first identify nuclear lncRNAs that exhibit dynamic regulation during germ layer differentiation. To this 
end, I curated a panel of 27 lncRNAs and analyzed their expression in PSC-derived multipotent progenitor 
cells. I then focused on the paraspeckle lncRNA NEAT1, which is up-regulated at the onset of 
differentiation in a lineage-independent manner. Developmental studies of NEAT1 were primarily 
performed in the murine system and data for paraspeckle formation in human cell types was lacking. To 
overcome this knowledge gap, I employed PSCs to construct an atlas of paraspeckle trajectories in 24 
human cell types including multipotent progenitors and terminally differentiated cells and dissected the 
expression of NEAT1 isoforms. I identified many novel cell types, especially from the mesenchymal and 
glial lineage tree that contain a high amount of paraspeckles. To explain the heterogeneity in the number 
of paraspeckles between cell types, I analyzed cellular and molecular features that correlate with 
paraspeckle appearance and found that nuclear size is one factor that can predict paraspeckle formation. 
Moreover, I identified the RBP TDP-43, which promotes the polyadenylation of NEAT1_1 in PSCs and its 
down-regulation upon pluripotency exit induced paraspeckle formation. Next, I sought to address 
molecular features of paraspeckle formation and found that small DNA-binding molecules, which are 
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regularly used in chemotherapy, can disintegrate paraspeckles and other chromatin-embedded lncRNA 
condensates, thereby demonstrating that DNA accessibility is important for the formation of nuclear DNA-
associated granules. Given that paraspeckles are up-regulated in neurodegenerative diseases, but also in 
many tumors, this finding might be relevant to develop strategies to dissociate paraspeckles and thereby 
having impact on disease progression. 
 Moreover, by genome editing approaches, I sought to interrogate the functional connection of 
NEAT1 isoforms and stem cell differentiation, which revealed that the architectural isoform of 
paraspeckles, NEAT1_2, is required for coordinated differentiation, whereas NEAT1_1 is dispensable for 
germ layer commitment. These findings were supplemented by the analysis of DBHS proteins SFPQ, 
NONO and PSPC1, which are regulated by translocation to paraspeckles upon differentiation. Selective 
knock-out of each member revealed that depletion of SPPQ could not be tolerated, whereas knock-out of 
NONO and PSPC1 primed hESCs for differentiation. Functional analysis showed that NONO mainly 
regulates genes of the cholesterol pathway, which is important for stem cell differentiation, whereas SFPQ 
generally regulates expression of genes involved in cell homeostasis, probably by acting as a 
polyadenylation factor.  
 To summarize, my work represents the first attempt to dissect the function of individual members 
of paraspeckles in maintenance and differentiation of pluripotent stem cells. I uncovered novel principles 
for the formation of lncRNA-containing, chromatin-embedded granules, which adds a layer of complexity 
to understanding mechanisms of formation of phase-separated granules. Furthermore, this study provides 
a comprehensive analysis of paraspeckle trajectories in human cell types and is important as a resource to 
tackle cell type-specific functions of paraspeckles.  
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2. Materials and Methods 
2.1 Chemicals and kits 
All chemicals were of research-grade; routinely used reagents are denoted in Supplementary Table 1. Kits 
that were used in this study are listed in Supplementary Table 2. 
 
2.2 PSC culture  
Human ESCs of the H9 line (WiCELL Research Institute) and iPSCs were cultured in StemMACS iPS-Brew 
XF (Miltenyi Biotec) and passaged by StemMACS Passaging Solution (Miltenyi Biotec) on tissue culture-
treated plates (Sigma) coated with Matrigel (ThermoFisher Scientific) diluted 1:100 in DMEM/F-12 
(ThermoFisher Scientific). All differentiation experiments were carried out with H9 cells, except lung 
progenitor and cortical neuron differentiation, which were performed with iPSC lines, namely NKX2.1-
P2A-eGFP [168] and foreskin fibroblast-derived iPSCs [169], respectively. For paraspeckle measurements 
in trophoblast progenitors and neural crest cells, I used differentiation protocols, as previously described 
[170], [171].  
 
2.3 Fibroblast reprogramming 
The reprogramming of human neonatal dermal fibroblasts was performed using StemRNA 3rd Gen 
Reprogramming Kit (Reprocell) according to the manufacturer`s protocol. The RNA transfection cocktail 
included synthetic, non-modified RNA of reprogramming factors OCT4, SOX2, KLF4, cMYC, NANOG and 
LIN28A, immune evasion mRNAs of E3, K3, B18 and reprogramming-enhancing mature, double-stranded 
microRNAs from the 302/367 cluster. 1.0x104 fibroblasts were plated per 60 mm organ culture dish 
(Corning) and reprogramming was started the following day by lipofection of the mRNA cocktail and 
incubation overnight. Transfections were repeated daily for three days and on day 9, distinct iPS colonies 
were forming.  
 
2.4 Spontaneous differentiation 
One day prior to the beginning of spontaneous differentiation, 5.0x105 cells, which were dissociated using 
Accutase (Sigma), were transferred to one Matrigel-coated well of a 12-well plate with StemMACS iPS-
Brew XF and 10 µM Y-27632 (R&D Systems). After 24 h, medium was replaced with medium containing 
20% KnockOut Serum Replacement (KSR), 1% GlutaMAX, 1% non-essential amino acids (NEAA) and 0.1 
mM beta-Mercaptoethanol (all ThermoFisher Scientific). Fresh medium was applied daily for up to 3 days.  
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2.5 Mesenchymal stem cell (MSCs), adipocyte and osteocyte differentiation 
MSC differentiation was induced by exchanging StemMACS iPS-Brew XF medium with differentiation 
medium containing 20% KSR, 1% GlutaMAX, 1% NEAA and 0.1 mM beta-Mercaptoethanol supplemented 
with 10 µM SB431542 (Miltenyi Biotec). Fresh medium was applied every other day and after 7 days, cells 
were transferred in a 1:3 ratio to a non-coated tissue culture treated plate with MSC expansion medium 
(Miltenyi Biotec). Fresh medium was applied daily before splitting the cells at differentiation day 14. 
Process control of MSC differentiation was performed by flow cytometry and RT-qPCR on day 21. On day 
21, MSCs were differentiated to adipocytes or osteocytes using StemMACS AdipoDiff Media or StemMACS 
OsteoDiff Media (both Miltenyi Biotec), respectively. Fresh medium was applied every 3 days for 20 days 
before process control by OilRed O or Alizarin Red staining, respectively.  
 
2.6 Cardiomyocyte differentiation 
Cardiomyocytes were generated according to a published protocol [172]. Briefly, 1.0x106 cells were 
dissociated as single cells using Accutase and plated in a well of a 12-well plate with StemMACS iPS-Brew 
and differentiation was induced the following day by changing the medium to RPMI-1640 (Sigma) with 
2% B-27 supplement without Insulin (ThermoFisher Scientific) and 10 µM CHIR99021(R&D Systems). Same 
medium was used the following day and on day 3, half of the medium was replaced with RPMI/B-27 
without insulin supplemented with 10 µM IWP-2 (Santa Cruz Biotechnology). On day 5 and 7, RPMI/B-27, 
first without insulin and then with full B-27 (ThermoFisher Scientific), were used. Fresh medium was 
applied after 3 days and cultures beginning to contract around day 12 were used for experiments. Process 
control of lateral mesoderm markers was performed on day 3. 
 
2.7 Nephron differentiation 
The protocol for differentiation of nephrons was optimized based on a published protocol [36]. Starting 
with undifferentiated cell cultures of ~70% confluency, a medium containing RPMI-1640, 1% GlutaMAX 
and 2% B-27 supplement (basal medium), 10 µM CHIR99021 and 500 nM dorsomorphin (Tocris) was used. 
Fresh medium was applied every other day and from day 4 onwards, the basal medium was supplemented 
with 10 ng/ml of ACTIVIN A (R&D Systems). On day 7, basal medium was supplemented with 10 ng/ml 
FGF9 (R&D Systems) and at day 9, with 3 µM CHIR99021 in addition for 48 h. Afterwards, basal medium 
supplemented with FGF9 was applied daily until day 21. Process controls were performed on day 7 for 
intermediate mesoderm markers, on day 14 for nephron progenitor markers and on day 21 for nephron 
markers by RT-qPCR and immunostaining. 
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2.8 Definitive endoderm, lung progenitor and hepatocyte differentiation 
The protocol for differentiation of definitive endoderm was based on a published protocol [173]. Briefly, 
hPSCs were dissociated using Accutase and 4x105 single cells were seeded in a Matrigel-coated 24-well in 
RPMI-1640 medium, supplemented with 2% B-27, 50 U/ml of penicillin/streptomycin (Pen/Strep; 
ThermoFisher Scientific), 100 ng/ml ACTIVIN A, 1 µM CHIR99021 and 10 µM Y-27632. Fresh medium was 
applied daily until day 6 without Y-27632, but with 0.25 mM sodium butyrate (Sigma) on the first day and 
0.125 mM afterwards. Process controls were performed on day 6 by flow cytometry and RT-qPCR. 
Subsequent differentiation towards lung progenitor cells was based on a published protocol [174]. 
Briefly, foregut endoderm was induced using day 6 definitive endoderm cells by DMEM/F-12 medium, 
supplemented with 1% GlutaMAX, 2% B-27, 1% N-2 (ThermoFisher Scientific), 50 U/ml Pen/Strep, 0.05 
mg/ml of L-ascorbic acid (Sigma), 0.4 mM of monothioglycerol (Sigma) (basal medium), 2 µM 
dorsomorphin and 10 µΜ SB431542. Fresh medium was applied daily and on day 10, lung progenitor 
differentiation was induced by applying basal medium supplemented with 20 ng/ml recombinant human 
BMP4 (R&D Systems), 50 nM retinoic acid (Sigma) and 3 µΜ CHIR99021. Fresh medium was applied daily 
until differentiation day 15 when expression of NKX2.1 was observed. 
Hepatocyte differentiation was based on a published protocol [37]. Briefly, 1.5x105 definitive 
endoderm cells were dissociated with Accutase, transferred to a Matrigel-coated 24-well and treated by 
DMEM/F-12 with 10% KSR, 1% NEAA, 1% GlutaMAX and DMSO (Sigma) together with 10 µM Y-27632 
and 100 ng/ml recombinant human hepatocyte growth factor (R&D Systems). Medium was changed daily 
without Y-27632 for 10 days and process controls were conducted by RT-qPCR and immunofluorescence.  
 
2.9 Neuronal stem cell differentiation  
The protocol for differentiation of neural stem cells (NSCs) was based on the generation of neurospheres 
[33]. Briefly, hESCs were harvested using a 2 mg/ml Collagenase IV solution (ThermoFisher Scientific) and 
resuspended in DMEM/F-12 medium supplemented with 20% KSR, 1% NEAA, 1% GlutaMAX, 10 µM 
SB431542, 5 µM dorsomorphin, 20 µM CHIR99021, 10 µM purmorphamine (Miltenyi Biotec) and 10 µM Y-
27632, and plated on an ultra-low attachment 6-well plate (Corning). Fresh medium was applied without 
Y-27632. 48 h later, the basal medium was exchanged with N2B27-based medium containing a 1:1 mixture 
of DMEM-F-12 and Neurobasal A (ThermoFisher Scientific) with 0.5% N-2, 1% B-27 minus Vitamin A, 1% 
NEAA and 1% GlutaMAX, and the small molecules described above. At day 5, N2B27-based medium 
supplemented with 50 µg/ml L-ascorbic acid, SB431542 and dorsomorphin was applied. On day 7, the 
neurospheres were mechanically dissociated and plated on Matrigel-coated plates. 24 h before the 
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replating, the medium was supplemented additionally with 5 ng/ml bFGF (Peprotech). Plated 
neurospheres were maintained for 7 days using the same medium and on day 14, confluent neuroepithelial 
outgrowths were passaged in a 1:10 dilution using Collagenase IV. The NSC cultures were passaged every 
7 days and maintained in N2B27 medium with SB431542, dorsomorphin and bFGF at same concentrations 
as above with medium change every other day. Process control of NSC differentiation was performed on 
day 21.    
 
2.10 Astrocyte differentiation 
The protocol of astrocyte differentiation was based on a published protocol [35]. Briefly, tissue culture-
treated plates were coated for 2 h with 10 ng/ml laminin/poly-L-ornithine (Sigma) and day 21 NSCs were 
dissociated using Accutase and plated at a ratio of 2.8x105 cells per well of a 12-well plate with N2B27 
medium supplemented with 20 ng/ml bFGF, 10 ng/ml BMP4 and 5 ng/ml CNTF (R&D Systems). On day 
15, medium was supplemented with 10 ng/ml bFGF, 10 ng/ml EGF (Sigma) and 10 ng/ml Neuregulin (R&D 
Systems) and the cells were differentiated for additional 15 days and then analyzed.  
 
2.11 Motor neuron differentiation 
The protocol of motor neuron differentiation was based on a published protocol [34]. Briefly, plates were 
coated, first with 10 ng/ml laminin, poly-L-ornithine, collagen I and collagen IV (Sigma) for 1 h each and 
then with 10 ng/ml vitronectin (Peprotech) for 1 h. 10 ng/ml fibronectin (Sigma) instead of vitronectin was 
used for later passaging.  1.5x105 day 21 NSCs were seeded per well of a 12-well plate with N2B27 medium 
supplemented with 100 ng/ml SHH, 10 ng/ml BDNF, 10 ng/ml GDNF, 10 ng/ml IGF (all from R&D System) 
and 100 nM retinoic acid. After 15 days, the medium was supplemented with 0.1 µM y-secretase inhibitor 
XXI (Merck) and 0.1 µM cAMP (Sigma Aldrich). Cells were analyzed at day 75.   
 
2.12 Cortical neuron differentiation 
The protocol of cortical neuron differentiation was based on a previously published protocol [175], with 
minor modifications. Briefly, iPSCs were plated in a 1:1 mixture of DMEM/F-12 and Neurobasal A, 1% N-
2, 2% B-27, 1% GlutaMAX, 1% NEAA, 1000 U/mL Pen/Strep, 5 µg/ml human insulin (ThermoFisher 
Scientific) and 0.1 mM β-mercaptoethanol with 10 µM SB431542 and 1 µM dorsomorphin, and fresh media 
was applied daily. At day 10, cells were dissociated with Accutase and plated on poly-L-ornithine (1:1000) 
and laminin (1:200) coated plates at 1:4 dilution with the same medium supplemented with 10 µM Y-27632. 
From the next day onwards, the cells were treated by medium without SB431542 and dorsomorphin. Cells 
 2. Materials and Methods  
34 
 
were passaged every six days. Process control for neural induction and cortical neuron progenitor 
differentiation was performed after 15 and 35 days. 
 
2.13 Somatic cell lines 
Somatic cell lines used in this study were GIBCO® Human Skeletal myoblasts that were cultured for two 
days in DMEM (ThermoFisher Scientific) together with 2% horse serum (ThermoFisher Scientific), which 
induced differentiation to myotubes. Additionally, primary human epidermal keratinocytes (ATCC® PCS-
200011™), primary adult human dermal fibroblasts (ATCC® PCS201012™), primary human neonatal 
foreskin fibroblasts (ATCC® CRL-2522™) and primary human astrocytes (ScienCellTM Research 
Laboratories, #1800) were cultured according to provider`s instructions.  
 
2.14 Derivation of primary murine mesenchymal stem cells 
Cultures of murine MSCs were established from the femoral bone marrow of female FVB/N mice (Charles 
River Laboratories, Sulzbach, Germany) by aspiration from the marrow cavity with 1 ml ice-cold PBS and 
a 0.4 mm injection needle. A solution of single cells was produced by pipetting, filtering through a 70 µm 
cell strainer (BD) and 5 min centrifugation at 300 g. Cells were plated in 12 ml of DMEM/F-12 with 1g/l 
glucose, 10% MSC-qualified FBS (ThermoFisher Scientific), 1% GlutaMAX and 10 µM Y-27632 in T75 cell 
culture flasks. Cells were kept under hypoxic conditions (2% O2, 5% CO2) at 37°C in a humidified 
atmosphere. Non-adherent cells were depleted by exchanging the medium 2 and 4 h after initial plating, 
whereas later on, fresh medium was applied every 3.5 days. When reached approximately 80% confluency, 
cells were passaged in a 1:3 ratio using Accutase. 
 
2.15 Derivation of primary murine astrocytes  
Primary mouse astrocytes of the C56BL/6 P3 strain were derived from whole cortex preparations. The brain 
was washed with HBSS (Sigma) supplemented with 50 U/ml Pen/Strep and meninges and blood vessels 
were removed. The cortex was isolated and cut into smaller pieces, and further resuspended in 10 ml 
HBSS/Pen/Strep. The minced tissue was plated on poly-D-lysine-coated plates (40 µg/ml, 1 h incubation) 
in DMEM/F-12 supplemented with 10% FBS, 50 U/ml Pen/Strep, 10 ng/ml FGF2 and10 ng/ml EGF. Fresh 
medium was applied every other day until the culture became confluent. 
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2.16 Derivation of primary murine cardiomyocytes 
Primary mouse cardiomyocytes cultures were prepared using the Primary Cardiomyocyte Isolation Kit 
(ThermoFisher Scientific) according to the manufacturer`s instructions.  
 
2.17 Derivation of primary murine hepatocytes 
The protocol of primary hepatocyte derivation was based on a published protocol [176]. Liver was obtained 
from 14-week old C56BL/6 mice and digested using 2 mg/ml collagenase IV solution (ThermoFisher 
Scientific) at 37ºC for 45 min. The digested tissue was plated in a 10 cm dish with Williams E medium 
(Sigma) supplemented with 5% FBS and mechanically dissociated. Then, cells were filtered using a 70 µm 
cell strainer and 6 ml cell suspension was layered on top of a Percoll (Sigma) gradient of 1.12 g/ml, 1.08 
g/ml and 1.06 g/ml in PBS. Cells were centrifuged for 20 min at 800 g and washed with Williams E medium 
with 5% FBS. After another centrifugation at 300 g for 10 min, the cells were resuspended in Williams E 
medium with 5% FBS, 1% GlutaMAX, 50 U/ml Pen/Strep, 50 ng/ml EGF, 1 µg/ml Insulin, 10 µg/ml 
transferrin (Sigma), and 1.3 µg/ml of hydrocortisone (Sigma) and plated on 10 µg/ml rat tail collagen I 
(Sigma) coated plates with daily medium change. 
 
2.18 Animal data 
Mouse keeping was done at the central facilities at the Helmholtz Center Munich in accordance with the 
German animal welfare legislation and guidelines of the Society of Laboratory Animals (GV-SOLAS) and 
of the Federation of Laboratory Animal Science Associations (FELASA). 
 
2.19 Oil Red O staining 
Following adipocyte differentiation, cells were washed twice with PBS, fixed with 10% neutral buffered 
formalin (Sigma) for 45 min, then washed twice with tap water and fixed again with 2-propanol (Sigma) 
for 5 min. Filtered Oil Red O solution (1.8 mg/ml in 2-propanol; Sigma) was added to the cells and incubated 
for 10 min. After two washes with PBS, cells were counterstained with Mayer`s hematoxylin solution 
(Sigma) for 3 min, before two washes with tap water, addition of PBS and imaging with a phase-contrast 
microscope. All steps were performed at RT. 
 
2.20 Alizarin Red staining 
Following osteocyte differentiation, cells were washed twice with PBS and fixed with 10% neutral buffered 
formalin (Sigma) for 45 min. Next, cells were washed twice with tap water and incubated with filtered 
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alizarin red staining solution (20 mg/ml; Sigma) for 45 min. After 4 washes with de-ionized water, PBS was 
added to the cells and images were obtained with a phase-contrast microscope. All steps were performed 
at RT. 
 
2.21 Immunofluorescence staining 
Cells were grown on imaging slides (Ibidi), washed 3 times with PBS, fixed with 4% paraformaldehyde 
(Sigma) in PBS for 10 min, followed by 3 washes using PBS. After permeabilization using 0.5% Triton-X-
100 (Sigma) in PBS at 4°C overnight and 3 washes with PBS, slides were blocked with 0.1% Triton-X-100 
and 1% FBS in PBS for 1 h at room temperature. Incubation with primary antibodies was performed at 4°C 
overnight. After 3 washes with PBS, slides were incubated with the species-corresponding secondary 
antibodies (ThermoFisher Scientific) for 2 h at room temperature in the dark and washed 3 times with PBS 
afterwards. The samples were mounted with ProLong® Gold Antifade Reagent with DAPI (ThermoFisher 
Scientific) on a coverslip and imaged with an Axio Observer.Z1 inverted epifluorescence microscope (Zeiss) 
equipped with a 10x/0.3 Plan-NEOFLUAR objective (Zeiss). Primary antibodies were diluted 1:100 unless 
stated otherwise and secondary antibodies 1:1000 in blocking buffer. Primary antibodies that were used in 
this study are listed in Supplementary Table 3.  
 
2.22 Single-molecule fluorescence in situ hybridization (smFISH)  
Cells were plated on imaging slides (Ibidi), fixed with 4% paraformaldehyde, washed twice with PBS and 
permeabilized with 70% ethanol overnight at 4°C. After 2 washes with PBS and pre-hybridization solution 
(10% deionized formamide, 2x SSC), slides were incubated with 50 µl hybridization solution containing 2x 
SSC, 10% formamide, 50 µg competitor E.coli tRNA (Roche Diagnostics), 10% Dextran Sulfate (VWR), 2 
mg/ml BSA (UltraPure; Life Technologies), 10 mM vanadyl-ribonucleoside complex (NEB) and 1 ng/µl 
smFISH probes) for 6 h at 37°C. Afterwards, slides were washed twice with pre-hybridization solution at 
37°C, then twice with PBS with subsequent mounting with ProLong® Gold Antifade Reagent with DAPI. 
Slides were imaged after 12 hours when the mounting medium was fully cured on an Axio Observer.Z1 
inverted epifluorescence microscope equipped with a 63x/1.4 Plan-APOCHROMAT objective (Zeiss).  
Probe Designer software by Biosearch Technologies was used to design probes for hNEAT1 5` 
segment and mNEAT1 middle segment, both conjugated to Quasar®670 fluorescent dye. Sequences are 
listed in Supplementary Table 4. Probes for hNEAT1 middle segment, mNEAT1 5` segment and MALAT1 
(all conjugated to Quasar®570) were pre-designed by Biosearch Technologies.  
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2.23 Chemicals used for DNA binding 
Cells were treated either by 2 µM Actinomycin D (ThermoFisher Scientific), 100 µg/ml Hoechst 33342 
(ThermoFisher Scientific), 50 µM α-Amanitin (Cayman Chemical) and 5 µM Mithramycin A (Abcam). 
Vincristine (Selleckchem), Etoposide (Selleckchem) and Flavopiridol (Biomol) were used at concentrations 
specified in Fig. 20C. 
 
2.24 Image analysis for paraspeckle counting 
The spot detection program Airlocalize [177] was used for paraspeckle quantification based on 3D image 
stacks with 6 µm depth as described previously [47]. The averaged number of paraspeckles was calculated 
from images containing 20-150 cells. 7 images were analyzed per condition and replicate. 
 
2.25 Image analysis for NEAT1_2 single-molecule counting 
Quantification of single NEAT1_2 molecules based on smFISH was done with the Fiji software. For every 
image, a maximum intensity z-projection was generated and subjected background subtraction using the 
rolling ball method with 5-pixel thickness. Afterwards, the remaining intracellular background was 
measured by five consecutive intensity measurements and subtracted from the image. A threshold was 
applied to mask remaining spots and the integrated intensity of those spots was analyzed. A typical image 
yielded 500-2500 NEAT1_2 foci whose intensities were binned to generate a distribution histogram. The 
peak with the lowest intensity was defined as the intensity of a single NEAT1_2 molecule, and further peaks 
were defined accordingly with 2, 3, or more copies of NEAT1_2. Next, the intensity of all detected spots 
was divided by the intensity value for a single NEAT1_2 molecule to determine the total amount of 
NEAT1_2 molecules, which was then normalized by the number of cells. Importantly, this analysis was 
performed only in cells that were treated with Actinomycin for 0.5 – 1h, dependent on the cell type and 
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before any RNA degradation was observed. The method was adapted from a previously published paper 
[92] and is depicted in Fig. 9. 
Figure 9: Image-based NEAT1_2 single-molecule counting. A scheme and representative image and 
histogram displaying background subtraction and binning of NEAT1_2 signal intensities (arbitrary units) 
representing the analysis of one image containing ~30 cells and the mean intensity of a single NEAT1_2 
molecule. 
 
2.26 Quantification of nucleus size 
Quantification of nucleus size based on DAPI staining was done using the Fiji software. Per image, an 
intensity threshold was determined to mask the DAPI staining in a maximum projection of a 3D image 
stack with 6 µm depth. The total DAPI area was divided by the number of cells per image to determine the 
average nucleus size per cell per image. The determination of nuclear size in single cells (Fig. 17B) was 
done by manually masking DAPI labeled nuclei and analyzing the nuclear area by the “Analyze Particles” 
function in Fiji. 
 
2.27 Flow cytometry analysis  
Surface marker staining was performed by washing dissociated cells with FACS buffer (1% FBS in PBS), 
centrifugation, removal of supernatant and incubation with primary antibodies in FACS buffer for 30 min 
on ice. Next, after centrifugation and removal of supernatant, cells were incubated with species-
corresponding secondary antibody for 30 min on ice, before washing and final resuspension in FACS 
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buffer. A similar protocol was carried out with primary antibodies that were already conjugated to 
fluorophores.  
Intracellular staining was performed according to instructions of the Inside Stain Kit (Miltenyi 
Biotec). Primary antibodies were incubated for 1 h at room temperature with 2.0x105 cells. Secondary 
antibodies were incubated for 30 minutes on ice. Cells were washed once with Inside Perm solution before 
resuspending them in FACS buffer for analysis. 
Unconjugated primary antibodies were diluted 1:100 unless specified otherwise and secondary 
antibodies 1:1000 in FACS buffer. Samples were analyzed using the BD FACSAria III cell sorter (BD 
Biosciences) and data was processed using FlowJo software. Primary antibodies are listed in 
Supplementary Table 3. 
 
2.28 SmFISH combined with flow cytometry 
Based on smFISH signal, cells were sorted by flow cytometry according to a previously published protocol 
[178]. Briefly, 1x106 cells were harvested and resuspended in 500 µl of 4% paraformaldehyde and incubated 
at RT for 5 min. Fixed cells were centrifuged at 1000 g for 5 min, washed with 70% EtOH and resuspended 
in 70% EtOH with incubation overnight at +4°C. Next, the sample was split into half and resuspended in 
100 µl RNA protection and hybridization buffer containing 300 mM NaCl, 30 mM sodium citrate, 2.1 M 
ammonium sulfate, 10 mM EDTA, 1 mg/ml E. coli tRNA, 500 µg/ml BSA, 25% formamide with or without 
2 ng/µl NEAT1 probe. After incubation at 30°C for 12 h, cells were washed twice with wash buffer 
containing 25% formamide and 2x SSC before resuspension in 2x SSC and cell sorting using the BD 
FACSAria III cell sorter into ice-cold buffer consisting of 200 mM NaCl, 20 mM sodium citrate, 1.5 M 
ammonium sulfate, 5 mM EDTA, pH 5.2 and 2x SSC. The top and lowest 5% of cells were sorted, 
centrifuged at 1000 g for 5 min and resuspended in 100 µl reverse crosslink buffer that contained 100 mM 
NaCl, 10 mM Tris, pH 8.0, 1 mM EDTA, 0.5 % SDS (v/v) supplemented with 500 µg/ml proteinase K 
(ThermoFisher Scientific), followed by incubation at 50°C for 1 h. RNA was isolated using the QIAzol lysis 
reagent (Qiagen) according to the manufacturer`s instructions. 
 
2.29 RNA extraction and quantitative RT-PCR (RT-qPCR) 
RNA extraction was performed using the RNeasy Mini Kit (Qiagen) according to the manufacturer`s 
instructions. Reverse transcription was performed using the Verso cDNA Synthesis Kit (ThermoFisher 
Scientific) with 200 ng RNA per reaction. RT-qPCR was performed in 384-well plates using 5 µl of SYBR 
Green PCR Master Mix (ThermoFisher Scientific), 1 µl cDNA and 1 µl of 5 µM primer forward and reverse 
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mix in a 10 µl reaction. PCR conditions were 2 min at 50°C and 10 min at 95°C followed by 40 cycles of 15 
s at 95°C and 1 min at 60°C. Relative expression levels were calculated using the Delta-Delta Ct method 
normalized with GAPDH. Statistical analysis was performed with the GraphPad Prism 7 software. RT-
qPCR primers are listed in Supplementary Table 5. 
 
2.30 Western blot 
Cells were lysed in 50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1% Igepal CA-630 (Sigma I8896), 0.1% SDS, 
0.5% sodium deoxycholate and 1x protease inhibitor (Roche). After 30 min incubation on ice, the lysate was 
centrifuged at 21000 g for 30 min. The supernatant was transferred to a new tube and 2x Laemmli buffer 
(Biorad) was added in a 1:1 ratio together with beta-mercaptoethanol and incubated at 95°C for 5 min. The 
protein sample was loaded on a Mini PROTEAN® TGX stain-free gel (Biorad) together with SDS running 
buffer containing 3% (wt/vol) Tris base, 14.4% (wt/vol) glycine and 1% (wt/vol) SDS. Subsequent blotting 
was performed for 1 h with 100 V on a nitrocellulose membrane in blotting buffer containing 25 mM TRIS, 
192 mM glycine and 20% methanol. Next, the membrane was blocked with TBST buffer consisting of 20 
mM TRIS, 150 mM NaCl, 0.1% Tween 20 and 5% non-fat dried milk powder (Sigma) for 45 min at RT. The 
primary antibody was added in a 1:1000 dilution in blocking buffer and incubated at 4°C ON. After three 
washes with 1x TBST buffer, the membrane was incubated with a 1:10000 dilution of secondary antibody 
conjugated to horse radish peroxidase (HRP) in blocking buffer for 2 h at RT. After three washes in TBST 
buffer for 15 minutes each, the membrane was stained with Clarity Western ECL Substrate (Biorad) and 
imaged after 2 min incubation using a ChemiDoc MP Imaging System (Biorad). 
 
2.31 Generation of CRISPR-Cas9 modified hESCs  
Genomic manipulations of hESCs were carried out according to a published protocol [179]. Briefly, the 
Protospacer Adjacent Motif (PAM) sequence was identified using the crispr.mit.edu website. BbsI-digested 
pSpCas9(BB)-2A-GFP vector (Addgene plasmid ID: 48138) was ligated with annealed forward/reverse 
guide RNA (gRNA) mix (1:250 dilution) using T4 ligase (NEB). NEB® 5-alpha competent E.coli bacteria 
(NEB) were inoculated with ligated plasmid and plated on agar plates. Bacteria colonies were propagated 
and plasmids were isolated using the GeneJET Plasmid MiniPrep kit (LifeTechnologies) according to 
manufacturer`s instructions. Sanger sequencing was used to screen for correct integrations. 1.0x106 hESCs 
were nucleofected with 5 µg of up- and downstream gRNA/Cas9 plasmid mix using the P3 Primary Cell 
4D-Nucleofector® Kit (Lonza) according to the manufacturer`s instructions. Cells were plated 2 days later 
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and single clones were picked and analyzed for successful genomic deletion by PCR. Guide RNAs and 
primers for PCR-based screening are listed in Supplementary Tables 6 and 7.  
Generation of NEAT1YFP hESCs was done as previously described [95] by using plasmids provided 
by Addgene (IDs: 97088 for donor plasmid and 97082 for gRNA plasmid). 
Generation of NEAT1 hESCs with integrated stop cassette was performed in collaboration with 
Dong-Jiunn Jeffery Truong from the AG Westmeyer (Helmholtz Zentrum München, Institute of 
Developmental Genetics). Briefly, 4 µg of donor and 2 µg of CRISPR/Cas9 plasmid were transfected and 
selected for successful insertion with 0.5 µg/mL puromycin (ThermoFischer Scientific) for 7 days. Clones 
were picked and successful genomic insertion was confirmed by PCR. Plasmid sequences and exact cloning 
strategy are proprietary knowledge of the AG Westmeyer. 
 
2.32 Generation of SunTag hESCs and transient NEAT1 over-expression  
Generation of hESCs expressing the SunTag complex under control of a doxycycline-inducible promoter 
was performed as previously described [180]. 1.0x106 hESCs were nucleofected with 2 µg of PB-pCAG-
rtTA, SunTag PiggyBac and PBase vector provided by the authors of this publication. Cells were selected 
with 200 µg/ml Hygromycin B (Life Technologies) and 1 µg/ml doxycycline (Sigma) for 8 days before 
picking single green fluorescent clones, which were propagated and used for NEAT1 gRNA transfections. 
NEAT1 gRNA expressing vectors were generated as described in section 2.31. SunTag hESCs were 
transiently transfected with 5 µg of NEAT1 gRNA vector and seeded with 1 µg/ml doxycycline and 10 µM 
Y-27632. Spontaneous differentiation was induced after 24 h by adding KSR differentiation medium and 
cells were analyzed after 48 h of differentiation. NEAT1 gRNA sequences are listed in Supplementary 
Table 6. 
 
2.33 DNA extraction and polymerase chain reaction (PCR) 
Isolation of genomic DNA for screening of KO clones after transfection of CRISPR/Cas9 was performed 
using 30 µl QuickExtractTM (Biozym) according to the manufacturer`s instructions. PCR was performed 
using Q5 Polymerase master mix (NEB) with 100 ng DNA.  
 
2.34 SiRNA and antisense oligonucleotide (ASO) transfection 
H9 cells were transferred as single cells in a 24-well plate format and grown until 60% confluency was 
reached. LipofectamineTM RNAiMAX Transfection Reagent (ThermoFisher Scientific) was used with minor 
deviation from the protocol suggested by the provider. Briefly, per reaction, 100 µl Opti-MEM® 
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(ThermoFisher Scientific) and 5 µl Lipofectamine® were added to a mix of 100 µl Opti-MEM® and 0.1 µM 
pre-designed Silencer® Select siRNA (ThermoFisher Scientific). After 15 min incubation at RT, this mix was 
added to the cells together with 200 µl iPS-Brew. Medium was changed after 24 h and cells were harvested 
after another 24 h of incubation. The following siRNAs were used in this study: siSFPQ: s12712 and sictr: 
Stealth RNAiTM siRNA Negative Control medium GC (ThermoFisher Scientific). Transfection of ASOs 
(Supplementary Table 8) for down-regulation of NEAT1 expression was performed in a similar fashion. 
The final concentration of ASOs per reaction was 100 nM. 
 
2.35 Subcellular fractionation 
For subcellular fractionation, a modified protocol with the reagents from the Nuclear Complex Co-IP Kit 
(Active Motif) was employed. Cells were harvested, washed with 1 ml of 5% Phosphatase Inhibitors in PBS 
and centrifuged at 500 g for 5 min at 4°C. The cells were resuspended in 250 µl of 1x Hypotonic Buffer and 
incubated on ice for 15 min. After adding 12.5 µl detergent and mixing, the suspension was centrifuged for 
30 s at 14000 g at 4°C. While the supernatant (cytoplasmic fraction) was transferred to a fresh 
microcentrifuge tube, the nuclear fraction was washed three times with 1x Hypotonic Buffer supplemented 
with 5% detergent to remove cytoplasmic contaminations. For both fractions, RNA was isolated by adding 
1 ml QIAzol Lysis Reagent and heating the samples to 55°C for 10 min. 0.2 ml chloroform was added, the 
tubes were mixed vigorously and centrifuged at 12000 g for 15 min at 4°C. The upper, aqueous phase was 
transferred to a new tube, supplemented with 0.5 ml isopropanol, vortexed and incubated ON at -20°C. 
This was followed by centrifugation at 12000 g for 10 min at 4°C, before washing the RNA pellet with 1 ml 
of 70% EtOH and centrifugation at 12000 g for 5 minutes at 4°C. After removing the supernatant and briefly 
air-drying the pellet, the RNA was resuspended in 30 µl RNase-free water and cleaned up using the RNeasy 
MinElute Cleanup Kit (Qiagen). 
 
2.36 Transcriptome analysis 
Transcriptome analysis of NONO-/- hESCs was carried out by using the QuantSeq 3’ mRNA-Seq Library 
Prep Kit for Illumina (REV) with Custom Sequencing Primer (Lexogen) with 500 ng total RNA. Libraries 
were amplified and multiplexed with barcodes under the following conditions: 98°C 30 s, 14 cycles of 98°C 
for 10 s, 65°C for 20 s, 72°C for 30 s, and a final extension of 72°C for 1 min. Library preparation of SFPQ 
knock-down samples was prepared by following instructions of the TruSeq RNA Library Prep Kit v2 
(Illumina). Quality control of the libraries was performed with a 2100 Bioanalyzer using the High 
Sensitivity DNA Kit (Agilent Technologies). Libraries were denatured with 0.1 N NaOH, diluted to a final 
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concentration of 6 pM and sequenced by a HiSeq2500 machine (NONO-/- hESCs) or a NextSeq500 machine 
(SFPQ knock-down hESCs). Data analysis was carried out on the Galaxy platform [181]. RNA Sequencing 
reads were mapped and aligned to the human hg19 reference genome using TopHat2 [182]. Transcript 
assembly and read counts were analyzed with Cufflinks and differential transcript expression was 
analyzed using Cuffdiff [183]. 
 
2.37 Nuclear Co-immunoprecipitation (Co-IP) 
Nuclear Co-IP was performed by following the protocol of the Nuclear Co-IP kit (Active Motif). 10x106 cells 
were used per experiment, divided in a 1:1 ratio and one half was incubated with 5 µg SFPQ or 4 µg NONO 
antibody and the other half with the same amounts of corresponding IgG control antibody. Incubation was 
performed ON at +4°C on a rotating wheel. IP-High buffer condition without additional detergent and salt 
was used as precipitation and wash condition. After precipitation, the lysate was incubated with pre-
washed 40 µl Protein A Dynabeads TM and incubated for 1 h at RT. Subsequent washes of the beads were 
performed according to the instructions with additional three washes of PBS which was necessary before 
submitting samples to mass spectroscopy analysis. Finally, proteins were eluted by resuspending the beads 
in 20 µl 1x Laemmli buffer and incubation at 95°C for 5 min. Samples were either analyzed by Western Blot 
or subjected to mass spectrometry in collaboration with Dr. Stefanie Hauck (Helmholtz Zentrum München, 
Research unit Protein Science). 
 
2.38 ChiP-SICAP 
ChIP-SICAP is a protocol to pull down proteins and DNA associated with a target protein, which was 
established recently by Rafiee and colleagues [184]. This experiment was performed in the lab of Dr. Jernej 
Ule at the Francis Crick Institute with guidance by the first author of this publication. 10x106 cells were 
washed twice with PBS, harvested with Accutase, centrifuged at 1000 rpm for 5 min and fixed with 1.5% 
fresh formaldehyde solution for 14 min at RT. Glycine was added to reach a final concentration of 130 mM 
and incubated for 5 min. Cells were centrifuged at 2500 rpm for 2 min, washed once with PBS, centrifuged 
again and stored at -80°C until further processing. Cells were first washed with 10 mM TE buffer, pH 7.5 
with 2x protease inhibitor (Roche), centrifuged at 1000 g for 2 min, resuspended in 900 µl TE buffer, 
incubated on ice for 10 min before addition of 100 µl of 10% Triton-X-100 and further incubation on ice for 
5 min. Next, cells were centrifuged, washed twice with TE buffer and sonicated using a Covaris S220 with 
the following settings: time: 430s, Duty cycle: 10%, Intensity: 5, Cycle/Burst: 200. Afterwards, tubes were 
centrifuged at 12000 g for 10 min and 1% Triton-X-100 was added to the supernatant. Supernatant was 
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supplemented with 5 µg of Ser2-Phospho RNA PolII antibody or IgG control and incubated ON at 
+4°C/shaking. The following day, the chromatin was centrifuged at 12000 g for 10 min at 4°C and the 
supernatant was transferred to new tube. Magnetic Dynabeads conjugated with protein G 
(LifeTechnologies) were washed with IP buffer (1% Triton-X-100, 0.5% NP-40, 50 mM Tris-HCl; pH 7.5, 5 
mM EDTA, 150 mM NaCl) and 30 µl Dynabeads were added per sample and incubated for 3 h at +4°C on 
a rotating wheel. Beads were washed with 100 mM Tris-HCl (pH 7.5), then washed with 100 µl 1x TdT 
buffer and finally resuspended in 93 µl TdT buffer with 5 µl dCTP-Biotin (1 mM stock, Jenabioscience) and 
2 µl Terminal Deoxynucleotidyl Transferase (20 U/µl, ThermoFisher). Beads were incubated for 30 min at 
37°C with 500 rpm agitation before washing them 6 times with ice-cold IP buffer at RT and resuspension 
and subsequent resuspension in 100 µl SDS 7.5% and 200 mM DTT and incubation for 30 min at 37°C. 
Supernatant was collected and diluted with 1000 µl IP buffer and 30 µl of Streptavidin magnetic beads 
were added to the wash tube. Beads were rotated for 1 h at RT before washing them 3 times with SDS wash 
buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 200 mM NaCl, 1% SDS). Then, beads were washed three 
times with 40% acetonitrile, transferred to PCR tubes and resuspended in 14 µl SDS 0.1% with 50 mM 
ammonium bicarbonate. 1 µl of 100 mM DTT was added and incubated for 20 min at 95°C. After cooling 
down the tubes, 1 µl Indole-3-acetic acid (IAA, 200 mM) was added and incubated 30 min in the dark. 
Another 1 µl DTT was added to neutralize the IAA, liquid was transferred to a new tube and proteins were 
digested with 200 ng Trypsin and 50 ng LysC at 37°C for 16 h. Peptides were cleaned up according to a 
previously published protocol [185] and analyzed by mass spectroscopy.  
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3. Results 
3.1 Nuclear lncRNAs in the pluripotency - differentiation transition 
Embryonic stem cells express hundreds of lncRNAs with crucial gene-regulatory functions in stem cell 
maintenance [66], [186], however, to date there is no comprehensive analysis of lncRNA dynamics during 
human germ layer differentiation. To interrogate connections between lncRNAs and the regulation of early 
human cell differentiation, I analyzed progenitors of the human germ layers (Fig. 10A). Each germ layer 
was represented by an early progenitor population and a population of tissue progenitors that were 
produced by differentiation of human ESCs or iPSCs. I first established differentiation protocols of lateral 
mesoderm and mesenchymal stem cells (MSCs), definitive endoderm and lung progenitor cells, and neural 
stem cells (NSCs) and cortical neuron progenitors, which represented respectively, early and late stages of 
differentiation of the three germ layers mesoderm, endoderm and ectoderm. I observed the up-regulation 
of lateral mesoderm markers MESP1, T (Brachyury), FZD4 and MIXL1, and transcription factors TWIST and 
SLUG, which regulate epithelial-to-mesenchymal transition of MSCs, as well as surface markers that are 
characteristic for MSCs (Fig. 10B, E). When differentiated to definitive endoderm, I detected the up-
regulation of SOX17, FOXA2, surface markers CXCR4, CD117 and EPCAM, and later of the master lung 
transcription factor NKX2.1 (Fig. 10C, F-H). Moreover, the up-regulation of PAX6, SOX1, ASCL1, NESTIN 
and FOXG1 transcripts and proteins confirmed the differentiation to NSCs and cortical neuron progenitors, 
respectively (Fig. 10D, I, J). Finally, in all cell types, the pluripotency factors OCT4, SOX2 and NANOG 
were down-regulated (Fig. 10B-D). 
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Figure 10: Characterization of germ layer progenitors. A) A scheme illustrating the cell types that were 
produced in this study by differentiation of hPSCs. Starting with undifferentiated cells at the top, hPSCs 
were differentiated to precursors of the germ layers, embryonic and extraembryonic progenitors, and 
terminally differentiated cells. The lineage and approximate developmental distance was estimated based 
on the expression of developmental markers as outlined below. In addition, primary preparations of 
keratinocytes, fibroblasts (adult and neonatal) and myotubes were analyzed. B-D) RT-qPCR analysis of 
lineage-selected markers corresponding to lateral mesoderm, and mesenchymal stem cells (MSCs) (B); 
definitive endoderm and lung progenitors (C); and neural progenitors and cortical neuron progenitors (D). 
Pluripotency genes OCT4, SOX2 and NANOG were analyzed in all samples. E) Analysis of mesoderm 
differentiation towards MSCs showing the expression of characteristic markers CD73 and CD90 in 
accordance to [187]. F-H) Analysis of the differentiation towards definitive endoderm showing the up-
regulation of CXCR4, EPCAM and CD117 cell surface markers (F) and a cohort of characteristic markers as 
well as the down-regulation of pluripotency genes by RT-qPCR (G), and the expression of eGFP integrated 
in NKX2.1, which marks the formation of human lung progenitors [168] (H). Scale bar: 10 µm. I, J) 
Representative immunocytochemistry images of NSCs showing the expression of characteristic markers 
PAX6, SOX1 and NESTIN on day 21 of NSC differentiation (I), and the cortical neuron progenitor markers 
FOXG1 and PAX6 (J) [175]. Scale bar: 50 µm. 
n=2 independent experiments of cells in different passages. Error bars represent standard deviation. 
 
Strikingly, the vast majority of lncRNAs, 24 out of 27, which were chosen for their participation in 
transcriptional and post-transcriptional regulation [186], were expressed in undifferentiated human ESCs 
and/or progenitor cells, and exhibited highly dynamic and diverse expression patterns including lineage-
specific and temporal regulation (Fig. 11). A notable example for lineage-specific expression was the 
induction of H19 (p<0.0001) in lung progenitor cells, and several lncRNAs that were up-regulated in all 
germ layers including PINCR, LINC00472 and NEAT1_2 (p<0.05 in ≥5 lineages). These findings indicated 
the involvement of nuclear lncRNAs in regulation of differentiation and diversification of human cell 
lineages. Because NEAT1_2 was previously implicated in the regulation of development and differentiation 
[47], [113], I sought to further characterize its expression and function in the formation of the germ layers, 
tissue progenitors and differentiated cells. 
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Figure 11: Analysis of developmentally regulated lncRNAs. A, B) The absolute (A) and relative (B) 
expression of nuclear lncRNAs in undifferentiated human ESCs and germ layer and tissue progenitors as 
in Fig. 10B-D based on RT-qPCR analysis. n=3 independent experiments, error bars represent standard 
deviation, Cells at different passages were used for replicates. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p< 
0.0001, unpaired t-test. Abbreviations: LM: lateral mesoderm, MSC: mesenchymal stem cells, DE: definitive 
endoderm, LP: lung progenitors, CNP: cortical neuron progenitors, NSC: neural stem cells.  
 
3.2 Analysis of NEAT1 isoforms reveals dynamic regulation upon germ layer differentiation 
3.2.1 Atlas of paraspeckle trajectories during cell fate conversions 
To quantify paraspeckle dynamics during the differentiation of the human germ layers, I performed single-
molecule FISH (smFISH) for analyzing foci of NEAT1_2 in single cells. I expanded the repertoire of cell 
types by using numerous differentiation protocols as follows: mesoderm was represented by 
differentiating MSCs to adipocytes and osteocytes, lateral mesoderm to cardiomyocytes, and intermediate 
mesoderm to nephron progenitors and nephrons; definitive endoderm cells were differentiated to 
hepatocytes and lung progenitors; NSCs which are from ectoderm origin were differentiated into motor 
neurons and astrocytes, and cortical neuron progenitors were cultured to a mature state; neural crest 
progenitors, which represent the “fourth” germ layer, which give rise to multiple lineages that migrate 
throughout the body [188], were produced by a differentiation protocol that involves the formation of 
neurospheres [189]. Moreover, I differentiated trophoblast progenitors which represent extraembryonic 
tissues [170] and analyzed primary myoblasts, keratinocytes and fibroblasts from somatic sources (Fig. 
10A). 
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Analysis of the expressed transcripts and proteins confirmed these lineages: differentiated MSCs exhibited 
lipid droplets and calcium deposits, which are observed in adipocytes and osteocytes, respectively (Fig. 
12A, B); differentiation of lateral mesoderm progenitors led to up-regulation of cardiomyocyte progenitor 
markers including NKX2.5 and ISL1 (and cells began to spontaneously contract), while the precursor 
markers T and MESP1 were down-regulated (Fig. 12C); and expression of SIX2, PAX2 CDH5, WT1 and 
additional nephron progenitor markers were overtly apparent (Fig. 12D, E, J). In the direction of endoderm 
differentiation, liver markers AFP, ALB, HNF4A were strongly induced (Fig. 12F, J). Characterization of the 
neuronal cell populations was based on the formation of TUBB3 and NFH positive axons in the case of 
motor neurons, MAP2 positive axons in the case of cortical neurons, and GFAP positive star-like projections 
in the case of astrocytes (Fig. 12J). Moreover, these cell populations expressed the characteristic 
transcription factors MNX1, ISL1, TBR1 and SOX9, respectively (Fig. 12J), which were confirmed by 
analysis of gene expression together with neuronal markers CHAT and TBR2 as well as markers of 
astrocytes SLC1A2 and SLC1A3 (Fig. 12G-I). Finally, the identity of fibroblasts and keratinocytes was 
validated by expression of VIM / HSP47 and KRT14 / IVL, respectively (Fig. 12J).  
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Figure 12: Characterization of differentiated cells. A, B) Oil Red O (A) and Alizarin Red (B) staining of 
human MSCs differentiated to adipocytes and osteocytes, respectively. Scale bar: 500 µm. C, D) Time 
course RT-qPCR analysis of representative pluripotency, mesoderm and cardiac markers during lateral 
mesoderm differentiation to cardiomyocytes (C) [172], and of representative intermediate mesoderm and 
nephron progenitor markers during nephron differentiation (D) [36]. E) Representative images showing 
the expression of characteristic nephron progenitor markers at day 14 of differentiation. F) RT-qPCR 
analysis of representative pluripotency, definitive endoderm and hepatocyte markers during 
differentiation to hepatocytes at day 16 [37]. G-I) RT-qPCR analysis of representative pluripotency, motor 
neuron, glial and cortical markers following differentiation to motor neurons (G), astrocytes (H) and 
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cortical neurons (I). J) Representative immunocytochemistry images of terminally differentiated cell 
preparations stained with antibodies, specific for markers of the respective cell types (scale bar upper 
panels: 50 µm) and analyzed by smFISH with NEAT1_2 probe (bottom panel, probe in red, DAPI staining 
in blue; scale bar: 10 µm).  
n=2 independent experiments, error bars represent standard deviation, cells in different passages were 
used for replicates. 
 
Inspection of the atlas confirmed the previous observations that the number of paraspeckles increases when 
hPSCs exit the pluripotent state [47], [88] and it became apparent that this is a general phenomenon which 
includes precursors of the ectoderm and neural crest (Fig. 13A-C, F). However, the number of paraspeckles 
varied considerably between the different types of cells: differentiated cells of the mesoderm lineages 
generally exhibited a similar number of paraspeckles as their precursors, with the exception of MSCs and 
their adipocyte, osteocyte and fibroblast progeny, which exhibited the highest number of paraspeckles of 
all cell types (Fig. 13A-C, F). In the endoderm lineages, lung progenitors exhibited a similar number of 
paraspeckles as the definitive endoderm progenitor stage, and hepatocytes exhibited a smaller amount. In 
the neural lineages, all mature cells exhibited low number of paraspeckles, however, astrocytes, which were 
derived from NSCs in parallel to motor neurons, exhibited a very high amount of paraspeckles. Neural 
crest progenitors exhibited a similar number of paraspeckles as the other three types of germ layer 
precursors, but the number of paraspeckles in the extraembryonic lineage of trophoblasts was two times 
higher. Interestingly, adult dermal fibroblasts exhibited significantly more paraspeckles compared to 
fibroblasts of neonatal, foreskin origin (Fig. 13C, F). Finally, keratinocytes, which belong to the ectoderm, 
exhibited some of the highest numbers of paraspeckles (Fig. 13F). In general, there was only a minor 
correlation between paraspeckle number and differentiation time per cell type (Fig. 13D), whereas a 
stronger positive correlation with NEAT1_2 expression was observed (Fig. 13E). I concluded that the 
quantity of paraspeckles is not overtly related to a specific germ layer or developmental stage, and that 
cells of mesenchymal and glial origin exhibited high amount of paraspeckles, whereas neuronal, hepatic 
and terminally differentiated cells of the mesoderm lineage exhibited little paraspeckle formation. 
Importantly, the individual cells within all populations exhibited heterogeneous amounts of paraspeckles 
(Fig. 13G), which confirms paraspeckle heterogeneity observed in tumor cell lines [190].  
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Figure 13: Analysis of paraspeckles in a panel of cell types and differentiated states. A, B) Representative 
images of NEAT1_2 (red) in cells representing tissue progenitors (A), and terminally differentiated cells 
(B). C) The number of paraspeckles per cell in progenitors and differentiated cell types used to calculate 
the average number of paraspeckles in F. Each dot represents the average of one microscopic image 
displaying 20-150 cells. n=3 independent replicates using cells of different passages were analyzed with 5-
7 images per replicate. Changes in number of paraspeckles are statistically significant for all cell types 
compared to ESCs (p < 0.0001, unpaired t-test, *** p < 0.001). D) Correlation of differentiation time as 
specified in the method section and averaged number of paraspeckles per cell type. E) RT-qPCR of 
NEAT1_2 in 19 cell types and correlation with the averaged number of paraspeckles per cell indicated in F. 
RNA was obtained from 2-3 independent differentiations of cells in different passages. F) Summary of 
paraspeckle amounts in diverse developmental and terminally differentiated cell types, and during 
reprogramming of human neonatal fibroblasts. Size of circles corresponds to the average number of 
paraspeckles in the different cell types, which was quantified by automated spot (foci) detection in a total 
of 200 - 2000 cells per type representing 3 independent experiments G) Violin plots depicting the number 
of paraspeckles in 100 single cells from all tested human cell types based on F, black line represents mean 
value and dashed lines the quartiles. H) Analysis of the correlation of NEAT1_2 total intensity and the 
number of paraspeckles per cell in representative human and mouse cell types. Each point represents a 
microscopic image. r in D, E, H is the Pearson`s correlation coefficient and dashed line in H is the linear 
regression line.  
 
To evaluate the conversion of paraspeckle phenotypes in mammals, I analyzed mouse ESCs and primary 
mouse MSCs, cardiomyocytes, hepatocytes, and astrocytes, which represented the three germ layers. 
Similar to the equivalent cell types in the human, murine MSCs and astrocytes exhibited higher amounts 
of paraspeckles compared to cardiomyocytes and hepatocytes (Fig. 14A, B). However, the number of 
paraspeckles in murine MSCs and astrocytes was significantly lower compared to the human equivalent 
cell types (Fig. 14A, B). Finally, I verified that human astrocytes exhibited an exceptionally large amount 
of paraspeckles by analyzing primary cells of this type (Fig. 14B). Furthermore, I validated that the number 
of paraspeckles that I counted per cell was linearly correlated with the intensity of the NEAT1_2 smFISH 
signal, which I used for measuring their amount (Fig. 13H). Taken together, I concluded that the tendency 
to exhibit higher or lower amounts of paraspeckles in specific cell types is evolutionally conserved and that 
human cell types tend to have more paraspeckles compared to murine cells. 
To corroborate the general conclusion that differentiation promotes an increase in the amount of 
paraspeckles, I analyzed paraspeckle kinetics during cellular reprogramming, which is the reverse process 
of differentiation. I utilized human fibroblasts, which exhibited some of the highest amounts of 
paraspeckles (Fig. 13F) and reprogrammed them into iPSCs by synthetic RNAs that encode the 
pluripotency factors OCT4, SOX2, NANOG, KLF4, MYC, and LIN28A. Analysis of paraspeckles revealed an 
oscillatory pattern as the amount declined and increased before declining again and settling on 1 - 2 
paraspeckles per cell in the nascent iPSCs upon activation of the endogenous pluripotency genes (Fig. 13C, 
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F, Fig. 14C-E). This further confirmed the inverse correlation between pluripotency and paraspeckle 
formation. 
 
Figure 14: Characterization of paraspeckles in murine primary cell types and upon reprogramming of 
human fibroblasts. A) Representative images of NEAT1_2 (red) in mouse ESCs and primary 
cardiomyocytes, hepatocytes, MSCs and astrocytes, next to the same cell types from the human. B) 
Quantification of paraspeckles in primary murine cell types (n=3 independent replicates using ESCs, or 3 
different mice for the other cell types). **** p< 0.0001 unpaired t-test. C, D) Representative brightfield (C) 
and NEAT1_2 (D) images taken during reprogramming of human neonatal fibroblasts. n=2 independent 
reprogramming experiments using cells of different passages were analyzed with 7 images per replicate; 
nascent iPSC colonies are marked with white circles. Quantification of paraspeckle numbers in Fig. 13C, F. 
E) Time-course RT-qPCR analysis of endogenous transcription of pluripotency factors OCT4, SOX2 and 
NANOG during fibroblast reprogramming. n=2 independent reprogramming experiments.  
Error bars represent standard deviation. DAPI staining in blue; scale bar is 10 µm in smFISH images and 
50 µm in brightfield images. 
 
3.2.2 Localization of NEAT1_1 outside of paraspeckles is developmentally regulated 
Both short and long NEAT1 isoforms are generally confined to paraspeckles [191], however recently it was 
demonstrated that a subpopulation of NEAT1_1 is localized outside of paraspeckles in the surrounding 
nucleoplasm in HEK293 cells where it primarily forms small foci containing 1-3 NEAT1_1 molecules [95]. 
Supporting this notion, I observed NEAT1_1 foci outside of paraspeckles in human and mouse ESCs, 
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however, the NEAT1_1 foci disappeared upon prolonged differentiation (Fig. 15A, B). To interrogate 
general principles of NEAT1_1 foci expression trajectories, I extended the paraspeckle atlas (Fig. 13F) by 
the analysis of NEAT1_1 in those cell types and found that while most cell types were devoid of NEAT1_1 
foci, myotubes, neural crest cells, cardiomyocytes and cells committed to germ layer differentiation for 1-2 
days exhibited NEAT1_1 localization outside of paraspeckles (Fig 15C, D). Interestingly, the number of 
NEAT1_1 foci outside of paraspeckles was inversely correlated with the number of mature paraspeckles 
(Fig. 15E), indicating that increased expression of NEAT1_2 promotes trans-localization of NEAT1_1 to 
paraspeckles. I concluded that the formation of NEAT1_1 foci is developmentally regulated and anti-
correlated to the number of paraspeckles in mature cell types. 
 3. Results  
56 
 
 
Figure 15: Characterization of NEAT1_1 foci in ESCs and differentiated cells. A) Representative images 
of dual smFISH with probes for NEAT1 5`end targeting both NEAT1 isoforms (NEAT1_t(otal), red) and 
probes for the NEAT1 middle segment targeting NEAT1_2 (green) in mouse and human ESCs after 24 hours 
of differentiation. Arrowheads indicate NEAT1_1 foci outside of NEAT1_2/paraspeckles. B) Quantification 
of NEAT1_1 foci in mouse and human ESCs during spontaneous differentiation. n=6 images per time point. 
C) Representative images of cell types with or without NEAT1_1 foci. Imaging as in A. D) Ratio of number 
of NEAT1_t and NEAT1_2-only foci. A value of 1 indicates the absence of NEAT1_1 foci. Cell types and 
image analysis as in Fig. 13C. E) Correlation of NEAT1_t / NEAT1_2 ratio and NEAT1_2 foci in all cell types. 
r represents Pearson`s correlation coefficient.  
Error bars represent standard deviation. DAPI staining marks nuclei in blue; scale bar: 10 µm. 
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3.2.3 Paraspeckle amount correlates with nucleus size 
The paraspeckle atlas revealed that drastic changes in the amount of paraspeckles took place during 
differentiation without overt patterns of cell lineages or timing. I therefore asked what other cellular 
features might correlate with the amount of paraspeckles based on the cell atlas database. I noticed first a 
strong positive correlation between the amount of paraspeckles and the size of nuclei for individual cells 
within neonatal and adult fibroblasts (Fig. 16A, B). This prompted me to investigate whether nuclei size is 
in general a predictive factor for paraspeckle quantity. Strikingly, analyzing nuclei size in all cell types of 
the atlas revealed lineage correlation with the number of paraspeckles (Fig. 16C).  Moreover, I found that 
the oscillating pattern of paraspeckle formation during reprogramming was correlated to changes in 
average nuclear size (Fig. 16D). This led me to hypothesize that the differences in paraspeckle amount 
between human and mouse astrocytes and MSCs (Fig. 14B) could be also explained by nucleus size 
differences. Indeed, adjusting the number of paraspeckles to the size of the nucleus in mouse MSCs and 
astrocytes showed that the corrected values of paraspeckles are similar (Fig. 16E, F). Moreover, differences 
in paraspeckles numbers between neonatal and adult fibroblasts (Fig. 13C, F) could be explained by the 
nucleus size (Fig. 16G, H). This provided a cell-intrinsic explanation for the high degree of variability in 
the number of paraspeckles observed between cells of the same type and for different types of cells. 
Next, to assess whether the size of the nucleus determines the amount of paraspeckles or vice versa, 
I analyzed NEAT1-/- and NEAT1ΔpA hESCs (introduced in section 3.4), which are either devoid of 
paraspeckles or exhibited 2-fold increase in the amount of paraspeckles due to the deletion of the internal 
polyA site [47] (Fig. 16I). Analyzing the size of nuclei did not reveal differences between NEAT1-modified 
cell lines compared to wildtype (Fig. 16J), thus I concluded that it is the nucleus size that determines the 
amount of paraspeckles.  
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Figure 16: Paraspeckle formation correlates with the nuclear size within and across different cell types. 
A) Images and quantification of nuclear area (µm2) by DAPI staining (blue) and number of NEAT1_2 foci 
analyzed by smFISH (red) of representative human neonatal fibroblasts that exhibited different sizes (Scale 
bar: 10 µm). B) Analysis of the correlation between the number of paraspeckles and nucleus size of 100 
human adult and neonatal fibroblasts. C) Analysis of the correlation between the averaged number of 
paraspeckles and averaged nucleus size per cell in 24 cell types analyzed in the atlas database represented 
in Fig. 13F. D) Averaged nucleus size (black) and number of paraspeckles (red; based on Fig. 13F) analyzed 
during reprogramming of human neonatal fibroblasts. E-G) Averaged number of paraspeckles per cell (E, 
G) based on Fig. 13F and averaged nuclear size (F, H) in mouse (grey) and human (black) MSCs and 
astrocytes (AC), as well as in adult (grey) and neonatal (black) fibroblasts. Numbers on top are the fold 
changes between the respective cell types from the human and the mouse. The numbers in red represent 
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predicted fold changes based on the slope of the regression line in C. I, J) Averaged number of paraspeckles 
per cell (I) and averaged nuclear size (J) of NEAT1-/-, NEAT1ΔpA and WT hESCs in pluripotent condition 
or differentiated by RA addition for 3 days.  
Nucleus size in C, F, H, J represents the averaged value of 7-14 images per cell type from 2 independent 
experiments with 10-100 cells per image (details in methods). Error bars represent standard error of the 
mean (SEM). r in B, C represents the Pearson`s correlation coefficient and dashed line is the linear 
regression line.  
 
3.2.4 TDP-43 regulates paraspeckle formation 
Nuclear size seems to be a predictive factor for paraspeckle formation (Fig. 16), but the molecular 
mechanism regulating developmental paraspeckle formation remains unknown. The following findings 
were generated together with my colleague Miha Modic and were recently published, hence are described 
in this section only very briefly and the following figure was adapted from the publication [47].  
It was shown by individual-nucleotide resolution Cross-Linking and Immunoprecipitation (iCLIP) 
that the multifunctional RBP TDP-43 binds to NEAT1 [192], which prompted us to investigate its role in the 
regulation of NEAT1 transcription. Indeed, we observed TDP-43 down-regulation during exit from 
pluripotency, which was correlated with the expression of NEAT1_2 (Fig. 17A-C). Strikingly, the number 
of h/mESCs with expression of NEAT1_2 foci increased significantly upon depletion of TDP-43, similar to 
the deletion of the NEAT1 polyA site, which inhibits NEAT1_1 processing and promotes NEAT1_2 
expression (Fig. 17D, E). RNA sequencing confirmed the up-regulation of NEAT1_2 in h/mESCs after 
down-regulation of TDP-43 (Fig. 17F). Next, we performed iCLIP which showed enrichment of TDP-43 at 
UGUG repeats upstream of the NEAT1 polyadenylation site (Fig. 17G). Importantly, when deleting this 
region, we observed an increase in the number of NEAT1_2 foci (Fig. 17H), which led us to conclude that 
TDP-43 inhibits processing of NEAT1_2 in pluripotent cells by binding and regulating the usage of its 
polyadenylation site. These findings were recently validated by others that linked paraspeckle formation 
to the depletion of nuclear TDP-43 in spinal cord neurons of ALS patients [128].  
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Figure 17: TDP-43 inhibits NEAT1_2 processing by regulating NEAT1 polyadenylation. A) Expression 
analysis of NEAT1_2 and TDP-43 based on transcriptome data of hESCs and differentiated cells [193]. B, 
C) TDP-43 mRNA (B) and protein (C) expression during mesoderm differentiation induced by daily 
addition of 10 µM CHIR to hESCs. D, E) Percentage and representative images of human (D) and mouse 
(E) ESCs that are labeled with NEAT1_2 probe (red). NEAT1_1 and NEAT1_2 foci were counted separately 
in 200 cells per condition. F) Representative mapping of NEAT1/Neat1 RNA sequencing reads in murine 
and human ESCs and after depletion of TDP43/Tdp-43. G) TDP-43 cross-linked positions (red bars) based 
on iCLIP in mESCs. Sequence conservation is indicated as grey bars. Zoom into the region that was deleted 
for paraspeckle quantification in H. H) Quantification of NEAT1 expression in mESCs with deletion of the 
TDP-43 binding site, as indicated in G. Cells were counted as in D, E. Mann-Whitney U test; **p < 0.001, 
***p < 0.0001. Figure was adapted from [47]. 
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3.3 DNA accessibility is required for paraspeckle assembly 
The broad range in the amount of paraspeckles in cells with different sizes of nuclei led me to interrogate 
what common traits could regulate their structural similarity across different types of cells. Because 
NEAT1_2 can form RNA-DNA triple helix structures, similarly to many other lncRNAs such as HOTAIR 
and MALAT1 [111], I hypothesized that changing the accessibility of the major groove could perturb 
paraspeckle formation. Actinomycin D (ActD) is a small molecule that binds the minor groove of double-
strand DNA (dsDNA) and changes its conformation [194], [195]. I therefore tested whether ActD treatment 
can promote the disassembly of paraspeckles. Strikingly, I noted a sharp increase and spreading of 
NEAT1_2 foci in diverse types of cells that were treated by ActD for one hour, including trophoblast 
progenitors, NSCs and endoderm progenitors that were derived from hPSCs, as well as in primary 
astrocytes and neonatal fibroblasts (Fig. 18A, D). Importantly, the number of NEAT1_2 foci was reflected 
by the number of paraspeckles in respective cell types of the atlas and peaked between 1 and 2 hours after 
ActD treatment (Fig. 18F). Contrarily, the paraspeckle core proteins SFPQ and NONO localized to 
perinucleolar caps after addition of ActD (Fig. 18C), which is in line with previous observations that 
reported perinucleolar localization of paraspeckle proteins after transcriptional inhibition [82] and during 
cell division [133] when NEAT1_2 is down-regulated. This suggested that the NEAT1_2 foci arising upon 
ActD treatment are not functional. Moreover, the intensity distribution of resulting NEAT1_2 speckles 
indicated a high proportion of single NEAT1_2 molecules after ActD treatment (Fig. 9), based on which I 
was able to estimate the amount of NEAT1_2 molecules per cell. According to the NEAT1_2 intensity profile 
after ActD addition, I estimated that, dependent on the cell type, cells contained on average between 20 
and 50 NEAT1_2 molecules (Fig. 18E), which is in the range of the 26 NEAT1_2 molecules estimated by RT-
qPCR in U2OS cells [95]. I concluded that treatment by ActD induced the disintegration of NEAT1_2 foci 
to single molecules.   
Disintegration of paraspeckles was observed before after 4 hours of ActD treatment in HeLa cells, 
however, the authors argued that this is due to ActD-mediated global inhibition of transcription [85]. To 
test whether this is true or alternatively, the disintegration of paraspeckles occurred as a result of the 
disruption of dsDNA, I treated trophoblast progenitors with α-Amanitin, which selectively inhibits RNA 
polymerases [196]. In parallel, the cells were treated by Hoechst 33342 and Mithramycin A which, similarly 
to ActD, are known to bind to the minor groove of dsDNA and disrupt its confirmation [197], [198]. 
Importantly, I observed similar kinetics of accumulation and decay of NEAT1_2 foci upon Hoechst 33342 
and Mithramycin A treatment as with ActD, but not following α-Amanitin, which ruled out inhibition of 
RNA polymerases as the mechanism of the immediate paraspeckle disintegration by ActD (Fig. 18B, F). Of 
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note is that all treatments including α-Amanitin led to NEAT1_2 down-regulation after several hours of 
treatment (Fig. 18A, B, F), which is in agreement with previous observations and likely due to the decay of 
NEAT1_2 [199].  
 3. Results  
63 
 
 
 
 3. Results  
64 
 
Figure 18: Treatment by DNA-binding small molecules promotes paraspeckle disassembly. A, B) 
Representative images of NEAT1_2 smFISH after treatment of cells by 2 µM Actinomycin D (ActD) (A), 100 
µg/ml Hoechst 33342, 5 µM Mithramycin A and 50 µM α-Amanitin (B) in trophoblast progenitors produced 
by 3 days of BMP4 treatment of hESCs. C) Immunocytochemistry of nucleolar protein fibrillarin (FBL) and 
paraspeckle proteins SFPQ and NONO in untreated trophoblast progenitors and after treatment by 2 µM 
ActD for 1 hour. D) Analysis of the averaged amount of NEAT1_2 foci following ActD treatment in 5 
different cell types E) The number of NEAT1_2 molecules per cell, calculated based on the averaged 
intensity of a single NEAT1_2 molecule (Fig. 9). F) Analysis of the averaged amount of NEAT1_2 foci in 
trophoblast progenitors following treatment by the four chemicals shown in A, B. Error bars in D, F 
represent SEM and standard deviation in E. 7 images were analyzed in E and 14 in D, F representing 2 
independent replicates using cells of different passages. 
 
It is known that small DNA binding molecules can induce DNA double-strand breaks [200], which might 
be the underlying reason for paraspeckle disintegration. Indeed, after ActD treatment, I observed a 
significant increase in DNA double-strand breaks, which were analyzed by the appearance of γ-H2A.X foci 
[201], however, the treatment by Hoechst or Mithramycin A did not change the percentage of cells 
expressing γ-H2A.X (Fig. 19A, B) and thus I concluded that paraspeckle disintegration is not induced by 
DNA damage. 
ActD and Mithramycin A are part of chemotherapeutic regimens to inhibit tumor growth [202] and 
I was interested whether paraspeckle disintegration could be induced by other chemotherapeutic reagents. 
I tested this by treating the cells with the microtubule inhibitor Vincristine [203], the DNA intercalator 
Doxorubicin [204], the topoisomerase II inhibitor Etoposide [205] or with Flavopiridol, an inhibitor for 
cyclin-dependent kinases [206]. Indeed, I observed a significant increase in NEAT1_2 foci after treatment 
by Etoposide and Flavopiridol, but not by Vincristine (Fig. 19C) and since only the first two molecules were 
shown to bind dsDNA [207], [208], this supported the conclusion that DNA binding by small molecules 
induces paraspeckle disintegration (Fig. 19E). An exception was Doxorubicin, which, added to the cells, 
induced complete degradation of NEAT1_2, whereas NEAT1_1 foci disintegrated similarly to NEAT1_2 foci 
in the other treatments (Fig. 19C, D). Strikingly, this was a very concentration-sensitive effect, observed 
already by increasing the concentration of Doxorubicin from 4.3 µM to 5.7 µM. It seemed that Doxorubicin 
is detrimental for paraspeckle formation but possibly has a severe effect on NEAT1_2 stability. 
 Lastly, to test whether the disintegration of nuclear lncRNAs is a general phenomenon, I analyzed 
MALAT1 by smFISH after ActD treatment. Strikingly, I found that MALAT1 speckles disintegrate with 
similar kinetics as paraspeckles (Fig. 19F, G). I concluded that dsDNA binding serves as structural basis 
for assembly and maintenance of paraspeckles and other nuclear lncRNAs.  
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Figure 19: Chemotherapeutics disintegrate NEAT1_2 foci. A, B) Representative images (A) and 
quantification (B) of γ-H2AX foci after addition of small DNA binding molecules. n=8 images. Note that 
already untreated hESCs exhibited γ-H2A.X foci, which were observed in mESCs, before [209]. C) 
Averaged amount of NEAT1_2 foci following 2 h of treatment by the chemicals in Fig. 18F and different 
concentrations of the chemotherapeutic reagents Vincristine, Doxorubicin, Etoposide and Flavopiridol. D) 
SmFISH of NEAT1 5`end indicating the presence of both NEAT1 isoforms and of NEAT1_2 in trophoblast 
progenitors treated by different concentrations of Doxorubicin for 2 hours. E) A table with the mode of 
action (MoA) of small molecules used in this study and their ability to bind DNA, to inhibit transcription 
and to disintegrate paraspeckles. F, G) Representative images (F) and quantification (G) of MALAT1 
smFISH in cells treated by ActD as above. n=2 independent replicates with 7 images per replicate.  
Cells were differentiated to trophoblast progenitors by addition of BMP4 for 3 days. Dashed lines in D, F 
depict the locations of the borders of the nuclei. 
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3.4 NEAT1_2 but not NEAT1_1 regulates exit from pluripotency  
3.4.1 Manipulation of NEAT1 expression reveals cell type-specific regulation of paraspeckle formation 
Both isoforms of NEAT1 exhibited drastic expression changes during germ layer differentiation (Fig. 13, 
15), however, their function during this process remains unknown. To interrogate the role of NEAT1 in 
differentiated cells, I generated hESCs with deletions of different functional parts of the NEAT1 gene (Fig. 
20A). To reduce NEAT1 expression, I targeted its promoter by deleting 1150, 2300 and 6000 base pairs (bp) 
surrounding the NEAT1 TSS. This led respectively to 10, 50 and 99% reduction of NEAT1 expression (Fig. 
20B) and a complete absence of paraspeckles for the biggest deletion (Fig. 20C, D), which therefore was 
referred to as NEAT1-/- hESCs. Alternatively, I inserted a polyA-YFP stop cassette  directly after the NEAT1 
TSS according to a previously published study in HEK293 cells [95]. Interestingly, this integration did not 
abrogate paraspeckle formation (Fig. 20E), indicating that NEAT1 exhibits cell type-specific regulation and 
has an alternative TSS in hESCs. To test this, I deleted 1150 bp surrounding the NEAT1 TSS in HEK293 cells 
and strikingly, whereas this deletion reduced NEAT1 expression only by 10% in hESCs, paraspeckle 
formation and NEAT1 expression was completely abolished in HEK293 cells (Fig. 20B, F). I concluded that 
NEAT1 has one or multiple alternative TSSs in hESCs, but not in HEK293 and possibly other somatic cells. 
The NEAT1∆1150 HEK293 cells were used by collaborators to show that the (G4C2)n RNA arising from the 
C9ORF72 gene locus forms foci which co-localize with paraspeckle proteins, a process that is not influenced 
by NEAT1 [210]. 
 Additionally, I targeted the processing sites of NEAT1_1 and NEAT1_2, by deleting the genomic 
region encoding for the polyadenylation signal or the triple helix, respectively. While a complete down-
regulation of NEAT1_2 and paraspeckles was observed in HAP1 cells upon deletion of the triple helix [211], 
I observed a reduction in NEAT1_2 expression by 90% and number of paraspeckles by 50% in differentiated 
NEAT1∆TH hESCs (Fig. 20B-D). In contrast, the deletion of the NEAT1 polyA site resulted in the 
disappearance of NEAT1_1 foci in undifferentiated cells (Fig. 20G) and consequently to increased number 
of paraspeckles due to elevated levels of NEAT1_2 in pluripotent condition (Fig. 20B, H). Importantly, over-
expression of paraspeckles was significant only in pluripotent condition, whereas differentiated 
NEAT1∆pA hESCs did not exhibit substantially more paraspeckles compared to parental control cells (Fig. 
20H). To summarize, I generated hESCs with reduced expression of short (NEAT1∆pA), long (NEAT1∆TH) 
or both NEAT1 isoforms (NEAT1-/-). 
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Figure 20: Generation of NEAT1_1 and NEAT1_2 knock-out cell lines. A) The strategy of manipulating 
NEAT1 expression by CRISPR/Cas9. B) RT-qPCR of NEAT1 in cell lines presented in A. n=3 experiments of 
cells in different passages. Cells were differentiated by removal of pluripotency medium for 3 days. 
NEAT1ΔpA hESCs were kept in pluripotency medium. C, D) Representative images (C) and quantification 
(D) of NEAT1_2 foci (red) in NEAT1∆2700, NEAT1∆TH and NEAT1-/- hESCs differentiated for 3 days by 
addition of RA. E) Representative merged image of NEAT1_2 smFISH in NEAT1YFP hESCs differentiated 
for 3 days with RA. F) Representative images of NEAT1_2 foci in parental HEK293 cells and upon depletion 
of 1150 bp surrounding the NEAT1 TSS. G, H) Images (G) and quantification (H) of paraspeckles in 
pluripotent NEAT1ΔpA hESCs. Yellow arrows mark NEAT1_1 foci outside of paraspeckles.  
Scale bar is 10 µm; DAPI in blue marks nuclei, NEAT1_2 in red indicates paraspeckles. n =7-14 images in 
D, H representing 2 independent experiments. Error bars represent standard deviation. **** p<0.0001, 
unpaired t-test.  
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3.4.2 NEAT1_2 inhibits spontaneous and neural differentiation 
NEAT1-/- and NEAT1∆TH hESCs represented cells with complete or 50% reduction of paraspeckles and 
hence were used to address whether NEAT1_2/paraspeckles are important for hESCs differentiation. By 
analyzing the expression of developmental markers, I found that the pluripotency characteristics of both 
cell types in pluripotent condition were intact, same as in wildtype with exception of premature up-
regulation of FOXA2 and PAX6 (Fig. 21G). Remarkably, the induction of spontaneous differentiation 
accelerated the down-regulation of pluripotency transcription factors OCT4 and NANOG and cell surface 
markers TRA1-60 and SSEA5 in NEAT1-/- and NEAT1ΔTH cells compared to the parental cell line after three 
days (Fig. 21A-C). A similar acceleration was observed during neuroectoderm differentiation after 4 days, 
but not prior, at the time that paraspeckles started to form (Fig. 21D-F). Interestingly, when I used directed 
differentiation protocols that involved stimulatory cytokines, I did not observe overt acceleration of 
differentiation (Fig. 21H-L). I concluded that paraspeckles are functionally important in hESCs when they 
form during spontaneous or neural differentiation by slowing down the process, but the cells can 
compensate for their loss when treated by differentiation stimuli that can accelerate differentiation 
compared to normal development [212], [213]. 
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Figure 21: NEAT1_2 knock-out hESCs exhibit enhanced spontaneous and neural differentiation 
potential. A-F) RT-qPCR of pluripotency and differentiation markers (A, D), and flow cytometry of 
pluripotency markers after NEAT1ΔTH and NEAT1-/- hESCs were spontaneously differentiated for 3 days 
(A-C) or after 4 days of neuroectoderm differentiation according to the protocol to generate NSCs (D-F). 
G, H) RT-qPCR of pluripotency and differentiation markers of undifferentiated (G) NEAT1-/- and 
NEAT1ΔTH hESC clones and cells differentiated to astrocytes (H). I-K) RT-qPCR of pluripotency and 
endoderm markers (I) and flow cytometry analysis of endoderm surface markers (J, K) after 6 days of 
endoderm differentiation. L) RT-qPCR of pluripotency and mesoderm markers during cardiomyocyte 
differentiation. 
n=2 independent experiments using cells of different passages and with 3 knock-out clones per cell line. 
Forward and side scatter gating was employed to gate out debris and cell clumps. Error bars represent 
standard deviation, except in C, F where the SEM is shown. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p< 0.0001, 
unpaired t-test.   
 
3.4.3 Generation of NEAT1-/- hESCs by CRISPR knock-in confirms differentiation phenotype 
To exclude potential confounding effects due to the genomic deletions in NEAT1-/- human ESCs, I sought 
to validate the phenotype observed above by an independent editing strategy. Therefore, I inserted a stop 
cassette (sequence is of proprietary knowledge of the Westmeyer lab; Helmholtz Zentrum Munich) to block 
transcription ~ 1500 bp after the NEAT1 TSS. These NEAT1STOP hESCs exhibited reduced expression of 
NEAT1_2 and absence of paraspeckles (Fig. 22A-C). Of note is that NEAT1_1 foci were still observed in 
NEAT1STOP hESCs, indicating that 1500 bp of NEAT1_1 is enough to form aggregates (Fig. 22A), even though 
these aggregates are somewhat more diffuse compared to full-length NEAT1_1 foci (Fig. 15). 
 Importantly, integration of the stop cassette did not change the pluripotent character of the cells, 
as they expressed pluripotency and differentiation genes similar to the parental control cells (Fig. 22D-F). 
After spontaneously differentiating NEAT1STOP hESCs for 3 days, a significant reduction of the pluripotency 
surface markers SSEA4 and TRA1-60, and the pluripotency master transcription factors OCT4 and NANOG 
was observed (Fig. 22G, H), which confirmed that NEAT1 depletion promotes the exit from pluripotency. 
Interestingly, NEAT1STOP hESCs exhibited up-regulation of neural transcription factors PAX6 and SOX1 
indicating that NEAT1STOP hESCs are primed for the neuroectoderm lineage (Fig. 22I). To test this, I induced 
neural differentiation and observed a significant up-regulation of PAX6, together with other neural 
markers, concomitant with down-regulation of OCT4 and NANOG in NEAT1STOP hESCs compared to the 
control cell line (Fig. 22J). I concluded that the knock-out of NEAT1_2 promotes exit from pluripotency, 
possibly by priming neural differentiation.  
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Figure 22: NEAT1STOP hESCs exhibited increased differentiation potential. A-C) SmFISH (A) and RT-
qPCR (C) of NEAT1_t(otal) and NEAT1_2 (red), and quantification of paraspeckles in NEAT1STOP hESCs, 
which were spontaneously differentiated (C) or treated by BMP4 for 3 days (A, B). DAPI marks nuclei, 
scale bar is 10 µm. 7 images were analyzed per condition. D-J) Flow cytometry analysis of pluripotency 
surface markers and transcription factors together with RT-qPCR of pluripotency and differentiation genes 
of NEAT1STOP hESCs in pluripotent condition (D-F) and upon spontaneous differentiation for 3 days (G-I), 
together with RT-qPCR of neural genes (J) upon neuroectoderm differentiation for 4 days according to the 
protocol to generate NSCs. 
n=2 independent experiments using cells of different passages. Forward and side scatter gating was 
employed to gate out debris and cell clumps. Error bars represent standard deviation. * p < 0.05, ** p < 0.01, 
*** p < 0.001, **** p< 0.0001, unpaired t-test.   
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3.4.4 Over-expression of endogenous NEAT1 impairs exit from pluripotency  
Based on the results shown above, I hypothesized that NEAT1 over-expression induces up-regulation of 
the pluripotency machinery. NEAT1_2 is a very long RNA, hence it is hardly amenable for plasmid 
transfection-based over-expression, which is why I targeted it by CRISPR-mediated gene activation [214]. 
First, I generated stable hESCs expressing defective Cas9 (dCas) fused to the SunTag complex with the 
transcriptional activator VP64 [215] under control of a doxycycline-inducible promoter according to a 
previous study [180] (Fig. 23A). These cells, from here on referred to as Suntag hESCs, readily expressed 
the dCas9 construct upon doxycycline addition (Fig. 23B). Importantly, Suntag hESCs can be used to over-
express any gene-of-interest, simply by transfecting a gRNA targeting the transcription start site. I screened 
a panel of five gRNAs, including some that were tested before [211], to achieve transient over-expression 
of NEAT1_2 by 5-10 fold  (Fig. 23C). This was concomitant with significant up-regulation of pluripotency 
factors OCT4, NANOG, GDF3 and NODAL (Fig. 23C), the latter two being genes of the TGF-β pathway 
which are important to maintain pluripotency [216], [217]. The increase in pluripotency was confirmed by 
flow cytometry for pluripotency transcription and surface markers which were up-regulated compared to 
the SunTag cell line without NEAT1 gRNAs (Fig. 23D, E). To summarize, I generated hESCs with stable 
expression of a dCas9-SunTag-VP64 trans-activator complex, which exhibited increased expression of 
pluripotency factors after transfection of NEAT1 gRNAs, indicating that NEAT1 over-expression impaired 
exit from pluripotency. 
 3. Results  
73 
 
 
 
Figure 23: CRISPR-mediated activation of NEAT1 induced pluripotency retention. A) Workflow for the 
generation of stable SunTag-expressing hESCs according to [180] B) GFP expression (green) indicating the 
production of the SunTag-VP64 transactivator complex in SunTag hESCs after doxycycline treatment. DAPI 
staining in blue; scale bar: 50 µm. C-E) RT-qPCR of NEAT1_2 and pluripotency genes (C) and flow 
cytometry of pluripotency markers (D) in SunTag hESCs transfected with gRNAs targeting the NEAT1 TSS. 
An average of three gRNAs is shown in E. Cells were induced by doxycycline for 3 days and spontaneously 
differentiated for 2 days. n=2 independent experiments using cells of different passages. Error bars 
represent standard deviation. * p < 0.05, *** p < 0.001, **** p< 0.0001, unpaired t-test.   
 
3.4.5 NEAT1 regulates NANOG expression 
Gene expression analysis indicated that the expression of the pluripotency transcription factor NANOG 
was the most susceptible to changes in NEAT1 expression, indicating that NANOG is regulated by 
paraspeckles. To validate this. I knocked-down NEAT1_2 by transfection of NEAT1-directed antisense 
oligonucleotides (ASOs), which indeed prompted the down-regulation of NANOG (Fig. 24A), an effect that 
was slightly elevated by additional transfection of ASOs against MALAT1, the lncRNA that is in close 
proximity to NEAT1 at the genome. Next, I established a protocol for flow cytometry-based cell sorting of 
NEAT1-expressing cells, stained by smFISH, according to a published protocol [178]. To test the efficacy of 
the protocol, I analyzed pluripotent and RA-treated hESCs and observed, as expected, a shift in NEAT1 
expression in the differentiated cell population (Fig. 24B). I sorted the top and lowest 5% of NEAT1-
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expressing cells upon differentiation, which exhibited higher NANOG expression in the NEAT1-positive 
cell population (Fig. 24C, D). To conclude, NANOG expression correlated with NEAT1 levels, which 
validated findings from above by two orthogonal methods. 
 
Figure 24: NEAT1 regulates NANOG expression. A) RT-qPCR of hESCs transfected with ASOs for NEAT1 
and spontaneously differentiated for 2 days with or without the presence of BMP4 to induce trophoblast 
progenitor differentiation. For the latter, ASOs for MALAT1 were added in a separate experiment. RNA 
expression was normalized to the scrambled control ASO. B) Flow cytometry-based analysis of single cells 
stained by smFISH for NEAT1 in undifferentiated cells (red) and cells differentiated by addition of RA for 
4 days (blue). C, D) Flow cytometry-based single-cell sorting of the top (NEAT1pos) and lowest (NEAT1neg) 
5% of NEAT1-expressing cells that were spontaneously differentiated for 2 days. RT-qPCR of NEAT1 
positive population normalized to the negative population in D.  
n=2 independent experiments, except for spontaneous differentiation in A with only one replicate. Error 
bars represent standard deviation.  
 
3.4.6 NEAT1_1 is dispensable for germ layer differentiation 
Finally, I utilized the genetically edited NEAT1 hESCs to address the function of the short isoform, 
NEAT1_1, which was previously shown to form microspeckles outside of paraspeckles [95]. Since I did not 
observe different phenotypes for the NEAT1-/- and NEAT1ΔTH human cell lines (Fig. 21), although the latter 
produced the short isoform (Fig. 20B), I hypothesized that NEAT1_1 is dispensable for the differentiation 
of germ layer progenitors. Indeed, analyzing the differentiation of NEAT1ΔpA hESCs that harbor a deletion 
of the internal polyadenylation did not reveal a difference in the up- and down-regulation of differentiation 
and pluripotency genes (Fig. 25A-C). In undifferentiated cells however, an increase in germ layer markers, 
most notably T and PAX6 was observed (Fig. 25D), concomitant with increased expression of NANOG by 
10-fold (Fig. 25D), which is reminiscent of the phenotype after NEAT1 over-expression (Fig. 25E) and a 
reciprocal expression pattern compared to NEAT1-/- hESCs (Fig. 21, 22). To summarize, only the 
architectural isoform of NEAT1, NEAT1_2, was required for differentiation, whereas NEAT1_1, which in 
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hESCs, was localized outside of paraspeckles (Fig. 15A, B) did not affect the formation of germ layer 
progenitors.  
 
Figure 25: Characterization of gene expression changes in NEAT1ΔpA hESCs. A-C) RT-qPCR analysis of 
NEAT1ΔpA hESC clones differentiated to lateral mesoderm (A), definitive endoderm (B) and 
neuroectoderm by 4 days differentiation of NSCs (C). n=2 biological replicates of cells in different passages 
and 4 replicates representing two different clones for NEAT1ΔpA hESCs. D) RT-qPCR of NEAT1ΔpA clones 
in pluripotent conditions. n=2 biological replicates of cells in different passages. Error bars represent 
standard deviation.  
 
3.5 Functional assays to determine the mode-of-action of paraspeckles in differentiated PSCs 
Paraspeckles are a hub for proteins [83] and RNA [84] and NEAT1-dependent sequestration of both was 
shown to have an impact on cell fate [191]. To achieve first mechanistic insights into the molecular 
mechanisms executed by paraspeckles in differentiated hESCs, I sought to interrogate changes in RNA 
retention and protein composition in paraspeckle-depleted cell lines.  
 
3.5.1 Global changes in nuclear RNA retention after depletion of paraspeckles 
First, to analyze how the nuclear and cytosolic RNA landscape was changed in NEAT1-/- hESCs, a 
subcellular fractionation method for the subsequent isolation of nuclear and cytoplasmic RNAs was 
established. Process control was performed by western blot with enrichment of histone H3 and almost 
complete absence of β-actin (ACTB) in the nuclear fraction (Fig. 26A), and by RT-qPCR with cytoplasmic 
enrichment of GAPDH and mitochondrial MT-CYB mRNAs and the lncRNAs NEAT1, MALAT1 and 
SCARNA10 in the nucleus (Fig 26B). Next, I performed polyA-enriched RNA sequencing of differentiated 
NEAT1-/- and parental control cells. Enrichment of nuclear lncRNAs in the nucleus and mRNAs in the 
cytoplasm indicated successful fractionation (Fig. 26C). Amongst the ~10000 detected transcripts, 32% 
changed their location after paraspeckle depletion (p<0.05) (Fig. 26D). By comparing the nuclear-to-
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cytoplasmic ratio of transcripts in parental and NEAT1-/- cells, I identified transcripts of 76 genes that were 
exported to the cytoplasm and 135 genes that were retained in the nucleus by more than 2-fold after 
paraspeckle depletion (Fig. 26E). The nuclear retained transcripts are generally produced by cytoplasmic 
genes with metabolic and translational functions, whereas genes whose transcripts are exported to the 
nucleus after paraspeckle knock-out exhibited functions in RNA processing (Fig. 26F). To summarize, the 
transcript localization landscape was drastically changed upon loss of paraspeckles, which could lead to 
changes in the protein amount that might affect stem cell differentiation. However, no mRNAs of 
differentiation-associated genes were found to change their localization, which is why mRNA retention 
probably only indirectly contributes to the paraspeckle phenotype described above. 
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Figure 26: Subcellular fractionation combined with RNA sequencing determines changes in RNA 
localization upon NEAT1 depletion. A, B) Process control of cytoplasmic-nuclear fractionation by western 
blot for cytoplasmic β-actin (ACTB) and nuclear histone protein H3 (A) and RT-qPCR of nuclear lncRNAs 
(grey) and cytoplasmic transcripts (black) (B). Error bars represent standard deviation. C) Averaged 
cytoplasmic-to-nuclear ratio of cytoplasmic (black) and nuclear (grey) RNAs after RNA sequencing of 
differentiated wildtype and NEAT1-/- hESCs. Differentiation was performed for 4 days according to the 
protocol to generate NSCs. D) Number of transcripts that exhibited localization changes after NEAT1 
depletion (p<0.05) E) Scatterplot depicting the nuclear-to-cytoplasmic ratio of transcripts in differentiated 
wildtype (x-axis) and NEAT1-/- (y-axis) hESCs. F) GO enrichment analysis of genes whose transcripts are 
retained in the nucleus (green) or exported to the cytoplasm (yellow) in NEAT1-/- hESCs according to the 
string database. Numbers in bars represent the number of genes found per GO term. 
 
3.5.2 Analyzing the cross-talk between RBPs of paraspeckles and the RNA polymerase II  
Many RNA binding proteins are associated to paraspeckles [83], similar to the RNA polymerase II (RNA 
PolII) to which a plethora of transcriptional and co-transcriptional factors are bound [218]. I hypothesized 
that the repertoire of RBPs attached to RNA PolII is influenced by paraspeckles. To address this, I 
performed a pull-down of RNA PolII using an antibody for the phosphorylated Serine 2 residue of its C-
terminal domain (CTD), a marker of the elongating PolII [219]. I employed a recently published protocol 
for chromatin immunoprecipitation with selective isolation of chromatin-associated proteins (CHiP-
SICAP) [184] in parental and NEAT1-/- hESCs after 4 days of neural induction. By mass spectrometry, 34 
proteins were identified to be significantly differentially associated to the wildtype or NEAT1-/- RNA PolII 
CTD (p<0.05, Fig. 27A), amongst which 13 were splicing proteins (p=1.3x10-11) and 6 proteins that influence 
DNA conformational change (p=9.6x10-5) (Fig. 27B). As expected, 33/34 proteins were nuclear and 30/34 
regulate gene expression, which indicates that the experiment was free of cytoplasmic contaminants. I 
concluded that there is a cross-talk between paraspeckles and RNA polymerase and that depletion of 
paraspeckles changes the repertoire of RBPs attached to the RNA PolII, mostly by depleting splicing factors. 
Further experiments are required to untangle the connection between paraspeckles and splicing proteins 
and how this might be involved in promoting the pluripotency exit. 
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Figure 27: ChIP-Sicap reveals changes in RNA-PolII CTD repertoire after NEAT1 depletion. A) A table 
depicting genes that were significantly enriched in wildtype compared to NEAT1 knock-out RNA PolII, 
which was pulled down using an antibody for phosphorylated Serine 2 residue of the CTD. Proteins were 
identified by mass spectrometry. Differentiation was performed for 4 days according to the protocol to 
generate NSCs. B) Protein interaction network extracted from the string database (medium confidence 
setting) for significantly changed genes indicated in A. Splicing proteins are shown in red and proteins 
enriched with functions in changing the DNA conformation in blue.  
 
3.6 DBHS proteins regulate exit from pluripotency 
Members of the DBHS protein family are an integral part of paraspeckles [82] and often, the mode-of-action 
of paraspeckles can be explained by sequestration of DBHS proteins. In humans, three DBHS proteins are 
expressed, namely SFPQ, NONO and PSPC1, all of which are produced in hESCs at a level similar to the 
pluripotency genes and substantially higher than differentiation markers (Fig. 28A, B). In the following 
sections, I dissected the dynamics and effect of DBHS proteins on ESC maintenance and differentiation. 
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3.6.1 DHBS proteins localize to paraspeckles at the onset of differentiation 
NEAT1 up-regulation correlates with lineage-independent exit from pluripotency (Fig. 11) but it is 
unknown whether the expression of DBHS proteins exhibits a similar pattern. To address this, I performed 
differentiation of hESCs into the germ layers by differentiation towards cardiomyocytes, neural rosettes 
and definitive endoderm and analyzed the expression of SFPQ, PSPC1 and NONO. Moreover, I measured 
expression changes during reprogramming of hESCs that are generally in a primed state back to their naïve 
state. The latter will be outlined in detail in section 3.6.5. With exception of a minor down-regulation of 
PSPC1 during mesoderm and endoderm specification, the expression of DBHS proteins did not change 
drastically after exit from pluripotency and also not after reprogramming to the naïve state (Fig. 28C). 
However, as expected, DBHS proteins formed aggregates in differentiated cells but not in hESCs that are 
devoid of paraspeckles (Fig. 28D, E). I concluded that the expression of DBHS proteins and NEAT1 is 
uncoupled, but paraspeckles could act as sponge for DBHS proteins and thereby regulate their function. 
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Figure 28: Transcriptional and post-translational regulation of DBHS proteins in differentiated hESCs. 
A) RT-qPCR analysis of DBHS, pluripotency and differentiation genes in undifferentiated hESCs. B) 
Western blot depicting the expression of DBHS and pluripotency proteins in undifferentiated hESCs in 2 
replicates. C) RT-qPCR of DBHS genes during naïve conversion and differentiation of hESCs to 
cardiomyocytes, definitive endoderm and neural rosettes, for 70, 9, 6 and 14 days respectively. 
Differentiation time was normalized to the endpoint. Dashed line marks base line expression level in 
hESCs. D, E) Representative immunocytochemistry images labeling DBHS proteins (red) in differentiated 
(D) and undifferentiated (E) hESCs. DAPI (blue) marks nuclei and scale bar is 10 µm. Cells were 
differentiated for 3 days with retinoic acid. 
n=2 experiments using cells of different passages. Error bars represent SEM. 
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3.6.2 DBHS proteins PSPC1 and NONO maintain pluripotency in human ESCs 
To dissect the developmental functions of human DBHS proteins, I disrupted the first exons of NONO, 
PSPC1 and SFPQ in hESCs using CRISPR/Cas9 (Fig. 29A) and confirmed the functional depletion of the 
genes by analyzing the respective genomic sites, transcripts and proteins (Fig. 29B-H). Although deletion 
of the first exon of SFPQ was efficient, it was apparent predominantly in detached dead cells, and in 
accordance, none of the clones exhibited SFPQ mutant alleles that were detected in detached cells (Fig. 
29D). Nevertheless, I could knock-down 60-80% and 40-50% SFPQ transcript and protein using siRNAs 
(Fig 29I, J). 
I analyzed first, whether depletion of DBHS proteins was compensated by up-regulation of other 
DBHS family members, however, I did not observe any significant changes in pluripotent hESCs (Fig. 29K). 
To analyze the involvement of DBHS proteins in maintaining the pluripotent, undifferentiated state, I 
quantified the expression of key reprogramming - pluripotency genes. This showed that pluripotency is 
down-regulated by 40-60% in PSPC1-/- hESCs, but not significantly perturbed by removal of SFPQ and 
NONO (Fig. 29L). Moreover, I analyzed genes that drive the specification of the primary early germ layers, 
and genes involved in EMT, which characterizes some of the first embryonic developmental transitions 
[220]. Interestingly, I noted significant up-regulation in the basal expression of canonical germ layer genes 
primarily in NONO-/-, but also to some extent in PSPC1-/-  hESCs. This included PAX6, BRACHYURY (T) 
and SOX17, which drive the specification of ectoderm, mesoderm and endoderm progenitors, respectively 
(Fig. 29M). I concluded that paraspeckle-independent functions of DBHS proteins PSPC1 and NONO is to 
respectively prime the multilineage differentiation and promote pluripotency. Knock-down of SFPQ did 
not significantly affect the expression of differentiation genes (Fig. 29L, M), thus I concluded that 
perturbation of the pluripotency circuit is not a plausible mechanism for the lethal phenotype as a result of 
SFPQ disruption. Collectively, this indicates that DBHS proteins regulate pluripotency-differentiation 
balance and that SFPQ has house-keeping functions through mechanisms that are independent of key 
developmental genes. 
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Figure 29: Generation and analysis of DBHS-depleted hESCs. A) A scheme for the generation of NONO, 
PSPC1, and SFPQ knock-out hESCs by CRISPR/Cas9. B, C) PCR screening of genomic deletion in the 
NONO (B) and PSPC1 (C) coding sequence for two isolated clones. D) PCR screening of genomic deletion 
in the SFPQ coding sequence. Bulk represents living cells that attached while supernatant contained dead, 
detached cells. Bulk1, Sup1, Bulk 2, Sup2 and Sup3 were analyzed 2, 7 and 14 days after Cas9/gRNA 
transfection, respectively. E, F) Western blot for NONO (E) and PSPC1 (F) protein in two isolated clones. 
H3 was used as loading control. G, H) RT-qPCR analysis of NONO (G) and PSPC1 (H). I, J) SFPQ mRNA 
and protein expression two days after siRNA transfection analyzed by RT-qPCR (I) and western blot (J), 
respectively. Protein levels were normalized to H3.  K-L) RT-qPCR analysis of DBHS proteins (K), 
pluripotency transcription factors (L) and differentiation markers (M) in NONO-/- and PSPC1-/-  and SFPQ 
knock-down hESCs. RNA expression was normalized to GAPDH and is depicted relative to wildtype (WT) 
levels with n=3 biological replicates. * p<0.05, ** p<0.01, unpaired t-test. 
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3.6.3 NONO regulates spontaneous differentiation via metabolic control 
To further characterize how NONO promotes pluripotency independently of paraspeckles, I performed 
RNA sequencing of NONO-/- and parental undifferentiated hESC samples. Importantly, this revealed the 
down-regulation of 320 genes (p<0.05) that classified functional categories involved in the regulation and 
synthesis of cholesterol and related metabolic products (Fig. 30A). Cholesterol is produced from acetyl-
CoA, which also serves as a precursor for histone acetylation and thereby priming of differentiation genes 
in PSCs [221]. Therefore, reduction of cholesterol production could explain up-regulation of 188 genes 
(p<0.05) implicated in developmental processes (Fig. 30B), including HOX genes that are important for 
body axis development [56] and genes which have been implicated in neural differentiation and CNS 
formation (COL3A1, EPHA4, HES1, EGR1, ID4, FOXJ1) (Fig. 30C). I confirmed the down-regulation of 
cholesterol synthesis pathway by RT-qPCR for enzymes that actively take part in cholesterol metabolism 
and found that in pluripotent condition, all of them were down-regulated by 40-70% compared to parental 
control (Fig. 30D). Collectively, this implicates NONO in the paraspeckles-independent maintenance of 
pluripotency by regulating enzymes that shift metabolite synthesis, and thereby prime the activation of 
genes that promote germ layer development.  
Next, I assessed whether down-regulation of cholesterol synthesis has an impact on differentiation. 
As expected, I observed significant up-regulation of many developmental genes, such as the endoderm 
markers FOXA2, CXCR4 and the neural transcription factors FOXG1 and PAX6 in NONO-/- hESCs upon 
removal of the pluripotency medium (Fig. 30E). Importantly, this is in contrast to a previous study in mouse 
ESCs that showed an increase of the pluripotency gene expression after Nono knock-out, concomitant with 
reduced differentiation potential, which the authors demonstrated by impaired formation of embryonic 
bodies and more importantly, by impaired neuronal differentiation [222]. Strikingly, when differentiating 
NONO-/-  hESCs to motor neurons, I did not observe differences in the gene expression profile of neuronal 
markers compared to the parental control cell line (Fig. 30F, G), which led me to conclude that the function 
of NONO diverges from its mouse orthologue in human ESCs. 
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Figure 30: NONO-mediated gene expression changes in pluripotent and differentiated conditions. A) 
Heat map clustering of the top 20 highest and lowest significantly differentially expressed genes in NONO-
/- hESCs compared to parental cells. B) Gene ontology (GO) term analysis of up- and down-regulated genes 
in NONO-/- hESCs compared to WT. Analysis was performed on the String platform C) RT-qPCR analysis 
of genes of the cholesterol synthesis pathway in NONO-/- hESCs and comparison with RNA sequencing 
data. D) RT-qPCR of pluripotency-differentiation markers of NONO-/- hESCs spontaneously differentiated 
for 3 days. E, F) RT-qPCR (E) and immunostaining (F) of neuronal markers in NONO-/- and WT motor 
neurons differentiated for 75 days. Scale bar is 50 µm. 
n=4 biological replicates including two NONO-/- clones. * p<0.05, ** p<0.01, *** p<0.001, unpaired t-test. Error 
bars represent standard deviation. 
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3.6.4 PSPC1 depletion impairs in vitro adipogenesis 
Besides NONO, PSPC1 has been implicated in murine development including mouse adipogenesis, which 
is regulated by Pspc1 [223]. Since NONO-depleted hESCs exhibited a different phenotype compared to 
NONO-/- mESCs, I tested whether this is the case for PSPC1 as well. To address this, I sought to recapitulate 
the murine Pspc1 knock-out phenotype by differentiating PSPC1-/- human ESCs in vitro to adipocytes via 
MSCs. Indeed, there were morphologic differences in the MSC morphology with PSPC1-/- MSCs forming a 
loose monolayer of cells in contrast to MSCs of the parental cell line that exhibited dense colony-like 
morphology (Fig. 31A). This was concomitant with reduced expression of MSC surface markers CD73 and 
CD90 (Fig. 31B), of EMT markers SLUG and TWIST, a hallmark of functional MSCs, and of SIM2, an MSC-
specific transcription factor (Fig. 31C). Further differentiation of MSCs to adipocytes resulted in cells with 
lower expression of the adipocytes marker FABP4 (Fig. 31D) and importantly, Oil Red O staining of lipid 
droplets was markedly reduced in PSPC1-/- adipocytes (Fig. 31E). Nevertheless, expression of other markers 
of PSPC1-/-  MSCs and adipocytes was not affected suggesting that PSPC1 only to some extent is required 
for in vitro human adipogenesis, which is in contrast to the phenotype observed in mice [223].    
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Figure 31: Phenotypic analysis of PSPC1-/- MSCs and adipocytes. A) Morphology of PSPC1-/- and parental 
(WT) MSCs. B) Flow cytometry analysis of MSC surface markers CD73 and CD90 in WT (black) and PSPC1-
/- (cyan) MSCs. IgG control in grey. C) Time course RT-qPCR analysis of EMT markers and MSC 
transcription factors in PSPC1-/-  MSCs. RNA expression was normalized to WT on the respective days. D) 
Gene expression analysis of adipocyte and EMT markers for PSPC1-/-  adipocytes differentiated for 56 days. 
E) Oil Red O staining of lipid droplets in WT and PSPC1-/-  adipocytes with WT MSCs as negative control.  
Magnification in phase-contrast images is 5x with a scale bar of 500 µm. n=3 biological replicates for WT 
and 4 replicates including 2 different clones for PSPC1-/-  MSCs or adipocytes. Error bars represent standard 
deviation. 
 
3.6.5 NONO and PSPC1 inhibit naïve conversion of human ESCs 
Next, I asked whether PSPC1 or NONO are involved in the early developmental transitions of hESCs. To 
address this, I differentiated DBHS protein-depleted hESCs to intermediate mesoderm, definitive 
endoderm and neural rosettes and performed gene expression analysis for a panel of lineage-specific 
marker genes. No significant changes in the gene expression profile of lineage markers was observed upon 
depletion of PSPC1 and NONO indicating that both genes are not required for germ layer specification 
(Fig. 32).  
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Figure 32: Gene expression analysis of PSPC1-/- and NONO-/- hESCs committed to germ layer 
specification. A-C) Time course RT-qPCR for intermediate mesoderm (A), definitive endoderm (B), and 
neural rosette (C) differentiation of PSPC1-/- and NONO-/- hESCs. n=2 biological replicates for WT and 4 
replicates including two different clones for knock-out cell lines. Error bars represent standard deviation. 
 
It is widely accepted by now that mouse ESCs represent a ground, or naïve state of pluripotency, whereas 
the transcriptional profile and other phenotypic features of human ESCs are more similar to the primed, 
epiblast-like stage of pluripotency [26]. Recently, it was demonstrated that primed hESCs can be converted 
to the naïve stage, which prompted me to investigate whether DBHS proteins might influence this process. 
I employed a commercially available medium to generate naïve cells for 10 passages. While parental and 
NONO- or PSPC1-depleted hESCs exhibited similar dome-shaped colony formation (Fig. 33A), the flow 
cytometry analysis of primed surface markers CD24 and CD90 revealed a slightly accelerated loss of 
primed pluripotency in PSPC1-/- hESCs, which was more pronounced in NONO-/- cells (Fig. 33B, C). I 
verified successful conversion to the naïve stage by RT-qPCR analysis of naïve markers NANOG, LBP9, 
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KLF4, KLF2 and DNMT3L, which increased in expression with continued passaging. Strikingly, the 
expression of naïve markers was even further elevated in PSPC1-/- or NONO-/- hESCs for a majority of genes 
and at all time points (Fig. 33D). I concluded that both NONO and PSPC1 perturb the naïve-to-primed 
transition of human ESCs. Interestingly, when differentiating naïve PSPC1-/- and NONO-/- hESCs, I observed 
changes in their transcriptional profile compared to primed, PSPC1- or NONO-depleted hESCs (Fig. 33E, 
F), which indicated that the DBHS-related phenotype in PSCs depends on their developmental state.   
 
Figure 33: Generation of NONO and PSPC1 knock-out naïve human ESCs. A) Brightfield images of naïve 
WT, PSPC1-/- and NONO-/- hESCs at passage 10 (P10). Scale bar: 500 µm. B, C) Flow cytometry analysis of 
primed hESCs surface markers CD24 and CD90 in primed WT and naïve WT, PSPC1-/- and NONO-/- hESCs. 
Representative blots in B and quantification of 2 independent experiments with 2 knock-out clones in C. 
D) RT-qPCR of naïve markers in WT, PSPC1-/- and NONO-/- hESCs at passages 1, 5 and 10 of naïve 
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conversion. Expression was normalized to primed hESCs with 2 biological replicates of WT and 4 replicates 
including 2 different clones for PSPC1 and NONO knock-out hESCs. E, F) RT-qPCR of pluripotency and 
differentiation genes after 3 days of spontaneous differentiation of naïve and primed NONO-/- (E, primed 
values from Fig. 31D) and PSPC1-/- (F) hESCs.  
n=2 biological experiments. Error bars represent standard deviation. 
 
3.6.6 SFPQ mediates cellular homeostasis by association with the polyadenylation machinery 
Finally, I aimed to understand the function of the third DBHS protein, SFPQ, in the maintenance of PSCs. 
A full knock-out of SFPQ proved to be lethal for hESCs (Fig. 29D), however I could reduce its expression 
by RNA interference (Fig 29I, J). I performed RNA sequencing two days after siRNA transfection in 
pluripotent condition and found >700 differentially expressed genes (p<0.05). Amongst them were the top 
up-regulated genes FOXJ1 and NODAL (Fig. 34A), two proteins that are important for development and 
which were up-regulated in NONO-/- hESCs as well (Fig. 29L, 30A). Nevertheless, the overall overlap of 
differentially expressed genes after SFPQ and NONO down-regulation was minimal (Fig. 34B) indicating 
that both proteins control different cellular processes in hESCs. Down-regulated genes were classified with 
functions in the organization of organelles and cell cycle regulation, processes that are critical for cell 
survival (Fig. 34C). 
SFPQ regulates both, RNA- and DNA-related processes, dependent on the cellular background 
[146]. I performed co-immunoprecipitation (co-IP) of SFPQ to identify potential interacting partners, which 
would provide a first hint of how SPFQ exerts its pivotal function in hESCs. By mass spectrometry, 89 
proteins were identified to be significantly enriched over IgG control (p<0.05; enrichment >5-fold). With 
NONO, PSPC1, FUS, HNRNPM and MATR3, most of the known interactors of SFPQ were identified (Fig. 
34D). Moreover, the majority of immunoprecipitated proteins had annotated function in RNA processing, 
including splicing proteins but also 3`end processing (Fig. 34E). This includes almost the complete 
polyadenylation machinery that was co-purified together with SFPQ (Fig. 34F). Together, this data 
indicates that in hESCs, SFPQ controls gene expression by interaction with the splicing and 
polyadenylation machinery resulting in regulation of genes that have critical functions in cell homeostasis. 
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Figure 34: Characterization of SFPQ binding partners and regulated genes. A) Volcano plot of 
differentially expressed genes detected by RNA sequencing after SFPQ knock-down by siRNA transfection 
in hESCs. p<0.05 in red. n=3 independent experiments. B) Venn diagram showing the overlap between 
differentially expressed genes (p<0.05) upon depletion of SFPQ and NONO. C) GO term analysis of 
significantly down-regulated genes (p<0.05) after siSFPQ treatment. D) Mass spectrometry analysis of co-
immunoprecipitated proteins using SFPQ as bait protein. n=3 independent experiments of cells in 
pluripotent condition. Known SFPQ interactors are marked in orange (based on the SFPQ interactome 
published on the string database), proteins of the polyadenylation machinery in red. E) GO term analysis 
of significantly enriched proteins after SFPQ Co-IP. F) Proteins of the polyadenylation machinery. Green 
circles indicate proteins that were co-immunoprecipitated together with SFPQ. Circle circumference 
depicts fold enrichment compared to IgG control. Line thickness indicates the degree of interaction. Figure 
was adapted from Chan et al. [224]. 
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3.6.7 NONO is important for paraspeckle integrity but dispensable for NEAT1_2 stability 
Lastly, I sought to interrogate the connection between DBHS proteins and paraspeckle formation. It was 
shown in many studies, that NONO but not PSPC1 is critical for paraspeckle assembly, possibly by 
stabilizing NEAT1_2, the architectural backbone of paraspeckles [191]. However, these studies were carried 
out mostly in somatic cells and employed conventional FISH to analyze NEAT1 and thus paraspeckle 
formation [85]. Here, I performed smFISH to measure paraspeckle amounts in differentiated hESCs that 
lack expression of either PSPC1 or NONO. I treated the cells with retinoic acid, a potent inducer of 
paraspeckles [47] and in agreement with other studies [135], [190], PSPC1-/- hESCs exhibited similar 
amounts of paraspeckles as the parental cell line (Fig. 35A, B). In contrast, while previous literature 
suggested a complete absence of paraspeckles in NONO-depleted cells [85], they were still present in 
differentiated NONO-/- hESCs (Fig. 35A, B). Strikingly, next to paraspeckles, differentiated NONO-/- hESCs 
exhibited many NEAT1_2 foci with low intensity, which fell below the intensity threshold for automated 
paraspeckle detection (Fig. 35E). I termed these foci NEAT1_2 microspeckles, analogous to microspeckles 
formed by NEAT1_1 that have been identified, recently [95]. NEAT1_2 microspeckles were detected in 84% 
of NONO-/-  cells while only 16% exhibited a reduced amount or zero paraspeckles (Fig. 35C). A cross-
section of NEAT1_2 microspeckles revealed that they displayed a relatively uniform intensity profile and 
hence contain most likely only one or a few NEAT1_2 molecules (Fig. 35D, E). I concluded that NONO is 
important for paraspeckle integrity, however, its depletion is not sufficient for degradation of NEAT1_2 
transcripts when treating the cells with retinoic acid. Moreover, the knock-out of NONO leads to the 
appearance of NEAT1_2 microspeckles similar to the single NEAT1_2 molecules formed after addition of 
DNA-binding molecules (Fig. 18, 19) 
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Figure 35: Paraspeckle formation in PSPC1-/- and NONO-/- hESCs. A) SmFISH of NEAT1_total (red) and 
NEAT1_2 (green) in WT, PSPC1-/-, NONO-/- and parental hESCs after treatment by RA for 3 days. B) 
Quantification of the number of paraspeckles based on NEAT1_2 staining depicted in A. n=2 biological 
replicates with 3-4 images per condition. C) Quantification of 200 NONO-/- hESCs based on their number of 
paraspeckles and NEAT1_2 microspeckles. D, E) NEAT1_2 intensity profile along the yellow line. Yellow 
arrows depict NEAT1_2 microspeckles along this line, which also crossed a paraspeckle, marked by the red 
arrow in E. 
Scale bar is 10 µm. DAPI in blue marks nuclei. 
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4. Discussion 
4.1 Identification of developmentally regulated nuclear lncRNAs 
Nuclear lncRNAs represent an additional layer of gene regulation, in part by binding to chromatin and 
attracting chromatin-modifying complexes [225]. Here, I showed that the expression pattern of many 
nuclear lncRNAs is changed during germ layer differentiation (Fig. 11), indicating their pivotal role in the 
pluripotency-differentiation transition. Importantly, besides lncRNA lncPRESS1, which has been shown to 
control pluripotency maintenance [69], many dynamically regulated lncRNAs have not been annotated so 
far in the context of stem cell differentiation. This includes the top two up-regulated lncRNAs PINCR and 
LINC00472, which in colorectal cancer cells, are respectively up- or down-regulated [226], [227], and the 
tumor suppressor lncRNA PVT1, which regulates MYC expression in breast cancer cells [228]. MYC is 
crucial for PSC maintenance [229] and promotes the generation of iPSCs [230], hence it is likely that down-
regulation of PVT1 during exit from pluripotency results in MYC down-regulation, thereby inducing stem 
cell differentiation. LncRNA MEG3 is another tumor suppressor gene, which is significantly down-
regulated in all germ layer lineages (Fig. 11), but also in solid tumors such as colorectal and breast cancer 
[231]. Interestingly, one of its target genes is BMP4 [232], a cytokine that is crucial for the development of 
many tissue progenitors [233]. Including RMRP [234], six out of the eight most up- and down-regulated 
lncRNAs are tumor suppressors or oncogenes, which supports the connection of stem cell self-renewal and 
cancer cell proliferation. Studies on protein-coding genes have shown that both processes are regulated by 
common pathways [235] and the data presented here hints that this notion applies also for the non-coding  
part of the transcriptome. 
Besides lineage-independent regulation of lncRNAs, I uncovered lncRNAs with a lineage-specific 
expression profile including the lncRNA HOTAIR, which was up-regulated in MSCs in agreement with its 
function in MSC differentiation [236], but also H19, which was highly up-regulated during lung progenitor 
differentiation, a process to which it has not been connected before (Fig. 11). H19 is a paternally imprinted 
gene [237], and its transcript was shown to sequester let-7 miRNA during muscle differentiation [61]. H19 
is expressed in some fetal organs such as heart and muscle [238] but it is severely down-regulated after 
birth [236], and only re-expressed in cancer cells where it acts as sponge for miRNAs or interacts with 
polycomb-group proteins [239]. Considering that miRNAs of the let-7 family have crucial functions in 
embryonic development [240], it would be interesting to interrogate their regulation by H19 and how this 
controls differentiation specifically to lung progenitor cells. A promising avenue is to analyze the 
connection to LIN28A, which targets let-7 miRNAs for degradation [241] and has recently been shown to 
regulate lung development [242].   
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In summary, this study represents a comprehensive analysis of lncRNA expression trajectories 
during the process of human ESC differentiation, which serves as basis for an in-depth analysis of lncRNAs-
of-interest for instance by performing a CRISPR screen to assign functionality during germlayer 
differentiation. Moreover, the intracellular localization of many developmentally-regulated lncRNAs 
remains unknown. It was recently demonstrated that several lncRNAs (including some of this study) form 
nuclear foci similar to paraspeckles [243], which might bind to multiple genomic loci, attract many RBPs or 
sequester miRNAs and thus regulate gene-expression and consequently cell fate transitions.  
 
4.2 The function of paraspeckles in human cell types 
Architectural lncRNAs (arcRNAs) are crucial for the stability of ribonucleoprotein aggregates [244], most 
prominently exemplified by NEAT1_2, the architectural backbone of paraspeckles [245]. Besides NEAT1, 
four other arcRNAs are known to date but only two are expressed in H.Sapiens, namely nucleolar intergenic 
spacer lncRNAs and satellite III RNAs of the nuclear stress body [244]. Amongst these, NEAT1 was studied 
the most, which is due to its dynamic expression pattern in development and disease [81], however up to 
now, no comprehensive analysis of paraspeckle formation in human cell types was performed, which likely 
is due to the scarcity of material.  Here, I employed PSCs to generate 8 mature and 13 progenitor cell types 
which were analyzed for paraspeckle content together with 3 somatic cell types. I observed that many 
human cell types exhibited NEAT1_2 expression and thus paraspeckle formation as they progressed 
through a stage of multipotency and lineage specification (Fig. 13). Multipotent cells are generally restricted 
to differentiate into a subset of cells [246] for instance neural stem cells that can differentiate amongst others 
to motor neurons or astrocytes (Fig. 12). While the former exhibited a low amount of paraspeckles, the 
latter had many paraspeckles and it is interesting to speculate that the heterogeneity in paraspeckle 
numbers generally observed in all cell types, including neural stem cells (Fig. 13G), determines the cell fate 
transition, for instance between neurons and glial cells.  
In mouse tissues, paraspeckle expression is restricted to certain organs, most notably the gut and 
the reproductive system [247]. Contrarily, in human differentiated cells, I identified several cell types that 
readily formed paraspeckles, often more than their mouse counterparts (Fig. 14B). This indicates a cell-type 
and species-specific function of paraspeckles. Astrocytes, a type of glial cells, contained many paraspeckles, 
which is supported by a recent study in murine brain sections that demonstrated high expression of 
paraspeckles in glial cells and low expression in neurons [248]. Moreover, oligodendrocytes, another glial 
cell type, exhibited high numbers of paraspeckles and down-regulation of NEAT1 impaired 
oligodendrocyte formation [249]. I did not observe any differentiation defects of NEAT1-/- hESCs towards 
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astrocytes (Fig. 21H), however, this might be a caveat of the in vitro system that is saturated with 
differentiation cytokines, which potentially overrides a NEAT1-related phenotype. It is also possible that 
paraspeckles take on different functions in astrocytes, and for instance, are required to maintain their 
immunogenic functions [250]. The function of NEAT1 in mediating the immune response is well established 
and many studies showed its up-regulation upon sensing an aberrant amount of dsRNA or dsDNA [129]. 
Moreover, Neat1 induces the activation of inflammasomes in macrophages, thereby mediating the immune 
response [251]. Besides astrocytes, other paraspeckle-expressing cell types including mesenchymal stem 
cells, adipocytes and osteocytes are implicated in locally regulating the immune response [252]–[254] and 
it is plausible that paraspeckles are involved in sensing of pathogens and mediating immunogenic 
functions in tissues occupied by these cells. Importantly, while paraspeckles are generally up-regulated 
upon viral infection, those cell types already exhibit a high amount of paraspeckles and thus might be able 
to react faster to the pathogen invasion. It would be interesting to challenge NEAT1-/- cell types with a virus 
and to analyze their behavior compared to the parental cell line. To conclude, I have identified many human 
cell types with a high number of paraspeckles, which could enable a fast immune response of those cells 
when encountering a pathogen. 
 
4.3 Paraspeckles could serve as potential markers for nuclear size 
Cell and nucleus size are interconnected features and highly dynamic during embryonic development 
[255], however how size changes confer phenotype is currently not known. I showed that nucleus size 
correlates with the number of paraspeckles within and across different cell types (Fig. 16B, C). This trend, 
while being intuitive, has not been observed for paraspeckles before and also other subnuclear aggregates 
do not necessarily follow this trend. For instance, the number of nucleoli decreases with increased neuronal 
cell body size, whereas the number of Cajal bodies follows a similar positive correlation [256]. Paraspeckles 
are one of only few nuclear bodies whose formation is directly affected by RNA expression [244]. It is 
known that bigger nuclei exhibit higher overall transcriptional activity [257], which could explain the 
increase in the number of paraspeckles. Contrarily, there are cell types that do not follow this trend, 
including hepatocytes with large nuclei and low numbers of paraspeckles and vice versa in keratinocytes 
and astrocytes, indicating that there are other variables that determine paraspeckle formation. One such 
factor could be the proliferation rate, which is high for keratinocytes and astrocytes and low for 
hepatocytes. Supporting this notion, it was shown that paraspeckles are crucial for cell cycle progression 
[258]. How paraspeckle numbers in different cell types can be explained on molecular level remains largely 
unknown, however, there are probably multiple pathways and regulatory proteins involved at different 
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stages of development, including, as I showed, TDP-43 that inhibits paraspeckle formation in pluripotent 
cells (Fig. 17). Up-regulation of the pluripotency factors during fibroblast reprogramming had an 
immediate effect on paraspeckle dissolution (Fig. 13F) indicating that the pluripotency machinery is 
upstream of a paraspeckle-inhibitory network, likely acting via a TDP-43-related mechanism. To 
summarize, I have identified factors that can predict paraspeckle formation, which include differentiation 
traits, size of the nucleus and potentially proliferation rate (Fig. 36A).  
Nuclear size correlates with paraspeckle formation, however, paraspeckles themselves do not 
determine nuclear size (Fig. 16I, J), which in turn is mainly affected by the meshwork of nuclear lamina 
[255], evidenced by the fact that changes in laminin expression is accompanied by reduction of nuclear size 
during mouse and frog development [259], [260]. Laminins are intermediate filament proteins that 
polymerize between the inner nuclear membrane and the peripheral chromatin [261]. Since the nuclear 
lamina is a tightly packed and highly interconnected network, it is plausible that paraspeckle formation is 
hindered in this environment due to spatial constraints. The thickness of the nuclear lamina is likely 
uncoupled from the nuclear size, hence cells with smaller nuclei have smaller relative nuclear inner volume 
(without volume occupied by nuclear lamina) compared to cells with bigger nuclei (see calculations in Fig. 
37B). This means that the spatial constraints are even more pronounced in cells with smaller nuclei, which 
could explain why smaller changes in nuclear size (~2-fold change between smallest and biggest nuclei, 
Fig. 16C) could lead to dramatic changes in the number of paraspeckles (~9-fold change between lowest 
and highest number of paraspeckles, Fig. 16C).  
Nuclear size is also connected to cancer and is used by cytopathologists as parameter for prognosis 
and to predict its stage of progression [262]. To date, the expression of only a hand-full of proteins are 
known to correlate with nuclear size, amongst others the laminin-like proteins LINC1 and LINC2 in 
Arabidopsis thaliana [263] and importin α during Xenopus development [264], however, mammalian factors 
are not known. I propose that the number of paraspeckles can be used as a determinant of mammalian 
nuclear size. Especially since NEAT1 expression and number of paraspeckles are well correlated (Fig. 13E), 
nuclear size could be predicted after assessment of single-cell RNA sequencing data, given that the long 
version of NEAT1 was measured. This way, a wealth of information regarding mammalian nuclear size in 
development and disease can be generated, thereby providing new insight into the connection between 
nuclear architecture and crucial biological processes.  
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Figure 36: Paraspeckle formation can be predicted by differentiation traits and nuclear size. A) Factors 
that predict paraspeckle formation. Proliferation rate seems to be positively correlated with paraspeckle 
formation, however, a detailed analysis is missing. Cell types are positioned according to their number of 
paraspeckles from left (low amount) to the right (high amount). B) Connection between nuclear size, lamina 
and paraspeckles. Red circles represent paraspeckles. Assuming a spherical shaped nucleus with a constant 
radius of nuclear lamina (rL), the inner volume of small nuclei that paraspeckles can occupy is only 42% of 
the actual nuclear volume, whereas it is 63% in big nuclei with doubled inner radius.  
 
4.4 Double-strand DNA stabilizes lncRNA foci  
Paraspeckle formation depends on interaction of NEAT1_2 and essential paraspeckle core proteins, which 
bind and stabilize the NEAT1_2 transcript [81], however, the connection of paraspeckle ribonucleoprotein 
particles to dsDNA is not well understood. Evidence for co-transcriptional assembly of paraspeckles stems 
from the fact that a subpopulation of paraspeckles is found at the NEAT1 genomic locus [265], and that 
artificial tethering of NEAT1 to another locus is sufficient for the assembly of paraspeckle proteins [266]. A 
dimer of the core paraspeckle proteins SFPQ and NONO binds first to a subdomain of NEAT1_2, before 
inducing polymerization, likely via their coiled-coil domain [136], to cover the whole NEAT1_2 lncRNA. 
Other essential paraspeckle proteins such as FUS and RBM14 are recruited, a process that is driven by 
liquid-liquid phase separation [245]. Paraspeckle integrity may also depend on RNA-RNA interactions, 
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which have been recently demonstrated to be crucial for granule formation in vitro [267]. Indeed, structural 
mappings revealed numerous RNA-RNA interactions within NEAT1_2, which could occur in paraspeckles 
[268]. To summarize, while the paraspeckle assembly at the NEAT1 locus is known reasonably well, it is 
not entirely clear, how the NEAT1:RBP complex relocates and becomes embedded elsewhere in the 
chromatin.  
NEAT1 possesses putative DNA binding domains that were implicated in forming DNA-RNA 
triple helix structures in the major groove [269]. By addition of small DNA binding molecules that cause 
conformational changes of the dsDNA [194], I sought to analyze the connection between paraspeckle 
formation and DNA integrity. Intriguingly, these molecules were able to disintegrate paraspeckles and 
splicing speckles within 30 minutes. A similar observation has been made by Sasaki and colleagues after 4 
hours of treatment by Actinomycin D, however, the authors assumed that this is due to transcriptional 
inhibition [85], whereas I showed that it is the DNA binding ability of the molecule that causes the 
disintegration (Fig. 18). This provides further evidence of the direct interaction between lncRNAs and the 
dsDNA. Moreover, this indicates that in addition to RNA and proteins, DNA itself is fundamentally 
important for the aggregation of chromatin-embedded lncRNAs. It cannot be excluded that the reagents 
directly disrupt the RNA-RNA interaction between NEAT1_2 molecules and thereby induce paraspeckle 
disintegration, however so far there is no evidence that ActD, Hoechst, Flavopiridol and others bind to 
RNA. Interestingly, paraspeckles in differentiated NONO-/- hESCs tend to be much smaller and look 
somewhat similar to NEAT1_2 foci after treatment by small DNA binding molecules. It is possible that the 
displacement of NONO and other essential paraspeckle proteins to the perinucleolar caps after treatment 
by DNA-binding molecules (Fig. 18C) is the cause for paraspeckle disintegration. It remains to be tested, 
whether this displacement is due to the disruption of the NEAT1:dsDNA triplex structure.  
These findings also suggest a tantalizing connection to chemotherapy treatments given to cancer 
patients. Many chemotherapeutic reagents bind to DNA often as a byproduct when high concentrations 
are used, as shown for the CDK inhibitor Flavopiridol [207]. Actinomycin D, Etoposide, and Mithramycin 
A, which readily disintegrate paraspeckles, are commonly used chemotherapies for example in the 
treatment of osteosarcoma [202], [270]. I have implicated these reagents here for the first time in the 
dissociation of lncRNAs from the chromatin, which plausibly is a general phenomenon. This raises the 
possibility that the mechanism-of-action and, or, the side effects of common chemotherapies that bind 
dsDNA are connected to genome-wide disruption of lncRNA architecture. 
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4.5 NEAT1 has alternative, developmentally regulated transcription start sites  
It is well established that NEAT1 has alternative transcription termination sites that produce either the short 
isoform by polyadenylation, or the long isoform by RNase P cleavage [84]. By genomic deletion of parts of 
the NEAT1 promoter, I showed that a consecutive increase in size of the deleted region led to a step-wise 
decrease of NEAT1 transcription in differentiated hESCs (Fig. 20B), indicating that besides alternative 
termination sites, NEAT1 also contains alternative transcription start sites. Deletion of similar regions in 
HEK293 cells induced stronger down-regulation of NEAT1 expression (Fig. 20B, E) indicating that 
alternative NEAT1 start sites exist in hESCs, but not in somatic HEK293 cells. Moreover, in contrast to 
HEK293 cells [95], the insertion of a YFP-polyA stop cassette directly after the NEAT1 TSS was not sufficient 
to eliminate paraspeckles (Fig. 20C). On the other hand, insertion of a stop cassette 1500 bp after the TSS 
fully down-regulated paraspeckles in hESCs (Fig. 22), which is evidence that the alternative NEAT1 
transcription start site(s) is located within the first 1500 bp of NEAT1 gene. For protein-coding genes, 
alternative transcription start sites result in differences in the length of the first exon [271], which 
respectively gives rise to different protein isoforms or has an impact on translational control [272]. 
Alternative transcription of NEAT1 results in shortening of both isoforms, which might not be meaningful 
for the 23 kb long, architectural isoform, but might be relevant for the processing of the 3.7 kb short isoform. 
Indeed, the aggregation potential of NEAT1_1 seems to be impaired in NEAT1STOP hESCs, which express 
only a 1.5 kb long isoform of NEAT1_1 that is able to form foci, which however, appeared more dispersed 
than full-length NEAT1_1 foci (Fig. 22A). It would be interesting to analyze if, besides the canonical short 
and long isoforms, hESCs express other isoforms of NEAT1, or whether the usage of alternative start sites 
is caused by the genomic deletion of the canonical TSS. Moreover, the use of alternative NEAT1 TSSs could 
exhibit tissue-specificity, which was shown for protein-coding genes due to the usage of different 
promoters and enhancer regions [273], [274]. In all, hESCs exhibit alternative NEAT1 transcription start 
sites that might be absent in somatic cells.  
 
4.6 Paraspeckles exhibit phenotypic differences in mouse and human ESCs  
Paraspeckles are up-regulated in various developmental processes and in general during cellular stress 
including proteasome inhibition, hypoxia and viral infection (Fig. 6), however, its function during these 
processes remains enigmatic. Here, I showed that NEAT1_2 was up-regulated during human germ layer 
differentiation (Fig. 11B) concomitant with the formation of paraspeckles (Fig 13F). Interestingly, NEAT1 
is one of only 18 genes that is up-regulated no matter what differentiation-inducing cytokine is added to 
the cell [47], which is why I initially reasoned that NEAT1 has a lineage-independent effect on 
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differentiation. A similar up-regulation was observed in differentiated mouse ESCs, which is the system 
that we (in collaboration with my PhD colleague Miha Modic) tackled first to analyze a potential 
developmental phenotype of paraspeckles. We generated mouse ESCs that harbored a deletion of the triple 
helix located at the 3`end of NEAT1_2, which had a ~60% reduction of paraspeckles, similar to NEAT1∆TH 
human ESCs (Fig. 20). Strikingly, differentiated murine NEAT1∆TH ESCs exhibited elevated levels of 
SSEA1, a pluripotency surface marker in mESCs, and also minor up-regulation of Nanog, indicating that 
paraspeckle depletion impairs exit from pluripotency [47]. Moreover, by performing a 2n-4n aggregated 
mouse complementation assay [275], embryos arising from NEAT1∆TH mESCs exhibited defects in 
primitive streak formation [47]. Unexpectedly, I observed the opposite trend in differentiated human ESCs 
that harbored a similar deletion in the triple helix where pluripotency markers were down-regulated 
relative to wildtype. These findings were validated in NEAT1-/- hESCs with a complete absence of 
paraspeckles, which had the same phenotype as NEAT1∆TH hESCs (Fig. 21). Furthermore, paraspeckle 
depletion by insertion of an expression stop cassette also induced down-regulation of pluripotency genes 
upon differentiation (Fig. 22G-J), in all indicating that the phenotype of human NEAT1 is reversed 
compared to murine ESCs. In general, it is not unusual that the functions of mouse and human orthologues 
diverge, which has been shown for many protein-coding genes [276] and might be true for non-coding 
transcripts that generally evolve faster than protein-coding genes [50]. It is well established that mouse 
ESCs are in a different developmental stage compared to human ESCs [26], which means that the conditions 
supporting self-renewal and differentiation differ greatly. It is also plausible that the paraspeckle 
composition of human and mouse ESCs is fundamentally different, and until today no systematic analysis 
of paraspeckle content in murine cells was executed. Furthermore, it was shown that the half-life of mouse 
and human NEAT1_2 is quite different (1 h vs 5 h, [199]) indicating different processing of NEAT1_2 in 
both species. The relatively unstable murine NEAT1_2 transcript could result in paraspeckles with a high 
turn-over rate where paraspeckle proteins are sequestered only transiently, which could lead to differences 
in the pluripotency-differentiation transition. Finally, it has to be pointed out that a thorough analysis of 
paraspeckle-depleted mESCs is still missing and should be done side-by-side with NEAT1-/- hESCs in 
similar conditions to untangle species-specific functions of paraspeckles. 
 In general, it is unexpected that paraspeckles delay the exit from pluripotency instead of promoting 
it, as their expression profile would suggest. It is important to point out that the phenotype was observed 
only after initial differentiation when a few paraspeckles had already formed. I hypothesize that 
paraspeckles serve as a control mechanism for the cell to fine-tune its differentiation, however, their loss 
can be compensated by hESCs after prolonged differentiation, which is in line with the fact that Neat1-/- 
 4. Discussion  
101 
 
mice do not exhibit an overt developmental phenotype [247]. Furthermore, the phenotype was primarily 
observed in spontaneous or neural differentiated cells but not in other germ layers, indicating a germ layer-
specific function of NEAT1. It is possible that the cytokines added to the various differentiation protocols 
mask a potential NEAT1-related phenotype in vitro and only the neural lineage, which was induced not by 
adding activating cytokines, but only inhibitory molecules of the TGFbeta pathway resulted in an enhanced 
exit from pluripotency. It would be interesting in the future to analyze the paraspeckle content across 
different germ layers, which I speculate could be quite different. 
 Two genes seemed most affected by changes in NEAT1_2 expression, namely NANOG and PAX6, 
which are respectively down- or up-regulated in differentiated NEAT1_2 knock-out hESCs. NANOG is a 
core pluripotency transcription factor, which, in high levels, allows the feeder-free culture of hESCs [277]. 
Its expression is regulated by the pluripotency factors OCT4 and SOX2 [278], which are activated by the 
FGF2 and ACTIVIN/NODAL signaling pathways [23]. Paraspeckles, on the other hand seemed to be 
inhibited by the activation of those pathways and up-regulated by other signaling cascades such as the 
Wnt3A and BMP4 pathways. How paraspeckles affect NANOG expression remains unclear. It is possible 
that they bind in close vicinity of the NANOG locus and attract transcriptional activators to counteract to 
some extent the down-regulation of NANOG induced by the loss of pluripotency signaling pathways. 
Another possibility is that paraspeckles contain transcriptional inhibitors of NANOG, which are released 
in NEAT1-/- hESCs to induce down-regulation of NANOG compared to wildtype. PAX6, on the other hand, 
is a transcription factor that induces neuroectoderm differentiation of hESCs and its up-regulation is 
correlated with down-regulation of NANOG [279]. Whether PAX6 expression is directly inhibited by 
NANOG is not known but is possible that PAX6 up-regulation is the result of reduced NANOG expression 
induced by the loss of paraspeckles. Interestingly, the signaling pathways that maintain NANOG 
expression in mESCs are very different compared to hESCs, which in mice is maintained primarily by the 
LIF/STAT3 and BMP4 signaling cascades [280]. This might be another explanation for the phenotypic 
differences that arise upon paraspeckle knock-out. 
To summarize, in humans, NEAT1_2 is modulating the early onset of differentiation by mediating the 
coordinated down-regulation of the pluripotency machinery. The mechanism behind this phenotype 
remains to be analyzed in future studies to understand the differences between paraspeckle biology in 
mouse and human development. 
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4.7 The function of the short NEAT1 isoform 
While NEAT1_2 foci are generally up-regulated during differentiation, NEAT1_1 foci exhibit a reciprocal 
trend and their disappearance correlates with the onset of differentiation (Fig. 15B). This is probably due 
to the formation of paraspeckles by NEAT1_2, which, when in high abundance, sponge and remove 
NEAT1_1 foci from the nucleoplasm. Supporting this notion, cell types with high numbers of paraspeckles 
generally do not have NEAT1_1 foci (Fig. 15E). The existence of NEAT1_1 outside of paraspeckles was 
recently demonstrated in U2OS cells that form NEAT1_1 foci containing 1-3 molecules, termed 
microspeckles [95]. By eye, NEAT1_1 foci in PSCs seemed much bigger and to contain many more 
molecules, however a thorough analysis of NEAT1_1 content was not performed, yet.  
To analyze the function of NEAT1_1, I generated NEAT1∆pA hESCs, which do not express 
NEAT1_1 (Fig. 20G, H) due to the removal of the NEAT1_1 polyadenylation site that is required for 
NEAT1_1 production. While NEAT1_1 is dispensable for paraspeckles as shown by the fact that NEAT1∆pA 
hESCs readily formed paraspeckles, it is nevertheless possible that NEAT1_1 functions as a “helper 
molecule”, maybe by acting as seeding nucleus for the aggregation of NEAT1_2 in differentiated cells. This 
could be addressed by over-expression of NEAT1_1 in NEAT1∆pA hESCs. It has been demonstrated that 
the short isoform is able to recruit paraspeckle proteins [266], which in turn could attract NEAT1_2 upon 
its expression in differentiated cells. The question remains what could be the function of the short NEAT1 
aggregates in pluripotent cells. NEAT1∆pA hESCs exhibit both up-regulation of NANOG and of 
differentiation genes (Fig. 25D), however, it is difficult to assess, whether this is due to the absence of 
NEAT1_1 or the up-regulation of NEAT1_2 and paraspeckles. Since NANOG up-regulation was observed 
after over-expression of endogenous NEAT1_2 (Fig. 23C-E), whereas differentiation genes were not 
affected (data not shown), the latter might have been caused by the absence of NEAT1_1 foci in pluripotent 
cells. In mice, the 2n-4n complementation assay of NEAT1∆pA mESCs did not compromise the primitive 
streak formation [47] indicating that over-expression of NEAT1_2 and loss of NEAT1_1 are of no obvious 
developmental consequence. This was recently supported by the generation of NEAT1∆pA mice that did 
not exhibit any overt phenotypical changes compared to the wildtype strain [281], [282]. Even though a 
high amount of NEAT1_1 foci was observed in the G1 cell cycle phase, the deletion of NEAT1_1 did not 
affect the cell cycle or proliferation of murine cells. Moreover, only a few genes were differentially 
expressed in NEAT1∆pA U2OS cells, which substantiates the fact that NEAT1_1 on its own is not able to 
affect gene expression [281]. The authors suggest that NEAT1_1 itself is not functional but the cells need to 
constantly express it to ensure a rapid isoform switch to NEAT1_2 when the cells are under stress [281]. 
This could be similar during exit from pluripotency when the addition of differentiation cytokines triggers 
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an isoform switch and the onset of paraspeckle formation. To summarize, PSCs exhibit formation of 
NEAT1_1 foci, which disappear in differentiated cells. Deletion of NEAT1_1 induced up-regulation of 
differentiation genes in human ESCs, indicating that these cells are primed for differentiation, however, 
the differentiation propensity of NEAT1_1-depleted human and mouse ESCs was not affected. It is possible 
that NEAT1_1 expression represents the “cost” of the cell to have an active NEAT1 locus to react fast to 
changes in the environment by up-regulation of NEAT1_2 and paraspeckles. 
 
4.8 Developmental paraspeckles regulate global splicing by RNA and protein retention 
Paraspeckles are very complex structures containing, besides NEAT1, a plethora of RNAs and many 
proteins that together mediate the function of paraspeckles [81]. Given that ~25% of the 40 paraspeckle 
proteins in HeLa cells [247] are not expressed in hESCs or their differentiated progeny (based on 
transcriptome analysis; data not shown), the composition of developmental, “nascent” paraspeckles is 
likely quite different compared to paraspeckles in tumor and other somatic cells. Due to the vicinity of 
paraspeckles and splicing speckles [109], many paraspeckle proteins have annotated function in splicing 
regulation [83] together with general functions in transcription regulation and polyadenylation (Fig. 4A). 
Interestingly, this is quite similar to the repertoire of RBPs bound transiently to the RNA-PolII to mediate 
co-transcriptional processes [283], [284]. I hypothesized that paraspeckles and the RNA-PolII share a 
common repertoire of RBPs, which could mean that paraspeckle-depleted hESCs exhibit changes in the 
composition of RBPs attached to RNA PolII. Indeed, I identified mainly splicing-associated proteins that 
are enriched in wildtype compared to NEAT1-/- RNA-PolII (Fig. 27), which indicates that the depletion of 
paraspeckles causes protein translocations. It would be intriguing to untangle the molecular connection 
between RNA-PolII and paraspeckles. NEAT1 itself is transcribed by RNA-PolII [285] and given the fact 
that paraspeckles already assemble at the NEAT1 locus, proteins may be transferred from the CTD of RNA 
PolII to the nascent NEAT1_2 transcript. This transfer might be compromised in differentiated NEAT1-/- 
hESCs, which could explain the enrichment of splicing proteins in wildtype compared to paraspeckle-
depleted cells. By chromatin pull-down studies, a subpopulation of NEAT1 was found to overlap with 
H3K4me3 regions, which mark regions of actively transcribed genes [109]. Although the PolII complex 
itself was not identified in paraspeckles, it is plausible that the transcribing RNA-PolII encounters 
paraspeckles outside of the NEAT1 locus and it would be intriguing to analyze the spatiotemporal 
relationship between those two macromolecular complexes during active transcription. 
 Several RNAs have been identified in paraspeckles and their retention represents a means of the 
cells to inhibit translation [84], [97]. It has been hypothesized that paraspeckles contain many other 
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transcripts, especially those with inverted-repeat Alu elements in their 3`UTR [286], which prompted me 
to analyze global changes in RNA localization upon paraspeckle depletion. Intriguingly, I identified ~30% 
of transcripts that exhibited changes in their cytoplasmic or nuclear localization in paraspeckle-depleted 
hESCs (Fig. 26D). Interestingly, the proportion of RNAs that were retained in the nucleus was similar to 
the number of RNAs exported from the nucleus in differentiated NEAT1-/- hESCs, arguing against the 
hypothesis that paraspeckles are a global hub of RNAs. Of note is the high proportion of mRNAs that were 
generally enriched in the nucleus, which is in line with recent findings by Halpern et al. who identified 
mature mRNAs in the nucleus of B- and liver cells and proposed a function in the reduction of cytoplasmic 
gene expression noise [287]. RNAs that are more exported in NEAT1-/- hESCs are associated with mRNA 
processing, mostly by regulation of splicing (Fig. 26G), which indicates that the splicing process is affected 
in differentiated NEAT1-/- hESCs due to a) changes in splicing proteins associated with RNA-PolII (section 
4.7) and b) changes in the localization of transcripts encoding for splicing proteins. The notion that 
paraspeckles regulate splicing was demonstrated by a recent study that showed changes in alternative 
splicing of genes involved in axonogenesis and neuronal homeostasis in the cerebellum of Neat1-/- mice 
[248]. Moreover, it was shown in murine cells that Neat1 associates with the splicing factor SRp40 to 
regulate alternative splicing of Pparg, an essential gene for adipogenesis [288].  
In conclusion, after the depletion of paraspeckles, I identified changes in the subcellular 
localization of RNAs and proteins involved in splicing regulation but how this leads to the phenotype 
described above remains to be analyzed in detail. The fact that paraspeckles are such complex granules that 
can mediate gene expression by chromatin binding, RNA retention or protein sequestration (described in 
section 1.7) aggravates mechanistic studies on a molecular level. Further studies are required to identify 
the protein components and genomic binding sites of developmental paraspeckles and address how this is 
connected to the regulation of pluripotency genes. 
 
4.9 The function of DBHS proteins in the pluripotency-differentiation transition 
DBHS proteins are core paraspeckle components [191] that control transcription and RNA processing [135]. 
All three members of the DBHS family, SFPQ, NONO and PSPC1, are highly expressed in undifferentiated 
hESCs (Fig. 28A, B) indicating that they have a paraspeckle-independent function in pluripotency 
maintenance that has not been addressed, yet. Moreover, even though expression of these proteins does 
not overtly change during stem cell differentiation (Fig. 28C), the induction of paraspeckles induces the 
sequestration of DBHS proteins (Fig. 28D, E), which might affect their function in the nucleus. By genomic 
deletions, I sought to analyze the function of DBHS proteins in pluripotent and differentiated hESCs, 
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initially with the idea to pinpoint the paraspeckle phenotype described above to the misregulation of SPFQ, 
NONO and PSPC1. 
 
4.9.1 SFPQ regulates ESCs homeostasis via post-transcriptional processes   
SFPQ is a multifunctional RBP that is essential for the survival of thymocytes [145] and zebrafish embryos 
[289]. In line with these findings, I observed cell death in hESCs where coding parts of the gene were deleted 
(Fig. 29D). Knock-down of SFPQ was however tolerated and resulted in the down-regulation of genes that 
are essential for cellular homeostasis (Fig. 34C) without changing the pluripotency characteristics of the 
cell (Fig. 29M). Interestingly, the overlap of changes in the transcriptome after SFPQ knock-down and 
NONO knock-out hESCs was minimal (Fig. 34B), even though both proteins strongly interact with each 
other [135] and do so also in hESCs (Fig. 34D). This suggests that SFPQ has NONO-independent functions, 
which hints to the existence of a population of SFPQ protein that is not bound to NONO. It was shown 
before that the loss of one DBHS protein can be compensated by the up-regulation of another one [137], 
however here I did not observe any changes in the expression of DBHS genes upon depletion of SFPQ, 
NONO or PSPC1 (Fig. 29K). Nevertheless, it is possible that after down-regulation of SFPQ, PSPC1 or 
NONO, the two remaining DBHS proteins form complexes with different stoichiometry and functions, 
which could explain the low overlap in the transcriptional profile of SFPQ knock-down and NONO-/- 
hESCs. By co-immunoprecipitation, I observed an enrichment of splicing proteins, which was expected 
given that SFPQ was originally identified in a splicing complex [290]. To my surprise, however, I identified 
many proteins of the polyadenylation machinery that interact with SFPQ (Fig. 34F), which could represent 
another function of SFPQ that has been much less characterized. One hint that SPFQ promotes 
polyadenylation was provided recently by tethering SFPQ adjacent to a weak polyadenylation signal in the 
3`UTR of the COX-2 transcript, which was then polyadenylated [291], however, the mechanistic details are 
lacking. The pull-down of almost every member of the canonical polyadenylation machinery suggests that 
SFPQ regulates the polyadenylation globally or of a subset of genes. Interestingly, next to being enriched 
at the 5`and 3`splice sites, SFPQ seems to be bound to the 3`termination sites [292], [293], a fact that was 
neglected so far by the authors of these studies.  It would be interesting to analyze changes in the 
polyadenylation profile upon SFPQ depletion and to integrate this data with SFPQ iCLIP data to analyze 
which genes might be polyadenylation targets of SFPQ. To summarize, SFPQ is an essential gene for the 
survival of human ESCs and might act via modulating the polyadenylation and 3`end processing of genes 
crucial for cell survival. 
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4.9.2 NONO maintains pluripotency by regulating the expression of cholesterol synthesis enzymes 
NONO is a strong binding partner of SFPQ (Fig. 34D), however, the gene expression profile upon NONO 
depletion is quite different compared to differentially expressed genes after SFPQ down-regulation (Fig. 
34B). In contrast to SFPQ, the knock-out of NONO affects the pluripotency state of hESCs, indicated by the 
up-regulation of lineage specification markers PAX6, T, MIXL1, SOX17 and FOXA2 (Fig. 29M). This is 
evidence that NONO is required for pluripotency maintenance of hESCs by inhibition of differentiation-
inducing genes. Strikingly, an opposite phenotype was observed in mouse ESCs, which are more naïve and 
less likely to differentiate after the knock-out of Nono [222]. Here, I did not observe any changes in the 
neuronal differentiation of NONO-depleted hESCs (Fig. 30E, F) which was shown to be compromised in 
the mouse [222]. This suggests that similar to paraspeckles, deletion of NONO has the opposite outcome in 
human compared to mouse ESCs. Reasons for that could be the inherent differences between mouse and 
human ESCs [26], as discussed above, or that NONO has different species-specific binding partners and 
genomic binding preferences. On the other hand, naïve NONO-/- hESCs, which should be more similar to 
mouse ESCs, did not recapitulate the phenotype of mESCs (Fig. 33E) suggesting that differences in the 
developmental state of human and mouse ESCs cannot explain the reverse phenotype.  
A human-specific function of NONO could be its regulation of cholesterol synthesis genes in hESCs 
(Fig. 30B, C) and in cancer cell lines (Archa Fox; personal communication). Strikingly, all enzymes that are 
required for the cholesterol synthesis are down-regulated by approximately 2-fold suggesting that NONO-
depleted hESCs produce less cholesterol compared to wildtype. Metabolic analysis of NONO-/- hESCs is 
currently being performed to analyze changes in the cholesterol derivatives. Cholesterol is a main 
component of the cell wall [294] and a precursor for steroid hormones such as testosterone, estrogen and 
corticoids [295]. It was shown recently that these hormones are required for mesoderm specification of 
mESCs [296] and that cholesterol depletion resulted in neuronal cell death in the mouse cerebellum [297]. 
In humans, not much is known about the function of cholesterol in stem cell maintenance and 
differentiation. Moussaieff et al. reported that a biochemical inhibition of cholesterol-induced a small 
increase in pluripotency gene expression in differentiating hESCs [221]. This suggests that the phenotype 
of NONO-depleted hESCs is unrelated to the down-regulation of the cholesterol pathway. Nevertheless, 
the reduced expression of cholesterol could be masked by the stem cell maintenance medium that contains 
an excess of small metabolites such as sodium pyruvate, which is converted to acetyl-CoA, the starting 
molecule for the cholesterol synthesis [298]. It remains unknown whether the down-regulation of 
cholesterol synthesis is responsible for changes in the pluripotency characteristics of NONO-/- hESCs.  
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Finally, others have shown that NONO is required for the stability of NEAT1_2 and that down-regulation 
of NONO led to the complete absence of paraspeckles [85]. Here, I showed that differentiated NONO-/-
hESCs exhibited down-regulation of paraspeckles by ~70% concomitant with their disintegration to 
microspeckles (Fig. 35B). It is possible that increased expression of differentiation-associated gene in 
differentiated NONO-/- hESCs (Fig. 30D) is in part due to the down-regulation of NEAT1_2, which in turn 
increased differentiation, mostly by down-regulation of pluripotency genes, but also by up-regulation of 
differentiation genes FOXA2 and PAX6. Moreover, the phenotype of Nono and paraspeckle knock-out ESCs 
in mouse is similar [47], [222], which in all suggests that paraspeckles are a downstream mediator of NONO 
function and responsible for differences in phenotypic outcome. Given that paraspeckles itself are complex 
structures of 40 or more proteins, it is likely that their composition and possibly genomic binding 
preferences are quite different in mouse and human cells, which could explain the contrary phenotype 
observed in both species. It would be interesting to analyze whether other essential paraspeckle proteins 
such as RBM14, EWSR1, HNRNPK or DAZAP1 [81] exhibit phenotypic differences in mouse and human 
ESC differentiation.  
In conclusion, NONO regulates expression of cholesterol synthesis genes in hESCs, which might 
be the cause for the developmental phenotype observed in NONO-/- hESCs. Both NONO and paraspeckles 
exhibit a complementary phenotype in mouse and human ESCs which indicates that paraspeckles are in 
part responsible for conveying NONO gene-regulatory functions.  
  
4.9.3 The function of PSPC1 in PSCs and during adipogenesis 
The third member of the human DBHS protein family is PSPC1, which in contrast to SPFQ and NONO, is 
dispensable for paraspeckle formation [191]. A screen for pluripotency and differentiation genes revealed 
the down-regulation of pluripotency genes OCT4, SOX2 and NANOG by ~50-60%, concomitant with minor 
up-regulation of lineages-specifying markers in PSPC1-/- hESCs (Fig. 29L, M). Similarly, it was reported 
that the expression of many genes involved in developmental processes was changed in murine PSPC1-/- 
ESCs [299]. Interestingly, these genes are mostly enriched in markers of the 2-cell-like totipotent stage, 
including MERVL, a family member of endogenous retroviruses (ERV), which PSPC1 regulates together 
with the epigenetic DNA-modifying protein TET2. It is not known whether PSPC1 takes on a similar role 
in human ESCs. PSPC1-/- hESCs exhibited increased expression of naïve genes and less primed surface 
markers during the conversion towards naïve cells (Fig. 33) indicating that PSPC1 is required for the naïve-
to-primed conversion that happens during the development of the blastocyst to the epiblast stage embryo 
[300]. Whether this transition is also mediated by interaction with TET2 remains to be analyzed. While the 
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differentiation characteristics of PSPC1-/- hESCs remain largely intact upon initial germ layer commitment 
(Fig. 32), I observed impaired MSC and adipocyte differentiation (Fig. 31), which is in line with recent 
findings that demonstrated the importance of PSPC1 during murine adipogenesis [223]. However, while 
this publication reported down-regulation of master adipocyte regulators Pparg, aP2 (Fabp4) and 
Adiponectin, PSPC1-/- human adipocytes were mostly similar in their gene expression profile to the parental 
cell line except for the down-regulation of the fatty-acid chaperone FABP4. Besides NEAT1_2 and NONO, 
this is the third paraspeckle component whose function diverges to some extent compared to the mouse 
orthologue. In summary, PSPC1 represents another paraspeckle protein that influences human stem cell 
differentiation, mainly towards adipocytes.  
 
4.10 Conclusion and outlook 
Paraspeckles are complex structures that have attracted a lot of interest over the last years because they 
represent phase-separated, dynamic granules that are up-regulated when cells or the organism are 
subjected to developmental changes or stress. Germ layer differentiation is accompanied by paraspeckle 
formation which raised the question about their function in this process. A thorough dissection of ESCs 
that exhibited down-regulation or complete absence of NEAT1 isoforms or the paraspeckle core protein 
components revealed that NEAT1_2, NONO and PSPC1 generally are required for coordinated exit from 
pluripotency whereas NEAT1_1 and SPFQ do not change the gene expression of pluripotency and 
differentiation genes (table 1). Strikingly, the phenotype of NEAT1_2, NONO and PSPC1 is different 
compared to the mouse orthologues, which raises the question whether this is due to the in vitro model of 
development or whether these paraspeckle components truly exhibit human-specific functions. A more 
humanized model of development, which are currently being developed [301] is needed to address this 
question. Given that deletion of paraspeckle components can be compensated by prolonged differentiation 
and that mature cell types did not depict an overt phenotype, it is likely that paraspeckles are not essential 
for human development but might be needed when the organism is challenged by external stress such as 
pathogen infection.  
Paraspeckles represent membraneless organelles that can exchange their content with the 
environment in a dynamic manner [81]. Principles of granule formation are objective of many studies since 
certain membraneless aggregates were hypothesized to drive the pathogenesis of neurodegenerative 
diseases and cancer [302]. These studies focused mostly on the contribution of proteins [76] and RNAs [267] 
that are sought to come together by phase separation. Here, I showed that small DNA binding molecules 
disintegrate paraspeckles and other DNA-bound granules, which puts emphasis on a previously neglected 
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molecule for the formation of granules. DNA likely provides a scaffold for the aggregation of paraspeckles, 
which bind directly via triple helix formation of NEAT1 with the double-strand DNA [111], [303]. It is 
interesting now to analyze this phenomenon in the context of tumor treatment, which is mostly achieved 
by administration of a chemotherapeutic cocktail containing the same or similar DNA binding molecules 
that have been shown here to disintegrate paraspeckles. It is possible that the disintegration of chromatin-
bound lncRNAs is the first event that leads to subsequent cell death. 
PSCs represent a powerful tool to investigate developmental processes or molecular mechanisms 
of diseases. In this study, I have generated human pluripotent cell lines that exhibited deletions in many 
functional parts of NEAT1 or paraspeckle core proteins. While the exit from pluripotency and germ layer 
differentiation was analyzed in detail in those cells, due to the versatility of PSCs, it is possible now to study 
paraspeckles and their components in any cell type-of-interest, which represents a valuable asset for the 
paraspeckle community. In all, this study represents a comprehensive analysis of lncRNA trajectories 
during germ layer differentiation with focus on paraspeckles where I demonstrated novel mechanisms of 
formation, function and principles of their regulation in human PSCs, mature cell types and upon 
reprogramming. 
 
Table 1: Effect of paraspeckle components on hESC maintenance and differentiation. 
Paraspeckle components Pluripotency genes in KOs Differentiation genes in KOs 
NEAT1_1 Up-regulated  Up-regulated 
NEAT1_2 Down-regulated  PAX6 up-regulated 
SFPQ Unchanged  Unchanged  
PSPC1 Down-regulated  Up-regulated 
NONO Unchanged Up-regulated 
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6. Appendix 
6.1 Supplementary Table 1. Chemicals, reagents and solutions routinely used in this study. 
Reagent cat. # Supplier 
16% Formaldehyde (w/v), Methanol-free  10321714 Thermo Fisher Scientific 
2-Mercaptoethanol M3148 Sigma 
Albumin from bovine serum (BSA) A9647-10G Sigma 
Ampicillin sodium salt A-166 Sigma 
Ammonium sulfate solution (3.2M) sc-291897 Santa Cruz 
Biozym LE Agarose 840004 Biozym 
Boric acid, electrophoresis grade 15166.02 Serva Electrophoresis 
DNA Gel loading dye, 6x R0611 Thermo Fisher Scientific 
Dynabeads(R) Protein A for Immunoprecipitation 10001D Life Technologies 
EDTA Dinatriumsalz Dihydrat >99% X986.1 Carl Roth 
Ethanol, 99.8% 9065.2 Carl Roth 
Deionized Formamide 4610 Merck Millipore 
Ultra pure glycerol 15514011 Thermo Fisher Scientific 
Glycine 23391.02 Serva Electrophoresis 
HEPES, 1M Buffer Solution  15630122 Life Technologies 
Isopropanol 6752.2 Carl Roth 
Lithium chloride (LiCl) 62480-500G-F Sigma 
Lithium Acetate dihydrate, 98% 15157442 Thermo Fisher Scientific 
Methanol 45631.02 Serva Electrophoresis 
Magenesium  chloride (MgCl2) KK36 Carl Roth 
Na-deoxycholate D6750-10G Sigma 
NaHCO3 S5761 Sigma 
Tergitol type NP-40 70% solution NP40S Sigma 
Nuclease-free water (H2O) AM9932 Life Technologies 
Powder Milk, blotting grade T145.1 Carl Roth 
Protease Inhibitor Cocktail Set III, EDTA-Free 539134 Merk Millipore 
SDS Solution, 20 % 20768.02 Serva Electrophoresis 
Sodium Chloride (NaCl) P029.2 Carl Roth 
Sodium Citrate S4641 Sigma 
SYBR® Safe DNA Gel Stain 5001208 Life Technologies 
TE buffer, pH 7.4, RNAse free 93302 Sigma 
TRIS PUFFERAN® 5429.3 Carl Roth 
Triton™ X-100 X100-500ML Sigma-Aldrich 
Tween(R)-20 P9416 Sigma-Aldrich 
 
6.2 Supplementary Table 2. Kits routinely used in this study. 
Kit cat. # Supplier 
GeneJET Plasmid Miniprep Kit K0502 Fermentas 
P3 Primary Cell 4D-Nucleofector® X Kit  V4XP-3024 Lonza 
PureLink HiPure Plasmid Filter Maxiprep Kit K210017 Life Technologies 
QIAprep Spin Miniprep Kit 27104 Qiagen 
QIAquick PCR Purification Kit  28104 Qiagen 
QIAquick Gel Extraction Kit 28704 Qiagen 
RNeasy MinElute cleanup kit 74204 Qiagen 
RNeasy Mini Kit 4104 Qiagen 
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6.3 Supplementary Table 3: List of primary antibodies. 
Targeted protein company Clone  Catalogue number 
SFPQ Thermo Fisher Scientific B92 MA1-25325 
NONO Abcam polyclonal ab70335 
PSPC1 Thermo Fisher Scientific 1L4 SAB4200503 
OCT4 CST C30A3 2840 
NANOG CST D73G4 4903 
SOX2 CST D6D9 3579 
TRA1-60 Abcam 2A6 ab16288 
SSEA5 Hybridoma supernatant 8.00E+11 --- 
FOXG1 Abcam polyclonal ab18259 
PAX6 Biolegend polyclonal 901301 
CD24-PE Miltenyi 32D12 130-095-953 
CD73-PE BD Biosciences AD2 550257 
CD90-PC5 Beckman Coulter Thy-1/310 IM3703 
CXCR4-PE LifeTechnologies S3.5 MHCXCR404 
CD117-APC LifeTechnologies 104D2 CD11705 
EPCAM-APC LifeTechnologies G8.8 17-5791-82 
SIX2 Santa Cruz H-4 sc-377193 
PAX2 Santa Cruz G-3 sc-377181 
CDH5 Santa Cruz F-8 sc-9989 
WT1 Santa Cruz H-1 sc-393498 
SOX1 R&D Systems polyclonal AF3369 
NESTIN R&D Systems polyclonal MAB1259 
PAX6  Merck Millipore polyclonal ab2237 
HNF4A Sigma Aldrich 3C6 SAB1412164 
ALB Abcam polyclonal ab106582 
AFP Sigma Aldrich 1G7 WH0000174M1 
GFAP CST D1F4Q 12389 
SOX9 CST D8G8H 82630 
MNX1 Merck Millipore polyclonal ABN174 
TUBB3 CST D71G9 5558 
CHAT Abcam polyclonal Ab18736 
NFH CST RMdO 20 2836 
ISL1 Abcam polyclonal Ab20670 
MAP2 Sigma Aldrich HM-2 M4403 
TBR1 Abcam polyclonal ab31940 
VIM Santa Cruz Biotechnology V-9 sc-6260 
HSP47 Santa Cruz Biotechnology G-12 sc-5293 
KRT14 Santa Cruz Biotechnology LL001 sc-53253 
IVL Santa Cruz Biotechnology A-5 sc-398952 
CAS9 CST 7A9-3A3 14697 
Phospho RNA-PolymeraseII (S2) Bethyl Laboratories polyclonal A304-407A 
Phospho H2A.X (Ser139) CST 20E3 9718 
IgG rabbit GeneTex polyclonal GTX35035 
IgG1 kappa mouse eBioscience P3.6.2.8.1 14-4714-82 
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6.4 Supplementary Table 4: Sequences of custom-designed smFISH oligonucleotides. 
Mouse NEAT1 5`end Human NEAT1 5`end 
cttctggaagctgaaagggt caagttgaagattagccctc 
tccagacaactaggccaaag agcccttggtctggaaaaaa 
aggtatccgtatcatgatgt aagttcagttccacaagacc 
caacagtcacactgttgtct caggccgagcgaaaattaca 
tctgtttgccaagagatctg ctgtcaaacatgctaggtgc 
ggtggacatgtcttttcatg aagcgttggtcaatgttgtc 
cttacacagtgtctttctgg gtggagtgagctcacaagaa 
acccttcttatacacaggaa cttaccagatgaccaggtaa 
tggctagaaaccctacaagg ttaccaacaataccgactcc 
aacatacccaccagagacaa cggtccatgaagcatttttg 
aggagagatgcatgggagat tcgccatgaggaacactata 
acaaaagcagctcctcagat atctgcaggcatcaattgag 
taattattgtcctctgcgtc agcaaggcctggaaacagaa 
tagccttcaaactacctgta catctgctgtggacttttta 
acacagaagacagttaccgc ttcatgggctctggaacaag 
caagacagtgtgtgatcctt gatgcagcatctgaaaacct 
ttacagctcagtgttaaggc aaactagtatgaccggaggc 
gttaactcagcatcttgtct ttgaagcaaggttccaagca 
ctctaaggaaacatccctgt tgttctacagcttagggatc 
tgaaaccatcagtgtgacgc tacaaggcatcaatctgcgt 
tatcctgacattcaggtagg caaacaggtgggtaggtgag 
agacctcttaatcagctcta cttctccgagaaacgcacaa 
atagctgtgtactctgtagg ccaagttatttcatcaggct 
agactggatgtcttcagagt tctaatatatccccagtcta 
aagggcagaagcagagcaag cacaacacaatgacaccctt 
cattcttctgtagttacctc caaactagacctgccatttc 
gtgatttctattctcactcc ctcctagtaatctgcaatgc 
aacgccattcaaacctttca aaagagcactaccggtgtac 
ccttcaaccaacaaccacaa tcctcttactagaatgccaa 
tctcagtgttagtagctagg ctaagcaacttctcacttcc 
 
taacacttcttcagtcttcc 
 cctttggttctcggaaaact 
 tgtgagatggcatcacacac 
 ccaggaggaagctggtaaag 
 ctctgaaacaggctgtcttg 
 tcacttgataacacccacac 
 cagcgaaggatgctgatctg 
 atcaaccacctaagttgcta 
 gtggtcccttaaatacgtta 
 agaagagcccatctaatctc 
 gatgtgtttctaaggcacga 
 ggtcttgttttccaaactga 
 catgtagtaaaggcacctcg 
 ccattggtattactttacca 
 ctctaaatcccaacgacagt 
 atttcacaacagcatacccg 
 ccagtactttcaaccatcta 
 agttcttaccatacagagca 
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6.5 Supplementary Table 5: List of primers used for RT-qPCR. 
Name Primer sequence Name Primer sequence 
GAPDH_Fwd GCTCATTTCCTGGTATGACAACG AFP_Fwd GCTTACACAAAGAAAGCCC 
GAPDH_Rev GAGATTCAGTGTGGTGGGGG AFP_Rev TAATAATGTCAGCCGCTCC 
OCT4_Fwd CAATTTGCCAAGCTCCTGAAG HNF4A_Fwd TACTCCTGCAGATTTAGCCG 
OCT4_Rev AAAGCGGCAGATGGTCGTT HNF4A_Rev GCATTTCTTGAGCCTGCAG 
NANOG_Fwd CCTTCCTCCATGGATCTGCTT ALB_Fwd GCCAAGACATATGAAACCAC 
NANOG_Rev CTTGACCGGGACCTTGTCTTC ALB_Rev TTCATCGAACACTTTGGCA 
SOX2_Fwd CCTCCGGGACATGATCAGCATGTA ASGR1_Fwd ACGTTCAGCAACTTCACAG 
SOX2_Rev GCAGTGTGCCGTTAATGGCCGTG ASGR1_Rev TTTCTTCCCACATTGCCTC 
T_Fwd CAACCTCACTGACGGTGAAAAA CYP3A4_Fwd TTGTCCTACCATAAGGGCT 
T_Rev ACAAATTCTGGTGTGCCAAAGTT CYP3A4_Rev GATCTGTGATAGCCAGCAC 
MESP1_Fwd CTGCCTGAGGAGCCCAAGT DHCR7_Fwd CTCATCAACCTGTCCTTCG 
MESP1_Rev GCAGTCTGCCAAGGAACCA DHCR7_Rev CAATCACGTAGATGGCCTG 
MIXL1_Fwd CCGAGTCCAGGATCCAGGTA MVK_Fwd GTACATGGCAAGGTAGCAC 
MIXL1_Rev CTCTGACGCCGAGACTTGG MVK_Rev CACTTTCCCATTGCTGTGG 
FZD4_Fwd TACAACGTGACCAAGATGC MSMO1_Fwd CTGCATAGACTCTTACACCAC 
FZD4_Rev AAAGGAAGAACTGCAGCTG MSMO1_Rev CCATTCCAAATGGAGCCTG 
TWIST_Fwd GAGCTGGACTCCAAGATGG MVD_Fwd TGCTCATCCTTGTGGTGAG 
TWIST_Rev TTAAGAAATCTAGGTCTCCGGC MVD_Rev TGTCCTTCATGGTCAGCTG 
SLUG_Fwd CACATTAGAACTCACACGGG SQLE_Fwd CTTAGAAGCCACTGACAATTCTC 
SLUG_Rev  CAAATGCTCTGTTGCAGTG SQLE_Rev GAAGAACACCTCGTTTCTTCAC 
SNAIL_Fwd TCTTTCCTCGTCAGGAAGC DHCR24_Fwd GTGAAACACTTTGAAGCCAG 
SNAIL_Rev AGGTAAACTCTGGATTAGAGTCC DHCR24_Rev ATACAGCATCTGGAAGCCA 
PPARG_Fwd TTCCATTCACAAGAACAGATCC EBP_Fwd TACGAAGACCTGCTTGGAG 
PPARG_Rev CTTTGATTGCACTTTGGTACTC EBP_Rev TTGTCACCCAGGATGTATCG 
GATA6_Fwd GACTTGCTCTGGTAATAGCA SCAP_Fwd ATCTTAGCCTGCTGCTACC 
GATA6_Rev CTGTAGGTTGTGTTGTGGG SCAP_Rev CTTGTTTGCGGTCAGAGTC 
SIM2_Fwd CTTATCCCAGGTGGAGCTC PCSK9_Fwd AAGTGTGACAGTCATGGCA 
SIM2_Rev CGAAGAAAGAACGACCTCTC PCSK9_Rev AAACTCCAGGCCTATGAGG 
FOXP1_Fwd TGCTCAAGGCATGATTCCA CYP51A1_Fwd TACTAGATGCTACATACAAGGATGG 
FOXP1_Rev CCTGTGGTTTCTTCTGCAG CYP51A1_Rev CTGCCAAGAGTAATCCAATAAGC 
SOX11_Fwd ACGCAGGAAGATCATGGAG INSIG1_Fwd CACGCCAGTGCTAAATTGG 
SOX11_Rev CAGCCTCTTGGAGATCTCG INSIG1_Rev CAAATGTCCACCAAAGGCC 
CXCR4_Fwd GAGCCCTCAGATTTGACCTGTC HMGCR_Fwd GGGAATTGTCACTTATGGCAG 
CXCR4_Rev CACCGCATCTGGAGAACCA HMGCR_Rev AATTGATCTTCGACCTGTTGTG 
SOX17_Fwd GCCCATTTCCTCGGTGTAGTT HMGCS1_Fwd CTAGCACAGTACTCACCTCAG 
SOX17_Rev GGCGCAGCAGAATCCAGA HMGCS1_Rev GAGAGTACAGAGTGGCAGC 
FOXA2_Fwd CCACGACTTGCCCAGCAT NPC2_Fwd CCTTCACCAGCAATATTCAGTC 
FOXA2_Rev GGGAGCGGTGAAGATGGA NPC2_Rev AATGGGAAAGGGAACTGGG 
NKX2.1_Fwd CTTCCCCGCCATCTCCCGCTTC FDPS_Fwd GGTAGTAGCATTCCGGGAG 
NKX2.1_Rev GCCGACAGGTACTTCTGTTGCTTG FDPS_Rev GGAAGAAAGCTTGCAGCAG 
PAX6_Fwd GCGGAGTTATGATACCTACACC PMVK_Fwd AGTATGCTCAGGAGCATGG 
PAX6_Rev GAAATGAGTCCTGTTGAAGTGG PMVK_Rev GATCATGTCCTTCCGAAAGG 
SOX1_Fwd GAGAACCCCAAGATGCACAA LSS_Fwd TCTTCACAAGAAAGGTGGTG 
SOX1_Rev CCTCGGACATGACCTTCCA LSS_Rev TCCCAGCTGTAAACATTCAG 
ASCL1_Fwd TTCACCAACTGGTTCTGAG FDFT1_Fwd AAACAAACATCATCCGTGAC 
ASCL1_Rev TAAAGATGCAGGTTGTGCG FDFT1_Rev CATACCTGCTCCAAACCTC 
FOXG1_Fwd GCTGGACATGGGAGATAGG TUBB3_Fwd TCAGCGTCTACTACAACGAGGC 
FOXG1_Rev GTTGATGCTGAACGAGGAC TUBB3_Rev GCCTGAAGAGATGTCCAAAGGC 
PVT1_Fwd GGATTTCCTTGCGGAAAGG MNX1_Fwd TCATGCTCACCGAGACCCA 
PVT1_Rev GACAGCTATGGTCTGGAGG MNX1_Rev TGGGTCACAAGTGCAAAGGTA 
KCNQ1OT1_Fwd CTTAAACAGCAACCTACACCA CHAT_Fwd CGTAGGCACCTGTAGCTGTTT 
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KCNQ1OT1_Rev CATTCATCCATTCTACCACCT CHAT_Rev AAAGAGGGTCTATCCTGGGCT 
PINT_Fwd CAGAATAAACCACTGAACAGGA S100B_Fwd GAAGAAATCCGAACTGAAGGAGC 
PINT_Rev AAGAGGTAGCTCATCTGCG S100B_Rev TCCTGGAAGTCACATTCGCCGT 
MALAT1_Fwd TCATCAGTAGTAAGAATCTCAGGG SLC1A2_Fwd CAGCTTAATCACAGGGTTGTC 
MALAT1_Rev GATTATATGTCATACCTCCATTGGG SLC1A2_Rev GACATGTAATACACCATGGCTC 
TERC_Fwd TTTCTCGCTGACTTTCAGC SLC1A3_Fwd CTGTCATTGTGGGTACAATCC 
TERC_Rev CTAGAATGAACGGTGGAAGG SLC1A3_Rev GAAAGGAGAAGTACTTGACTTCC 
MEG3_Fwd CATCTACACCTCACGAGGG TBR1_Fwd ATGGGCAGATGGTGGTTTTA 
MEG3_Rev ATCCTTTGCCATCCTGGTC TBR1_Rev GACGGCGATGAACTGAGTCT 
LINC00472_Fwd TTTCTCGACTCGTCGTCAG TBR2_Fwd CACCGCCACCAAACTGAGAT 
LINC00472_Rev GGAGTACCTGAAATCCGCA TBR2_Rev CGAACACATTGTAGTGGGCAG 
TUG1_Fwd GAAGACCTGAGTTTCTGTCCA NEAT1_Fwd GTGGCTGTTGGAGTCGGTAT 
TUG1_Rev CAAGGAGTCTGCTATCATAATTCAC NEAT1_Rev TAACAAACCACGGTCCATGA 
KLRA1P_Fwd AGAATTTCCTGCCGTTGATGT NEAT1_2_Fwd GTCTTTCCATCCACTCACGTCTATTT 
KLRA1P_Rev CTGATGATAGTCACAGTGTTGGT NEAT1_2_Rev GTACTCTGTGATGGGGTAGTCAGTCAG 
PINCR_Fwd ATGAGGAAAGCTCCTATTCCA DCX_Fwd GCCAGGGAGAACAAGGACTTT 
PINCR_Rev ATCTCCTAGGTATACTTCAAGGAC DCX_Rev CACCCCACTGCGGATGA 
MANTIS_Fwd AACTCCTGCTCCAAACTCACTC SOX9_Fwd AGGAAGCTCGCGGACCAGTAC 
MANTIS_Rev CCAGAGACTTTCCATTCTGATG SOX9_Rev GGTGGTCCTTCTTGTGCTGCAC 
LncPRESS1_Fwd CAGTAATTCTCCAGCAACAG ALDH_Fwd CAGAGGCCATTCACAACTG 
LncPRESS1_Rev TGGCAGGTAATCATCTCATAT ALDH_Rev ATGTCAGTTTCTGTTCACAGG 
HAND2-AS_Fwd CTAGCCTGTTTGAAGGCAC OTX2_Fwd CCAGACATCTTCATGCGAG 
HAND2-AS_Rev CTGCGAAAGTGAAGATCCC OTX2_Rev TCGATTCTTAAACCATACCTGC 
HOTAIR_Fwd ATCAGAAAGGTCCTGCTCC OLIG2_Fwd ATGCACGACCTCAACATCGCCA 
HOTAIR_Rev GTCTGTAACTCTGGGCTCC OLIG2_Rev ACCAGTCGCTTCATCTCCTCCA 
RMRP_Fwd CTGAGGACTCTGTTCCTCC NODAL_Fwd GCATACATCCAGAGTCTGCT 
RMRP_Rev ATGTCTACGTGCGTATGCA NODAL_Rev CACATACAGCATGCTCAGC 
PANDA_Fwd TCTCAAACCTCGACCTCAG GDF3_Fwd GAGACTTATGCTACGTAAAGGA 
PANDA_Rev CTGTAATCTCAGCACTTTGGG GDF3_Rev GGTAAAGAAAGAAACCTTGGTC 
H19_Fwd CTTGGAAATGAATATGCTGCAC NOG_Fwd AGCACTATCTCCACATCCG 
H19_Rev TTCCTCTAGCTTCACCTTCC NOG_Rev GATAGGGTCTGGGTGTTCG 
TARID_Fwd GCAACAACTAGATGCTGCT BMP4_Fwd CCACCACGAAGAACATCTG 
TARID_Rev TATTGCACTTCTGTGCTTCAG BMP4_Rev ATGCTGCTGAGGTTAAAGAG 
SLERT_Fwd TTAGTCAGCTCAGGCCCAGT SFPQ_Fwd CACATGAAGTGGATAGATACTTCTC 
SLERT_Rev AAGTGCTCCACCAACTCCAG SFPQ_Rev GTTGTCAGTCTGCTTGTGG 
FIRRE_Fwd AGTAGAAATGGGAAGACTTGG NONO_Fwd TGAGATGGAGAAGCAGCAG 
FIRRE_Rev CTTAGTGATCCATGCCCTC NONO_Rev CTCATCAAATCCTGTCTCATTAGC 
ANRASSF1_Fwd GGCAATTAGAACGCTCCTTG PSPC1_Fwd TCATCCGCTTGGAATCCAG 
ANRASSF1_Rev CTGTGCTAGGCGATAGAGATCC PSPC1_Rev CGTAGAGGTCTGCTCTTGAG 
PARTICLE_Fwd GGCTCAGTGGGAAACAAAGG KLF4_Fwd GGGAGAAGACACTGCGTCA 
PARTICLE_Rev ATGTGGTCACTGAGTCTGGG KLF4_Rev GGAAGCACTGGGGGAAGT 
APTR_Fwd AATTGCCGGGAATCAAGTC KLF2_Fwd CATCTGAAGGCGCATCTG 
APTR_Rev TACCTGGTGAAGCCTTGTC KLF2_Rev CGTGTGCTTTCGGTAGTGG 
CER_Fwd CAGGACAGTGCCCTTCAGCCA DNMT3L_Fwd TTCTGGATGTTCGTGGACAA 
CER_Rev ACAGTGAGAGCAGGAGGTATGG DNMT3L_Rev ACATCTGGGATGGTGACTGG 
EOMES_Fwd ACAGGAGATTTCATTCGGG LBP9_Fwd GCTCTTCAACGCCATCAAA 
EOMES_Rev TTGTAAGACTATCATCTGGGTG LBP9_Rev CAGGGGCACTCGATTCTG 
NKX2-5_Fwd TAAACCTGGAACAGCAGCA PAX2_Fwd CTCTGCTCTTTGTCCAGCCTC 
NKX2-5_Rev TAGGCACGTGGATAGAAGG PAX2_Rev CCTCACAGGTTCCCTTTCTCT 
ISL1_Fwd CAGTATTTGGACGAGAGCTG SIX2_Fwd GCACAACCCCTACCCTTCAC 
ISL1_Rev CCCGTACAACCTGATATAATCTC SIX2_Rev AGGTCTACTTACTCGTACCTTTCC 
TBX6_Fwd CGTGTGAAGAGGAAACTGCG PAX8_Fwd AAGGTGGTGGAGAAGATTGGG 
TBX6_Rev GACTACACTCACCTCCGCTC PAX8_Rev AGGCTGCTTTCTCTCTTACCTA 
LHX1_Fwd CCTCGCTCTCTGTAAGCCACT WTI_Fwd GGAATAGTGCGTGGCTATCTT 
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LHX1_Rev CCTCCCCTTGATTTACTCCCAG WTI_Rev AAACAGTAGGGACCTGGCTT 
SALL1_Fwd TTGCTCTCTCTGCACCATACC OSR1_Fwd CCTCTGGCCTCACCATCTTTC 
SALL1_Rev TCTCCCCCGTCAACCATGT OSR1_Rev TTTCCTGAACCCATGCTCCAA 
HOXD11_Fwd TTCCTGGGCCGTTGTAAAGT NNAT_Fwd TGCTGCATTTACTGGGTAGGA 
HOXD11_Rev ACTGGGAAAAGGCTCTCGAC NNAT1_Rev CACCGTGTATGCCAGCTTC 
GSC_Fwd GAGGAGAAAGTGGAGGTCTG   
GSC_Rev CTCCGACTCCTCTGATGAG   
 
6.6 Supplementary Table 6: Guide RNA sequences and genomic location. 
gRNA name gRNA sequence Genomic position (Hg19) 
NONO-/- _up AGGGGAGAAAATGCGCGCGT ChrX: 70503075 
NONO-/- _down GACCGCCGGAAACGAGACGA ChrX: 70503477 
PSPC1-/-_up TGCGTGTACGTCTTCTCGCC Chr13: 20356659 
PSPC1-/-_down AGTGTCAGGCGCCCGCGCGA Chr13: 20356503 
SFPQ-/- _up CTGTGGTCAAGGGGCGGTCG Chr1: 35658652 
SFPQ-/- _down CGAGGAGAAGATCTCGGACT Chr1: 35657824 
NEAT1∆1150_up CGAAAGTCACGCGCGCCTCC Chr11: 65189762 
NEAT1_∆1150_down CCAGACCTGGACGCTCCACC Chr11: 65190905 
NEAT1∆2700_up ACATTTCGCCTGCGTCTGTG Chr11: 65188930 
NEAT1∆2700_down CTGCAGGCATCAATTGAGGC Chr11: 65191548 
NEAT1-/-_up GGGGCGGCGCTTTAGAGTTG Chr11: 65186374 
NEAT1-/-_down CTTTGGGGAATTTAGTGCGT Chr11: 65192559 
NEAT1∆TH_up TCCCTTGTAAAGGCATAGCC Chr11: 65212842 
NEAT1∆TH_down CTGCTCACTCTTTCACAGAT Chr11: 65212999 
NEAT1∆pA_up ATGCAAACAATTACTGTCGT Chr11: 65193724 
NEAT1∆pA _down TGTTGAGAGTTGGTAATCAT Chr11: 65194218 
NEAT1YFP_cut GGTCCAGCCGGAGTTAGCGA Chr11: 65190160 
NEAT1STOP_cut CATCTGAAAACCTTTACCCC Chr11: 65191779 
NEAT1 gRNA#1 (SunTag) ATACACTGGGGTCCTTGCGT Chr11: 65190090 
NEAT1 gRNA#2 (SunTag) CTGGGAGACCATGCACCGCC Chr11: 65190119 
NEAT1 gRNA#3 (SunTag) AGAGACTCCCGGGCGGTGCA Chr11: 65190130 
NEAT1 gRNA#4 (SunTag) GCACCGCCCGGGAGTCTCTC Chr11: 65190131 
NEAT1 gRNA#5 (SunTag) TTTGGGAGGCGAATGCCATG Chr11: 65190015 
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6.7 Supplementary Table 7: Sequence and genomic location of primers used for screening of genomic 
deletion. 
PCR primer name Primer sequence Genomic position (Hg19) 
NONO-/-_det_F CCAGCAACAGGAGAAGCATC ChrX: 70502876 
NONO-/-_det_R GCCTCTTCCTTCGCTGATTG ChrX: 70503648 
PSPC1-/-_det_F CAGTGATACGTCTGGTCCGA Chr13: 20356050 
PSPC1-/-_det_R GCAAGTGCGCATTGAGAAAA Chr13: 20356876 
SFPQ-/-_det_F GCCTGCGCTTTTATGGAACTT Chr1: 35657477 
SFPQ-/-_det_R AGGAATGATCAGAGGTTCGCA Chr1: 35658880 
NEAT1∆1150_det_F CAGGAGTTCACCAGGTTTGC Chr11: 65189212 
NEAT1∆1150_det_R AATACCGACTCCAACAGCCA Chr11: 65191265 
NEAT1∆2700_det_F GAATCTTCCCCTGGCAGAGAAACAG Chr11: 65188748 
NEAT1∆2700_det_R CTGCTGGCATTCATGGGCTCTGGAAC Chr11: 65191848 
NEAT1-/-_det_F ACCAGCCCACATTAGGTCAA Chr11: 65185808 
NEAT1-/-_det_R CCCACACCCCAAACAAAACA Chr11: 65192890 
NEAT1∆TH_det_F CTCGTGAAGGCAGAGGGAG Chr11: 65212646 
NEAT1∆TH _det_R CCCAATGCTACCCCTCTAGG Chr11: 65213152 
NEAT1∆pA_det_F TGAGCCAAGACTAGAGGGGA Chr11: 65193434 
NEAT1∆pA_det_R CCTTGCTGCTCCCTTTGAAA Chr11: 65194789 
 
6.8 Supplementary Table 8: List of antisense oligonucleotides.  
ASO name ASO sequence Genomic position (Hg19) 
NEAT1_ASO 
 
[mC]*[mC]*[mC]*[mU]*[mC]*T*A*G*T*C*T*T* 
G*G*C*[mU]*[mC]*[mA]*[mU]*[mU] 
Chr11: 65193437 
 
MALAT1_ASO 
 
[mG]*[mG]*[mC]*[mA]*[mT]*A*T*G*C*A*G*A* 
T*A*A*[mT]*[mG]*[mT]*[mT]*[mC] 
Chr11: 65270276 
 
scrambled [mG]*[mT]*[mT]*[mA]*[mG*T*G*A*T*A*C*G* 
A*T*G*[mA]*[mT]*[mA]*[mA]*[mA] 
--- 
Asterix = phosphothioate-modified backbone, mN = 2`O-methoxyribonucleotides 
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7. List of Abbreviations 
ASOs  antisense oligonucleotides 
bp  base pairs 
BSA  bovine serum albumine 
CTD  C-terminal domain 
dsDNA  double-stranded DNA 
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kb:  kilo base pairs 
LncRNA long non-coding RNA 
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XCI  X-chromosome inactivation 
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